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Abstract 
 
This thesis details recent advances in the field of redox neutral organocatalytic aza-Wittig 
chemistry, contributing to ongoing research into the development of novel catalytic processes 
for the synthesis of heterocycles. Work described herein forms the next chapter in continuing 
research into the organocatalytic aza-Wittig reaction first published by the Marsden group in 
2008. Three distinct applications of novel catalytic aza-Wittig chemistry are reported. 
The first chapter reviews recent advances in the field of organocatalytic phosphorous 
reactions, covering both redox-mediated and redox-neutral methodologies. While there has 
been a recent spate of publications detailing a range of phosphine catalysed reactions the 
majority detail a redox mediated system whereby the phosphine oxide waste is reduced in situ 
to the active phosphine species which undergoes traditional reaction conditions, for example 
the Wittig, Staudinger and Appel reactions. Work by the Denton and Marsden group offers an 
alternative strategy employing a system which maintains a phosphorus(V) oxidation state. 
The subsequent results and discussion sections comprises four areas. Firstly, the use of 
hydroxamic acids and hindered ureas as masked isocyanate starting materials was 
investigated. The Lossen rearrangement was found to be a valid alternative to the Curtius 
rearrangement for the in situ formation of isocyanates for the application of the catalytic aza-
Wittig reaction. 1,1-Diisopropyl ureas were found to behave as masked isocyanates which 
produced the isocyanate on heating again proving to be suitable as starting materials for the 
catalytic intermolecular aza-Wittig. A range of phenanthridines were synthesised using the 
azide-free intramolecular aza-Wittig reaction, employing hydroxamic acids as starting 
materials. 
For the first time, the redox-neutral aza-Wittig reaction was used for the synthesis of a 
benzodiazepine, a biologically active seven-membered ring system. Catalyst loadings of 5 
mol% were successfully employed with no loss in yield. 
Finally, the metathetical nature of the catalytic aza-Wittig reaction was explored in the 
context of aza-enyne metathesis, an analogous reaction to the well-known metal catalysed 
enyne metathesis reaction. This novel reaction pathway led to the synthesis of a trisubstituted 
quinoline from simple and commercially available starting materials and led to interesting 
mechanistic observations. 
Relevant experimental procedures are reported in full alongside data for synthesised 
compounds. Bibliographic data is also presented at the back of the report.  
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1. Introduction to Catalytic Variants of Phosphorus-Mediated 
Reactions 
 
Phosphine-mediated chemistry is an important weapon in the arsenal of any synthesis 
chemist and is employed on a multi-ton scale for the synthesis of important pharmaceuticals.1 
So influential has been the chemistry of phosphines that some of the most well-known 
chemists made their names working in this area. The names Staudinger, Wittig, Appel and 
Mitsunobu are synonymous with phosphine mediated reactions, indeed both Staudinger 
(1953) and Wittig (1979) received Nobel prizes in chemistry. Staudinger published work on 
iminophosphoranes reporting the both the Staudinger reaction and the aza-Wittig reaction, 
which actually predates its carbon name sake reaction by 35 years.2, 3 Popular for formation of 
carbon-carbon double bonds, the Wittig reaction has been widely utilised by chemists since 
its discovery in 1954.4 The Appel reaction involves the conversion of an alcohol to the 
corresponding alkyl halide with inversion of stereochemistry.5 Similarly, the Mitsunobu 
reaction also results in inversion of stereochemistry but with the replacement of alcohol with 
a nucleophile (Scheme 1).6 
 
The unifying feature of these reactions is the formation of a phosphine oxide species 
which provides the driving force for these reactions. A phosphorus-oxygen double bond is 
very strong (128 kCal mol-1)7 whose formation is energetically favoured allowing reactions to 
be carried out under generally mild reaction conditions, typically at room temperature. One 
major drawback associated with this strategy is disposal of large amounts of inert phosphine 
Scheme 1: Important examples of phosphine-mediated reactions. 
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oxide waste after the reaction. Traditionally phosphine oxide waste streams are incinerated 
due to difficulties in separation and reduction. Reducing phosphine oxides to the 
phosphine(III) state requires toxic activating reagents such as phosgene or combination of 
forcing conditions and metal hydrides to pay the energetic costs associated with cleaving this 
strong bond.8 Disposal is not the only issue associated with the production of phosphine oxide 
waste. Removing phosphine oxides from desired products can be difficult, due to their water 
insolubility, amorphous solid state and polar nature, generally requiring chromatography on 
lab-scale which restricts their use on larger scales. Reactions producing stoichiometric 
phosphine oxide waste suffer from low atom efficiency because of the high molecular weight 
of these compounds (triphenylphosphine oxide mw = 278.29 g/mol, tributylphosphine oxide 
mw = 218.32 g/mol). In recent years more and more is being done to recover phosphorus 
compounds from waste streams because it is increasingly viewed as a finite resource due to 
costs associated with extracting it from minerals.9 While it is estimated that 0.1% of rocks 
contain phosphorus, it is thought that at current rates of consumption reserves of economically 
recoverable phosphorus are expected to be depleted in 50-100 years.9 
In recent years the pursuit of catalytic protocols for phosphorus-mediated reactions has 
become in vogue. The earliest attempts at producing a catalytic variant of phosphorus-
mediated reaction veered away from phosphorus compounds and resorted to other pnictogens 
(group 15 elements). Arsenic,10, 11 antimony12 and tellurium13 compounds have been reported 
to behave in an analogous manner to phosphorus but were appreciably easier to reduce, due 
to their weaker oxide bond, although it should be noted that the toxicity and carcinogenic 
hazards associated with these compounds limit their practicality, especially on an industrial 
scale.  
On the contrary, phosphine oxides are generally non-toxic and therefore have none of 
the poisoning issues associated with the use of transition metal catalysts, another advantage 
phosphine mediated processes have over traditional metal catalysis. Two distinct pathways 
have been developed for organocatalytic phosphine reactions (Scheme 2). Either;  
1) Redox catalysis: whereby the active phosphine(III) species is regenerated by 
selective in situ reduction of the phosphine oxide product. 
 
2) Redox neutral catalysis: the catalyst maintains a P(V) oxidation state, with an 
active species in the P(V) state generated from the phosphine oxide. 
4 
 
Both of these methods have pros and cons and have been applied to a number of 
systems, with each being favoured by different academic groups for a variety of reasons. 
  
Scheme 2: Pathways developed for organocatalytic phosphine reactions. 
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1.1. Redox-Mediated Organocatalytic Phosphine 
Methodologies 
 
Conceptually simple but practically difficult, redox methodologies require a selective 
reduction of phosphine oxide, leaving sensitive groups untouched.14 Traditional reducing 
agents such as lithium aluminium hydride and trichlorosilane which are known to reduce 
phosphine oxides are incompatible with other groups such as ketones, carboxylic acids and 
amides which are required in a number of phosphine-mediated methodologies.7 Recently 
milder silanes have been found to selectively reduce phosphine oxides, with and without the 
aid of a catalyst. Both O’Brien et al.14-16 and van Delft et al.17-19 have reported reactions 
utilising diphenylsilane as an in situ reducing agent for catalytic phosphine reactions. The first 
example of a phosphine-catalysed Wittig reaction was reported by O’Brien et al. in 2009 and 
has since been adopted by other groups.20, 21 van Delft et al. have developed catalytic 
methodology for the Appel reaction,17 Staudinger reduction18 and the aza-Wittig reaction.19 
Both O’Brien and van Delft have reported extensively on the subject with other groups 
reporting briefly on the results of their redox-mediated phosphorus catalysed reactions. 
 
 Redox-Mediated Catalytic Wittig Reaction 
 
The original work by O’Brien’s group produced a total 50 examples of alkenes in 
moderate to excellent yields with some degree of selectivity (Scheme 4). This protocol 
tolerated aliphatic, aromatic and heterocyclic aldehydes to produce di- and trisubstituted 
alkenes. Organobromides sporting esters, nitriles, ketones and electron-deficient benzyl 
derivatives react with the active phospholane (1a) species producing the corresponding 
phosphonium salt, which is deprotonated by a base to form the stabilised ylid species. This 
then undergoes the traditional Wittig step, forming the desired alkene product and the 
phosphole oxide which is then subsequently reduced by the silane (Scheme 3). These silanes 
reduce phosphine oxides with no loss of chirality at the phosphorus. The phosphine of choice 
for these reactions was the cyclic phospholane oxide (1b) which has been found to undergo 
reduction more rapidly than acyclic phosphines. A range of process-friendly solvents could be 
employed using either a biphasic system with solid sodium carbonate base suspended in 
solution or a single-phase system using a soluble base diisopropylethylamine (DIPEA).15  
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While the average E/Z selectivity was moderate at 66:34, E selectivity was markedly 
higher for ,-unsaturated products (Scheme 4). It was found that products derived from 
bromides sporting ketones and esters had higher E selectivities than those derived from 
bromoacetonitriles which was accounted to a phosphane-mediated isomerisation. This process 
was found to lead to the complete conversion of (Z)-cinnamic acid methyl ester to the (E)-
alkene in 10.5 hours. While the propenenitrile only underwent a 6% conversion after 50 hours. 
Of note was the N-tosyl pyrrole derivative which was (Z)-selective (34:66, E:Z) this unusual 
selectivity is attributed to the N-tosyl group stabilising the cis-oxaphosphetane preventing 
interchange between isomers leading to the kinetic product as reported by Gilheany and 
Byrne.22 
 
 
 
 
 
 
 
Scheme 3: Proposed mechanism for the catalytic Wittig reaction.15 
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Scheme 4: Examples of products from O’Brien et al. catalytic Wittig chemistry.15 
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Originally prolonged high temperatures were required for the reaction to proceed, 
generally 100 °C for 24 hours, but more recently O’Brien reported that addition of catalytic 
4-nitrobenzoic acid and a switch from diphenylsilane to phenylsilane enhanced the rate of 
reaction to the point that reactions could be carried out at room temperature in as little as 6 
minutes. Alternatively, less active acyclic phosphines, such as triphenylphosphine, could be 
used alongside the 4-nitrobenzoic but to offset the reduced activity, high temperatures were 
required. Either system can be used with little to no loss of yield (Scheme 5).16 The authors 
proposed that the 4-nitrobenzoic acid proton acts as a Lewis acid, increasing the activity of 
the silane, accelerating the rate of reaction. Although it should be noted that this mechanism 
is unlikely as the acid will be deprotonated by the DIPEA.  
 
Werner et al. reported a set of conditions for a microwave-assisted catalytic Wittig 
reaction, which boasts reduced reaction times (3 hours), increased yields and the use of acyclic 
tributylphosphine oxide as catalyst. They also demonstrates the use of (S,S)-Me-DuPhos (2) 
as an asymmetric catalyst under these conditions to give (3) in a 39% yield and good E/Z 
selectivity of 81 : 19.21 Before the publication of this microwave assisted protocol, Werner et 
al. reported the synthesis of (3) by conventional heating with E/Z selectivity up to 95 : 5, 
taking the honour of producing the first enantioselective catalytic Wittig reaction (Scheme 
6).20 
 
 
Scheme 5: Enhancements to redox mediated catalytic Wittig reactions.16 
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More recently, O’Brien et al. have published their work on the catalytic Wittig reaction 
of semi- and nonstabilized ylids, bearing benzyl, cinnamyl, heterocylic and aliphatic groups.23 
To enable the use of semi- and nonstabilized ylids, a stronger base had to be found, one that 
could deprotonate protons with higher pKa values (pKa 17-18 for semistabilized ylids and 22-
25 for nonstabilized ylid), yet mild enough to be compatible with the reaction conditions. 
Typically NaHMDS, nBuLi, NaOtBu or NaOH are used for the deprotonation of non-stabilized 
ylids but these would not be compatible with the catalytic Wittig reaction protocol. The use 
of the masked base NaCO3
tBu met both of these demands by gradually releasing NaOtBu in 
situ avoiding undesired side reactions. With a pKa of 18, NaOtBu would still be incapable of 
adequate deprotonation of nonstabilized ylids (pKa 22-25) so the phosphine portion of the ylid 
had to be tuned to increase acidity. They found the optimal catalyst to be bicyclic phospholene 
oxide (4) which incorporating an electron-withdrawing aryl group to increase the acidity of 
the proton and an additional ring to shield one face, allowing for E/Z-selective reactions. As 
expected, using catalyst (4) led to increased E selectivity, increasing average selectivity from 
66 : 34 observed using the cyclic phosphole (5) to > 95 : 5 for semistabilised system and 75 : 
25 for non-stabilised ylids. Unfortunately decreased electron-density on the phosphorus 
reduced its activity requiring an increase in reaction temperature from 100 °C to 140 °C 
Scheme 6: First examples of enantioselective catalytic Wittig reaction.20,21 
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(Scheme 7). This is claimed to be the first catalytic Wittig system suitable for semi- and 
nonstabilised ylids, and at time of writing is the only example reported. 
 
 
  
Scheme 7: Catalysed Wittig reaction of semi- and non-stabilized ylids. a) Catalyst (5) 
used.23  
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 Redox-Mediated Catalytic Appel Reaction 
 
The first example of redox-mediated phosphine-catalysed Appel reaction was reported 
by van Delft et al. in 2011 and involved the in situ reduction of substoichiometric phosphine 
oxide. One of the main differences between this work and O’Brien’s is the use of 
dibenzophosphole (6a) as the catalyst (Scheme 8). It was hoped that the oxide of an aromatic 
phosphole would be a better catalyst, more readily reduced because of increased ring strain 
and the return to aromaticity on reduction. Interestingly, the reduction of dibenzophosphole 
oxide (6b) was found to be approximately 1.5 times slower than the reduction of O’Brien’s 
phospholane oxide catalyst (1b). Even after this surprising discovery dibenzophospholes were 
still selected as the catalyst because of their novelty and the ability to tune their electronics. 
Oxides of electron-poor dibenzophosphole (7) sporting CF3 groups had a decreased rate of 
reduction, while the oxide of the electron-rich 2,8-dimethoxy-dibenzophosphole (8) had an 
increased rate of reduction and increased nucleophilicity, which also led to low conversions 
due to alkylation of the phosphole by the bromide products. Unsubstituted aromatic 
dibenzophosphole (6a) was found to be superior to substituted dibenzophospholes and the 
aliphatic phospholane (1a) for the application of the catalytic Appel reaction with a yield of 
82% using dibenzophosphole (6a), 68% for 2,8-di methoxy-dibenzophosphole (8) and 17% 
using phospholane (1a). A variety of bromonium donors were screened. Bromine, 
tetrabromomethane, N-bromosuccinimide, N-bromoacetamide and 2,4,4,6-
tetrabromocyclohexa-2,5-dienone were found to react rapidly with the diphenylsilane, leading 
to its consumption before it could reduce the phosphine oxide. Further investigation found 
diethyl bromomalonate reacted sufficiently slowly with the silane allowing it to be utilised as 
a bromonium source.  
Scheme 8: Proposed mechanism for the redox-mediated Appel reaction. 
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By using 10 mol% dibenzophosphole (6), diphenyl silane and diethyl bromomalonate, 
primary, secondary and tertiary alcohols were converted into the corresponding bromides 
(Scheme 9). Attempts were made to develop the corresponding Appel reaction for the 
formation of the chlorides, but no suitable chloronium donors could be found.17 
  
Scheme 9: Results of the van Delft’s phosphine catalysed Appel reaction.17 
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 Development of Redox-Mediated Staudinger/Aza-Wittig 
Reaction 
 
The catalytic Staudinger reduction was the next reaction developed, an important step 
towards a redox-mediated catalytic aza-Wittig reaction.18 Unlike traditional Staudinger 
methodology the catalytic reaction is carried out under anhydrous conditions due to the 
incompatibility of the silanes with water. Instead, upon completion of the reduction step an 
aqueous quench is performed to hydrolyse the silane-amine adduct. Once again van Delft et 
al. use their favoured catalyst, dibenzophosphole (6), and offer a comparison with 
triphenylphosphine. Monitoring the reduction of dibenzophosphole-derived 
iminophosphorane (9) by 31P NMR shows complete conversion to phosphole (6) within 160 
minutes, while the analogous triphenylphosphine iminophosphorane takes 20 hours to go to 
completion. The control reaction omitting phosphole verified that the reducing reagent alone 
cannot give the expected amine product. The proposed reaction mechanism involves the 
formation of the iminophosphorane by the classic Staudinger reaction, which is then reduced 
by the phenylsilane to recover the phosphine and form the silane-amine adduct which readily 
undergoes hydrolysis on aqueous work-up (Scheme 10). Using this methodology eleven 
azides were reduced to the corresponding amines including aromatic azides, benzylic azides 
and aliphatic azides in good to excellent yields. Reaction conditions were found to be tolerant 
of nitro, carboxylic acids, esters, alcohols and olefin groups (Scheme 11). Success with this 
reaction led the van Delft group to adapt this reaction into a catalytic aza-Wittig variant. 
  
Scheme 10: Proposed catalytic cycle for van Delft’s Staudinger reaction.18 
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van Delft et al. envisaged the iminophosphole intermediate (9) formed during the 
catalytic Staudinger reaction could react with a pendant ester group to produce N-heterocycles 
via the aza-Wittig reaction (Scheme 12).19 Competing with the desired cyclization was the 
undesired reaction of iminophosphorane with silane, the pathway employed in the previously 
mentioned Staudinger reduction. It was found that both the reduction of N-benzo-
iminophosphorane derived from (6) and dibenzophosphole oxide took 20 hours to go to 
completion. Indeed, the reduction of the iminophosphorane was a serious complication, with 
the amine by-product accounting for the majority of lost yield. For the synthesis of 2-phenyl-
benzoxazoles, the use of phenylsilane, a stronger reducing reagent than the previously used 
diphenylsilane, resulted in a lower yield (50% yield) than the less active diphenylsilane (74% 
yield) due to increased reduction of the iminophosphorane intermediate. In the absence of 
silane only 10% conversion to the aza-Wittig product was observed, accounting for a single 
turnover of the amount of phosphole catalyst (10 mol%). Slow addition of silane over 24 hours 
was found to lead to higher isolated yields for the 5-chlorobenzoxazole (65% yield vs. 55%) 
as did higher catalyst loadings (35 mol%, 84% yield). The optimised conditions (10 mol% of 
dibenzophosphole, 1.1 equivalents of diphenylsilane at 0.2 M in dioxane heated to reflux for 
24 hours), produced ten benzoxazoles with a range of substituents isolated from the 
corresponding 2-azidophenyl esters. It was found that starting materials sporting electron-rich 
esters led to higher isolated yields and those with electron-poor esters suffered from lower 
Scheme 11: Results from van Delft’s catalytic Staudinger reduction.18 
15 
 
yields. This result are at odds with those reported for the classical aza-Wittig by Johnson et 
al. who found electron-poor esters had an accelerated rate of reaction.24 Variations on the 
aromatic ring seemed to have a smaller impact on the yield, with both electron-withdrawing 
and electron-donating groups leading to lower yields (Scheme 13). Both of these observations 
suggest that the increased complexity of the catalytic system complicates electronic effects.  
 
 
  
Scheme 12: Proposed mechanism for redox mediated aza-Wittig reaction.19 
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Next the group turned to the synthesis of pharmaceutically interesting benzodiazepines. 
Using conditions optimised for the synthesis of benzoxazoles a range of benzodiazepines were 
produced in poor to good yields (Scheme 14). While the more constrained proline derivatives 
gave good yields, the flexible amino acid derivatives suffered from low yields and in some 
cases led to only isolation of the aniline product, formed from the direct Staudinger reduction.  
Scheme 13: Results from the redox mediated aza-Wittig reaction.19 
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Another of Staudinger’s reactions, the ligation of carboxylic acids with azides, has also 
been developed into a redox-mediated catalytic cycle by Ashfield et al..25 Similar to the aza-
Wittig reaction, the Staudinger ligation reaction proceeds via an iminophosphorane 
intermediate, which adds to the carboxylic acid to form intermediate (10) which rearranges to 
the amide and phosphine oxide (Scheme 15). Aiming to reduce the amount of 
iminophosphorane consumed by the silane, triphenylphosphine was used as the catalyst due 
to the sluggish reduction of triphenylphosphine derived iminophosphoranes as reported by van 
Delft.19 Using catalytic triphenylphosphine (10 mol%) and phenylsilane as the reducing agent 
a range of aryl and alkyl azides coupled with both aryl and alkyl carboxylic acids in high 
yields (Scheme 16). The reaction also worked with acyl azide to give a modest yield of imide 
(11). 
Scheme 15: Proposed mechanism for the catalytic Staudinger ligation reaction.25 
Scheme 14: Results for synthesis of benzodiazepines using redox mediated catalytic aza-
Wittig reaction. (Percentages in parenthesis are yield of corresponding anilines).19 
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As previously demonstrated by the redox-mediated Staudinger reaction (Scheme 10), it 
is feasible the iminophosphorane intermediate is reduced by the silane under the reaction 
conditions casting doubt on the proposed mechanism. The reaction may alternatively proceed 
via a silane mediated mechanism whereby the carboxylic acid is activated by the silane. 
However they report that pre-formed silyl ester failed to produce more than trace amounts of 
amide on addition of triphenylphosphine and azide, though it should be noted that phenylsilane 
was replaced with less reactive diphenylsilane in this test. No control reactions lacking 
phosphine were reported. 
 
Scheme 16: Results of the catalytic Staudinger ligation reaction.25 
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More recently, Ding et al. reported a redox-mediated catalytic aza-Wittig reaction for 
the synthesis of quinazolinones and the natural product vasicinone using a mixture of 
tetramethyldisiloxane (TMDS) and 10 mol% Ti(OiPr)4 as the reductant system.26 The 
advantage of this system is that the stoichiometric reductant, TMDS, is an inexpensive by-
product of the silicon industry (£398/Kg27). While the addition of an additional catalyst is less 
than ideal the use of TMDS is a dramatic improvement over the use of diphenylsilane and 
phenylsilane both economically and environmentally. In the absence of Ti(OiPr)4 or phosphine 
oxide there was no reaction, no product was observed. Even replacing the TMDS and Ti(OiPr)4 
with diphenyl-, phenyl- or triethylsilane failed to produce any product. Surprisingly, there 
proved to be little to no difference in activity between the cyclic phosphines (1a) and (6) and 
triphenylphosphine oxide. Optimisation studies found that catalyst loadings could be reduced 
to 5 mol% with no loss in yield, but the rate of reaction dropped, going from being complete 
in 8 hours (for 20 mol% catalyst loading) to 24 hours (for 5 mol%). Optimised conditions (5 
mol% phosphine oxide, 10 mol% Ti(OiPr)4, refluxing toluene, 24 hours) gave high yields of 
Scheme 17: Results from Ding et al. catalytic aza-Wittig reaction.22 
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the quinazolinones from the corresponding azides, including the natural product vasicinone 
(Scheme 17). 
In terms of future developments it is notable that alternative catalysts have been found 
for the chemoselective reduction of phosphine oxides using these cheap silanes as the terminal 
reducing agent. Beller et al. have reported two such reactions, the first of which utilised 10 
mol% copper triflate and TMDS (3.0 eq.),28 the second a phosphoric acid catalyst (7.5 mol%) 
which acts as a Lewis acid activating diethoxymethylsilane (4.0 eq.).29 Both methods produced 
a range of phosphines in good to very good yields and were chemoselective tolerating 
aldehydes, ketones and olefins. Indium tribromide (InBr3) was found by Lemaire et al. to be 
an active catalyst for the reduction of phosphine oxides using TMDS. Very low loadings of 
InBr3 (1 mol%) proved to be comparable to the reductions using 10 mol% Ti(O
iPr)4.
30 
One example of catalytic reduction was employed in the reduction of silyl protected 
peroxides.31 Woerpel et al. developed a catalytic protocol for the reduction of triethylsilyl 
peroxides to the protected alcohols utilising a triphenylphosphine catalyst in a redox mediated 
reaction (Scheme 18). Optimisation of this reaction involved a balancing act with respect to 
the reducing agents; too strong (e.g. LiAlH4 and Cl3SiH) and the peroxide would be reduced 
to the alcohol without intervention of the phosphine, too weak and the phosphine oxide would 
not be reduced and the catalytic cycle would not turn over. The ideal conditions involved a 
mixture of Ti(OiPr)4 (5 mol%) and TMDS (2.0 eq.) as the reductants and catalytic 
triphenylphosphine (5 mol%) in a solution of toluene at 100 °C stirred over 24 hours. The best 
protecting group was found to be triethylsilyl, which was robust enough to survive the reaction 
conditions and aqueous work up. Trimethylsilyl protecting groups did not survive extraction, 
providing low isolated yields of the silyl ester. Interestingly, although un-protected peroxides 
were readily reduced by the mixture of Ti(OiPr)4 (5 mol%) and TMDS (2.0 eq.) in the absence 
of the phosphine, the silyl protected peroxides did not undergo reduction without the 
phosphine catalyst, leading to complete recovery of starting material. Using these optimised 
conditions a range of triethylsilyl esters were prepared from the corresponding protected 
peroxides in good yields with complete retention of configuration where applicable (Scheme 
19). The low yield of (11) can be attributed to the volatility of the product. 
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 Life-cycle Assessment of Redox-Mediated Protocols 
 
To investigate whether the use of silane reducing agent and small amounts of 
phosphorus is indeed environmentally advantageous Huijbregt et al. published a life cycle 
assessment of both classical and redox-mediated Wittig and Appel reactions.8 Their 
calculations show that catalytic Appel reaction does not offer any advantage with respect to 
greenhouse gases release or energy consumption. The production of diethyl chloromalonate, 
the chlorination reagent required to replace the tetrachloromethane in the catalytic reaction, 
requires more energy than the amount offset by replacing the phosphine reagent with silane. 
Interestingly, Figure 1 clearly shows the significant contribution that the solvent, acetonitrile, 
makes to greenhouse gas production and cumulative energy demand. Indeed it is known that 
in most cases solvent production adds about 75% of total energy usage.32  
 
Scheme 18: Catalytic cycles involved in the reduction of silyl peroxides.31 
Scheme 19: Results of the catalytic reduction of silyl peroxides.31 
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However switching to a catalytic Wittig reaction offers a marked reduction in energy 
demands and greenhouse gas production (Figure 2). The results are even more marked when 
using polymethylhydrosiloxane, an industrial by-product similar to TMDS, which again 
shows the importance of further research into the use of by-product silanes. Diphenylsilane 
and phenylsilane both provide an 18% reduction in energy demands and 35% reduction in 
greenhouse gas emission. These results are very interesting and highlight issues that need to 
be addressed to improve the redox-mediated reactions, in particular the use of more 
environmentally friendly silanes and the use of less energy demanding solvents or reduction 
in the amount of solvents used.   
 
 
  
Figure 1: Life cycle assessment of redox mediated catalytic Appel reaction as calculated by 
Huijbregt et al..32 
Figure 2: Life cycle assessment of redox mediated catalytic Wittig reaction as calculated 
by Huijbregt et al..32 
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 Miscellaneous Redox-Mediated Phosphine Catalysed 
Reactions 
 
A methodology for the formation of amide bonds utilising a redox-mediated phosphine 
catalytic cycle has recently been reported by Mecinović et al.33 It was first shown that Appel 
conditions (stoichiometric triphenylphosphine and CCl4) could be used to activate carboxylic 
acids for the formation of amides. By introducing the phosphonic acid (12) catalysed reduction 
similar to those reported by Beller29 to the reaction, the phosphine could be used catalytically 
(Scheme 20). Alternative methods for the in situ reduction of phosphine oxide were attempted 
but failed to turn the reaction over leading to little/no product. Para-substituted benzoic acids 
were coupled with benzylamine in excellent conversions (70% - 90%) with isolated yields 
between 54 and 76%, the para-methoxy benzoic give a low conversion of 52%. Picolinic and 
quinaldic acids gave excellent conversions of 99% and 72% yields respectively. A range of 
primary and secondary amines sporting both aliphatic and aromatic groups were coupled with 
4-nitrobenzoic acid in good to excellent conversions (65% - 98%), with the exception of 
aniline which, expectedly, suffered from a low conversion (35%) attributed to low 
nucleophilicity. Enantiomerically pure (S)-1-phenylethylamine gave 90% conversions with 
complete retention of stereochemistry. As expected in the absence of silane and phosphonic 
acid the conversions were below 25%, which corresponds to the amount of triphenylphosphine 
in the reaction (25 mol%).  
 
Scheme 20: Phosphine catalysed methodology for amide bond formation.33 
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A completely novel methodology has been developed by Radosevich et al. which 
utilises a constrained phosphorus compound that emulates metal complexes ability to carry 
out transfer hydrogenation.34 The phosphorus is constrained into an unusual tricoordinate T-
shaped geometry by its substituents, analogous to a transition metal complex constrained by a 
tridentate ligands. This tricoordinate phosphine ‘complex’ can abstract two hydrogens from 
ammonia-borane to produce a trigonal bipyridal pentavalent species which was observed by 
31P-NMR as a triplet of triplets at -43.7 ppm with J = 670 and 34 Hz and 1H-NMR as a pair 
of doublets at ppm (1JPH = 670 Hz) and ppm (3JPH  = 34 Hz) displaying 
characteristic phosphorus-coupled doublet. It could be isolated in 75% yield by trituration and 
was examined using X-ray diffraction which found that the structure had distorted from the 
usual trigonal bipyridal towards a square pyramid shape around the phosphorus. This 
dihydridophosphorane was used to transfer hydrogens onto unsaturated azobenzene 
transforming it to 1,2-diphenylhydrazine in a 63% yield in 19 h at 40 oC. While there is no 
reaction between 4 equivalents of ammonia-borane and azobenzene in acetonitrile the addition 
of 10 mol% phosphine (13) leads to an 80% yield of diphenylhydrazine after 24 hours at 40 oC. 
Analysing the catalytic reaction using 31P-NMR showed the rapid conversion of (13) to the 
dihydridophosphorane species (14) which remained throughout the reaction. This is the first 
example of a catalytic transfer hydrogenation reaction using a phosphorus complex, a territory 
usually reserved for transition metals (Scheme 21). 
 
  
Scheme 21: Radosevich et al. phosphine catalysed transfer hydrogenation.34 
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1.2. Redox-Neutral Organocatalytic Phosphine Methodologies 
 
As mentioned earlier there is an alternative set of methodologies which forgo the redox 
cycle, instead maintaining the P(V) oxidation state throughout the reaction. Instead of 
undergoing reduction with silane the phosphine oxide is activated by addition of active starting 
material or reagent which forms the active phosphine species. These methodologies have the 
distinct advantage of not requiring stoichiometric amounts of reducing agents or phosphine 
reagents, increasing the atom efficiency drastically. Currently the two methods developed 
produce carbon dioxide as the major by-product and it is the loss of this gas which drives the 
equilibrium and the reaction (Scheme 22). 
 
1.2.1. Reactions with Catalytically Generated Halophosphonium 
Salts 
 
Denton et al. have developed a range of reactions based on the catalytic generation of 
chlorotriphenylphosphonium chloride using oxalyl chloride to recycle the phosphine oxide 
by-product. This underappreciated transformation was first reported by Masaki and Fukui in 
1977 as the key intermediate for their novel reduction of phosphine oxides using oxalyl 
chloride and thiols (Scheme 23).35 On addition of oxalyl chloride, phosphine oxides are 
transformed into the corresponding dichlorophosphines with the liberation of carbon dioxide 
and carbon monoxide. The dichlorophosphines are highly oxaphilic and can undergo addition 
of various oxygen containing groups such as alcohols (Appel reaction),36, 37 epoxides 
(dichlorination reaction),38 oximes39 and aldehydes.40  
 
Scheme 22: Redox neutral organocatalytic phosphine catalytic cycles. 
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The catalytic protocol using oxalyl chloride and phosphine oxide replaces the mixture 
of triphenylphosphine and tetrachloromethane typically used in the Appel reaction drastically 
reducing the amount of waste generated and greatly increasing the atom efficiency. The 
catalytic Appel reaction involves the slow addition of an alcohol to a phosphine oxide oxalyl 
chloride mixture yielding an alkyl chloride with inversion of stereochemistry.36, 37 To reduce 
the unwanted esterification of oxalyl chloride with alcohol, the solution of oxalyl chloride is 
added slowly throughout the reaction (Scheme 24). Slow addition over 7 hours increased the 
yield of the desired chloride (15) from 46% to 86% and dramatically reduced the formation of 
chlorooxalate (16) and diester (17) side products. Loadings of 15 mol% triphenylphosphine 
oxide led to high conversions and excellent isolated yields of primary and secondary aliphatic, 
allylic, benzylic and propargylic chlorides. Chiral GC and specific rotation of the products 
confirmed inversion of stereochemistry in all but one example, cholesterol, where possible 
participation of a nearby alkene led to retention of configuration. Sterically hindered alcohols, 
Scheme 23: Masaki and Fukui reaction for reduction of phosphine oxide via 
dichlorophosphine.35 
Scheme 24: Results from the redox neutral catalytic Appel reaction.36 
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cyclohexanol, menthol and neopentyl alcohol, suffered from low yields of desired product, 
instead leading to the isolation of the chlorooxalates and diesters. 
Addition of Hünig’s base or 2,6-di-tert-butylpyridine to neutralise released HCl allows 
for the reaction to tolerate benzyl and TBPS protecting groups, while triethylsilyl ethers were 
deprotected under the reaction conditions leading to dichlorinated products. Another 
modification found that while the expected use of oxalyl bromide failed to provide the bromide 
in adequate yields, addition of 2.3 equivalents of LiBr led to the bromination reaction. It is 
thought that the chloride ion precipitates out of the reaction as LiCl allowing for the formation 
of the active phosphonium bromide salt (18) (Scheme 25). These results led to the 
development of similar catalytic nucleophilic substitution reactions. 
 
Next, this methodology was applied to the dichlorination of epoxides.38 It was envisaged 
that the first step involved the formation of the dichlorophosphine, as per the previous Appel 
reaction; the phosphonium salt actives the epoxide allowing the first chloride ion to attack the 
least hindered side of the epoxide, resulting in inversion of stereochemistry. The activated 
alcohol formed from the opening of the epoxide then undergoes the Appel reaction as detailed 
above to give with dichloride with the expected inversion of the stereochemistry (Scheme 26). 
Initially yields were low as HCl present in oxalyl chloride reacted with the epoxides to product 
chlorohydrins which then led to the formation of inactive oxalate esters. Addition of the non-
nucleophilic base 2,6-di-tert-butylpyridine prevented this side reaction, increasing yields to 
69% from 58%. By increasing the amount of oxalyl chloride added throughout the reaction to 
1.3 equivalents allowed for the catalyst loadings to be reduced to 15 mol% while also 
increasing the yield to a satisfactory 91%. Using these optimised conditions (Scheme 27) a 
Scheme 25: Results of catalytic Appel reaction with additives.36 
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range of terminal epoxides underwent dichlorination at room temperature in moderate to 
excellent yields, alkenyl, aryl and TBDPS groups were well tolerated. At room temperature 
1,2-disubstuted epoxides did not undergo dichlorination but by replacing the chloroform 
solvent with benzene and increasing the reaction temperature to 80 °C the internal dichlorides 
could be isolated in moderate yields. 
 
 
The catalytic protocol was adapted for the deoxydichlorination of aldehydes, an 
important transformation for the synthesis of geminal dichlorides (Scheme 29). Dichlorides 
are an important starting point for many carbon-carbon bond forming reactions as well as 
being a moiety known to be present in bioactive natural products.41 This reaction was 
successfully employed for the conversion of substituted benzaldehydes, both electron-rich and 
electron-poor, cinnamaldehyde and trans-2-undecanal in good yields. Disappointingly, 
reactions with unactivated aliphatic aldehydes proceed at low conversions (Scheme 28). The 
1,2-dibromides could also be formed with the use of oxalyl bromide. The synthetic precursor 
(18) to the bioactive stilbene, resveratrol, was synthesised using intermediates produced by 
the in situ application of deoxydichlorination reaction.40 
Scheme 26: Proposed mechanism for the dichlorination of epoxides. 
Scheme 27: Results of the dichlorination of epoxides.38 
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Another interesting application for this methodology was the synthesis of nitriles via 
the catalysed decomposition of oximes.39 In this case there was no need for the slow addition 
of oxalyl chloride to the reaction mixture as, unlike previous examples, the oxalyl chloride 
Scheme 29: Results of the deoxydichlorination reaction of aldehydes.40 
Scheme 28: Proposed mechanism for the deoxydichlorination reaction of 
aldehydes.40 
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ester (19) is active and reacts with the phosphine oxide undergoing the decomposition step via 
the adducts (20) and (21). This methodology was used for the decomposition of various 
aliphatic, aromatic and heteroaromatic oximes to the corresponding nitriles in good to 
excellent yields with low catalyst loadings of 5 mol% and a small excess of oxalyl chloride 
(1.2 eq.) at room temperature over an hour. The reaction conditions tolerated basic groups and 
heteroaromatics such as pyridine, pyrrole and systems incorporating nitro, ketone, hydroxy 
and trifluoromethoxy functional groups. These mild conditions were employed in the 
synthesis of natural product pyrrole nitrile (22), a compound found in the sea sponge Agelas 
oroides (Scheme 31).  
 
  
Scheme 30: Proposed mechanism for the synthesis of nitriles from oximes utilising the 
catalytic phosphonium salts.38 
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Most recently Denton et al. have demonstrated the use of polymer supported 
triphenylphosphine oxide in the Appel reaction (Scheme 24, 27 and 28) and the previously 
mentioned dehydration reactions (Scheme 31) to simplify the purification of the product 
further.42 Commercially available supported triphenylphosphine oxide was suspended in a 
solution chloroform at room temperature then oxalyl chloride, oxalyl bromide or thionyl 
chloride was added leading to the observation of the corresponding halophosphonium salt. 
The polymer supported halophosphonium salt was then used in one of the above mentioned 
procedures (Scheme 32). The desired products could then be isolated by simple filtration and 
concentration under reduced pressure. In the first example, the chlorination of decanol the 
product was isolated in excellent yield and was considered pure by 1H-NMR analysis. The 
recovered polymer supported reagent could then be recycled and has been proven to be 
reusable three times with no loss in yield. This simple modification has huge ramifications, 
polymer supported reagents are popular in library synthesis and continuous flow protocols. 
  
Scheme 31: Results of the synthesis of nitriles from oximes utilising the catalytic 
phosphonium salts.38 
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Another reaction developed by Denton et al. employs a dioxyphosphorane (23) as an 
alternative to the triphenylphosphine and DEAD used in the Mitsunobu reaction.43 This redox-
free Mitsunobu reaction uses stoichiometric amounts of dioxyphosphorane, which can be 
reformed from the phosphine oxide by-product (85% of phosphine oxide could be recovered 
from reaction mixture) using oxalyl chloride and lithium trifluoroethoxide (Scheme 33). Using 
this methodology the esterification of benzoic acids proceeded in a good yield, while acetic 
acid derivatives could be used giving a moderate yield of ester. Menthol also underwent 
esterification at a low yield, interestingly, with inversion of stereochemistry, as expected from 
the Mitsunobu reaction. This novel protocol may use stoichiometric amounts of phosphine 
reagent but there is little consumption of phosphine as it can be recovered and recycled. The 
biggest advantage of this system is the absence of hazardous azodiester reagent typically 
required for the Mitsunobu reaction. 
 
 
 
 
Scheme 32: Appel reactions and dehydrations employing polymer supported 
triphenylphosphine oxide.42 
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Scheme 1: Results of redox free Mitsunobu reaction.43 Sche e 33: Results of redox free itsunobu reaction.
43 
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1.2.2. Development of Redox-Neutral Catalytic Aza-Wittig 
Reaction 
 
The initial inspiration for the redox-neutral catalytic aza-Wittig reaction came from 
Staudinger’s findings on the equilibrium between iminophosphoranes and phosphine oxides 
in the presence of carbon dioxide. Iminophosphoranes and carbon dioxide were found to be 
in equilibrium with the isocyanate and phosphine oxide. It was also found that the aza-Wittig 
formation of carbodiimides from isocyanates was reversible (Scheme 34).2 
 
In 1962 Monagle and Campbell reported the phosphine oxide-catalysed condensation 
of isocyanates in the synthesis of carbodiimides.44 It was proposed that isocyanates undergo a 
metathetical reaction with phosphine oxide evolving carbon dioxide and the 
iminophosphorane. The newly formed iminophosphorane reacts with a second equivalent of 
isocyanate, producing the carbodiimide and regenerating the phosphine oxide (Scheme 35). 
Monagle et al. carried out kinetic studies to gain further understanding of the mechanism. The 
reaction displays pseudo-first order kinetics with respect to the isocyanate. This suggests that 
addition of phospholene oxide to isocyanate to generate the iminophosphorane is the rate 
limiting step in the catalytic cycle. The second step, the nucleophilic attack of the 
iminophosphorane on the isocyanate is much more rapid (about 105-107 times faster).45, 46 
Therefore, there is only ever a small concentration of iminophosphorane present in the reaction 
at any point.  
 
 
 
 
 
Scheme 34: Staudinger’s observations which led to the development of catalytic 
carbodiimide formation.2 
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Catalyst screens found that although the ethyl substituted phospholene oxide (24) is 
more active, due to increased nucleophilicity, a fivefold increase in rate over the phenyl 
analogue (25),11 Compound (25) is generally favoured because the synthesis is considerably 
higher yielding and more importantly (25) has since been made commercially available. 
Campbell et al. found that cyclic phosphine oxides were much more active than the acylic 
variants (about 103 faster) which was attributed to the C-P-C bond angle; cyclic systems have 
an angle of approximately 95°, compared with 105° for acyclic systems.47 Cyclic systems 
therefore benefit from a lower barrier of transition from tetrahedral (109°) (phosphine oxide) 
to trigonal bipyridimal (95°) (oxazaphosphetane) relieving more of the ring strain.47, 48As 
mentioned previously, Radosevich et al. have developed a constrained phosphorus species 
which favours trigonal bipyridimal confirmation which allows for some unusual 
transformations (Scheme 21).34 Analogous to early attempts at redox mediated organocatalytic 
phosphine chemistry, alternative group V and VI oxide catalysts were screened by Monagle 
to investigate if the only requirement for the catalyst was a polar heteroatom oxygen bond (X-
O). Triphenylarsine oxide was more active than triphenylphosphine oxide, presumably due to 
increased polarization of the X-O bond (5.50 D for As-O compared with 4.31 for P-O), while 
the analogous trimethylamine oxide compound failed to provide any observable product due 
to the inability to adopt a trigonal bipyridimal confirmation. This lack of catalytic activity 
offered further evidence for the proposed pentavalent intermediate.11 
The nature of the isocyanate substrate also has an effect on the rate of reaction. As 
expected, electrophilic isocyanates react faster because the rate is dependent on the 
nucleophilic attack on the isocyanate from both the phospholene oxide and the 
Scheme 35: Proposed catalytic cycle for Monagle’s carbodiimide formation.44 
36 
 
iminophosphorane. Steric effects also play a role in the rate of reaction; a sterically hindered 
isocyanate reacts slower.49 
Marsden et al. have developed Monagle’s catalytic carbodiimide synthesis into a more 
general catalytic aza-Wittig reaction which can be used to produce imines and N-heterocycles 
(Scheme 36). To favour the reaction between the iminophosphorane and desired carbonyl the 
competing carbodiimide formation has to be suppressed. To achieve this in the intermolecular 
system highly reactive aldehydes were employed or in the case of tosyl imine synthesis the 
competing dimerization reaction made unfavourable.50, 51 For the cyclization reactions, 
diluting the reaction mixture reduced the likelihood of interaction between iminophosphorane 
and isocyanate, thus favouring the intramolecular reaction. Using the intramolecular 
methodology a range of phenanthridines, benzoxazoles and benzimidazoles were synthesised 
as well as electron-deficient imines using the intermolecular aza-Wittig (Scheme 37).50-52 
These reactions will be explored in greater details in later chapters. 
 
Scheme 36: Proposed mechanism for the catalytic aza-Wittig reaction.48 
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Scheme 37: Results of the redox-neutral catalytic aza-Wittig reaction.50-52 
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Chapter 2: 
Novel Applications of Organocatalytic Aza-Wittig 
Chemistry 
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2. Development of an Azide Free Catalytic aza-Wittig Reaction  
2.1. Introduction to Novel Methods for In Situ Isocyanate 
Synthesis  
 
Isocyanates are fundamental to the catalytic aza-Wittig reaction developed by the 
Marsden group.52 The condensation of isocyanates with phosphine oxides produces 
iminophosphoranes, with the liberation of carbon dioxide providing the driving force for the 
reaction. This chapter looks at alternative methods for the in situ generation of isocyanates in 
the catalytic aza-Wittig reaction. Currently, the most commonly employed method for the 
synthesis of isocyanates on a laboratory scale is the Curtius rearrangement (Scheme 38). 
Although this methodology is clean, mild, well studied and efficient, it involves the use of 
high energy acyl azides. Azides can decompose on the slightest input of energy and, in the 
case of small molecules, the results can be violent, which limits their use on large scale. 
 
An alternative to the Curtius rearrangement is the Lossen rearrangement which involves 
O-functionalised hydroxamic acids. Electron-withdrawing groups attached to the oxygen 
result in it becoming a labile leaving group whose loss initiates the rearrangement. 
Traditionally, O-acyl,53 sulfonyl54 or phosphoryl55 hydroxamic acid intermediates are 
generated in situ and, in some cases, forcing conditions are required to initiate the 
rearrangement (Scheme 39). For example, O-(acetoacetyl) benzohydroxamic acid undergoes 
thermal rearrangement between 300 and 400 °C.56, 57 More commonly a strong base is used to 
initiate the rearrangement at lower temperatures, ideally with the leaving group precipitating 
out of solution as a salt to aid purification and prevent interaction with the isocyanate 
intermediate.56 The ease of rearrangement is dependent on the nature of the leaving group, 
with more electron-withdrawing groups, such as sulfonyl and phosphoryl groups, reacting 
faster. Indeed the O-sulfonyl and phosphoryl hydroxamate esters rearrange so rapidly that the 
active O-substituted intermediates are not usually isolated. The R group of the hydroxamic 
acid also affects its propensity to rearrange, with substrates bearing electron-rich R groups 
tending to rearrange easier than electron-poor groups.56 
Scheme 38: The Curtius rearrangement. 
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Recently a number of novel methods for the activation of hydroxamic acids for the 
synthesis of carbamates and ureas have been developed. These range from new phosphates,55, 
58 simple and mild sulfur reagents,59 catalyst enhanced activation,54, 60 to metal assisted 
rearrangements.61 However, phosphate and sulphur-based methods suffer from low atom 
efficiencies and purification issues. For example 4-nosyl chloride (4-NsCl) has a molecular 
weight of 221.62 g/mol and the 4-nitrobenzenesulphonic acid by-product has to be removed. 
Many of the catalytic and metal assisted procedures are unsuitable for our desired application. 
A promising method was published by Dubé et al. detailing a carbonyl diimidazole (CDI) 
initiated Lossen rearrangement (Scheme 40).62 In this publication they report the use of CDI 
to activate hydroxamic acids which rearrange in the presence of a nucleophile. This 
nucleophile reacts with the isocyanate intermediate to form the corresponding carbamate or 
urea as shown below (Scheme 40).   
Scheme 39: Previous results of the Lossen rearrangement.53-57 
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One of the appeals of this method is the compatibility of the reagents and by-products 
with the aza-Wittig reaction. It was expected that carbonyl diimidazole (CDI) would 
selectively react with hydroxamic acids without interacting with other groups present in the 
aza-Wittig reaction. Carbon dioxide and imidazole are the only by-products produced during 
the reaction of CDI with hydroxamic acids. Cleavage of the high energy N-O bond provides 
the driving force for the rearrangement. Imidazole is weakly nucleophilic and reversibly forms 
an imidazolyl urea with the isocyanate and wasn’t expected to interact detrimentally with the 
desired aza-Wittig reaction.   
 
Dubé suggested a mechanistic pathway involving the formation of a dioxazolone which 
undergoes decarboxylation in the presence of a nucleophile, producing an isocyanate in situ. 
This isocyanate intermediate is subsequently trapped by the nucleophile, in the absence of 
another nucleophile, as an imidazolyl urea (Scheme 41) which was reported by Dubé.62 This 
methodology potentially offers mild in situ generation of isocyanates for the catalytic aza-
Wittig without the need for hazardous azides.62 
Scheme 40: Dubé et al. carbonyl diimidazole-mediated Lossen rearrangement results.62 
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Scheme 41: Intermediates in the carbonyl diimidazole-mediated Lossen rearrangement.62  
 
Another recent observation has led to an alternative method for the formation of 
isocyanates. Booker-Milburn et al. reported that hindered trisubstituted ureas, such as 1,1-
diisopropyl-3-phenyl urea, form carbamates on heating in methanol.63 While ureas are usually 
perceived as being inert, these hindered ureas were found to undergo solvolysis in a range of 
alcohols, yielding the carbamates expected from the reaction with isocyanates. Therefore 
hindered ureas could behave as masked isocyanates, dissociating into the isocyanate and 
amine on heating. Conditions were optimised to allow for only a small excess of nucleophile. 
A range of nucleophiles to be tested, providing the products expected from the capture of an 
isocyanate (Scheme 42) (Table 1). Bulkier ureas had a lower temperature of dissociation. For 
example, the solvolysis of 1,1-diisopropyl-3-phenyl urea went to completion after 18 hours at 
70 °C, while the reaction of 1-tert-butyl-1-isopropyl-3-phenyl urea was complete within an 
hour at 20 °C. Since high temperatures are required for the catalytic aza-Wittig reaction, ureas 
could provide a method for the in situ generation of isocyanates under the usual reaction 
conditions.  
 
Scheme 42: Hindered ureas as masked isocyanates. 
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Table 2: Hindered ureas as masked isocyanates in the synthesis of carbamates and ureas.63 
R R’ R’ T (oC) t (h) Yield 
(%)
Ph iPr iPr 70 18 81
Ph H tBu 70 18 0
Ph Me tBu 70 <5 min >99
Ph Et tBu 50 1 >99
Ph Et tBu 20 18 >99
Ph iPr tBu 20 1 >99
Bn iPr iPr 70 72 85
tBu iPr tBu 20 1 >99
NuH (eq.) t (h) Yield (%)
H2O (excess) 1 >99 
(PhNC(O)NPh)
MeOH (1.1) 6 >99
tBuOH (excess) 8 70
BnOH (1.1) 8 94
PhOH (2.0) 18 72
PhSH (2.0) 18 62
tBuNH2 (1.1) 5 >99
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2.2. Results and Discussion 
2.2.1. Developing a Protocol for Azide Free Intermolecular Aza-
Wittig Reaction 
 
Our group previously explored the application of catalytic aza-Wittig methodology for 
both intra and intermolecular reactions. The starting materials for these reactions were, in the 
case of intermolecular reactions, commercially available isocyanates or else formed via the 
Curtius rearrangement from the corresponding acyl azide. Using these methods a range of N-
phenyl imines and electron deficient N-tosyl and N-carboxyl imines were synthesised (Scheme 
43).  
 
Due to the hazards associated with the use of azides, alternative methods for the 
synthesis of isocyanates were sought. The potential of using the methodology developed by 
Dubé et al. of was explored in the context of the catalytic aza-Wittig reaction.62 Initially, to 
investigate potential starting materials for the in situ formation of isocyanates, the 
CDI-mediated Lossen rearrangement was performed in the presence of diisopropylamine to 
trap the isocyanate as a hindered urea. Addition of carbonyl diimidazole (CDI) to a solution 
of commercially available benzohydroxamic acid (26) in acetonitrile at room temperature and 
subsequent heating with diisopropylamine yielded 85% of the desired hindered urea (27) 
(Scheme 44).  
Scheme 43: Previous intermolecular catalytic aza-Wittig reaction results. 
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To confirm the intermediacy of the dioxazalone in the CDI-mediated Lossen 
rearrangement a sample of phenyl dioxazalone (28) was prepared following the literature 
procedure.64 Addition of CDI to the hydroxamic acid in DCM at 0 °C allowed the dioxazolone 
intermediate (28) to be isolated. The dioxazolone proved to be stable enough to survive a 
weakly acidic (0.5 M HCl) aqueous quench and recrystallization from DCM and hexane, 
furnishing us with pure dioxazalone (28) at an isolated yield of 68% (Scheme 45). On heating 
to 60 °C in the presence of diisopropylamine, the dioxazalone underwent rearrangement 
producing the 1,1-diisopropyl-3-phenyl urea in 85% yield (27) (Scheme 45), supporting the 
hypothesised intermediacy of dioxazalone in the CDI-mediated Lossen rearrangement.  
Scheme 45: Isolation and reaction of dioxazalone (28).  
 
Dubé et al. observed that heating a mixture of dioxazalone with imidazole to 60 °C led 
to conversion to the imidazolyl urea. This suggested that imidazole initiated the Lossen 
rearrangement of dioxazolone, acting as an nucleophile, triggering decarboxylation and 
ultimately forming an imidazolyl urea (Scheme 46).62 In solution it is known that imidazolyl 
ureas are in equilibrium with the corresponding isocyanate and imidazole (Scheme 46).65 This 
dissociation makes separation of 1-imidazolyl-3-phenyl urea (29) from imidazole and the 
isocyanate (30) impractical. In order to confirm that the imidazole could initiate the 
rearrangement in the absence of an additional nucleophile a test reaction was carried out with 
the aim to isolate the imidazolyl urea (29). Both the imidazolyl urea and the side-product 
diphenyl urea (31) could be observed by NMR spectroscopy (imidazolyl urea NH 10.31 ppm 
singlet) and IR (imidazolyl urea (C=O) 1730 cm-1). At room temperature the 1H-NMR shows 
almost exclusively imidazolyl urea. 
Scheme 44: CDI-mediated Lossen rearrangement as a method for the synthesis of hindered 
ureas. 
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We proposed that the phospholene oxide-catalysed self-condensation reaction of the 
isocyanate intermediate would be the simplest system to test the compatibility of novel 
methods for the in situ synthesis of isocyanates with the aza-Wittig reaction. This self-
condensation reaction is normally viewed as a side reaction, but it was hoped that by removing 
the need to compete with the self-condensation the reaction would be simplified. A solution 
of hydroxamic acid (26) and CDI was heated with the phospholene oxide catalyst (25) in an 
attempt to produce the expected diphenyl carbodiimide (32) product. The reaction was 
monitored by IR for the appearance and consumption of the isocyanate (2260 cm-1) and the 
formation of the carbodiimide (2140 cm-1) (Scheme 47). Unfortunately none of the expected 
carbodiimide product was observed by IR or 1H-NMR during or after the reaction. Instead the 
imidazolyl urea (29) was observed as the major product by 1H-NMR.  
 
To attempt the synthesis of carbodiimide (32), the proposed intermediates, dioxazalone 
(28) and imidazolyl urea (29) were also tested (Scheme 48). Neither of the reactions showed 
the desired carbodiimide infra-red absorption (2140 cm-1), suggesting no isocyanate self-
condensation occurred with these systems. The lack of desired product may be a sign that the 
concentration of isocyanate remains low throughout the reaction because the excess imidazole 
traps it as the imidazolyl urea. For the self-condensation the rate of reaction is highly 
dependent on the concentration of the isocyanate as the concentration of iminophosphorane is 
a function of isocyanate concentration, effectively making the isocyanate second order for the 
Scheme 46: CDI -mediated Lossen rearrangement formation of imidazolyl urea (29). 
Scheme 47: Proposed pathway for CDI mediated Lossen and catalytic carbodiimide 
formation. 
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self-condensation reaction, while the formation of imidazolyl urea is only first order with 
respect to the isocyanate. 
Scheme 48: Alternative starting materials for catalytic carbodiimide formation. 
 
Satisfyingly, however, the reaction of the hindered urea did display a noticeable amount 
of the characteristic carbodiimide absorption (2140 cm-1) during the reaction suggesting that 
the isocyanate was formed and had been converted by the catalyst to carbodiimide (Scheme 
49). After 24 hours stirring in refluxing toluene an aliquot was removed to analyse the crude 
reaction mixture by 1H NMR spectroscopy looking to assess the conversion to carbodiimide. 
Disappointingly, no signals could be found matching the literature values expected for the 
carbodiimide, suggesting that the carbodiimide had been consumed under the reaction 
conditions. Instead the majority of the reaction mixture was recovered as starting urea (27) 
and 10% of the diphenyl urea (33). 
Scheme 49: Catalytic carbodiimide formation from diisopropyl urea. 
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Further LC-MS analysis suggested that the isocyanate self-condensation reaction using 
diisopropyl urea (27) produced the corresponding guanidine (34) in small but detectable 
quantities. While none of the characteristic guanidine signals could be detected by 1H-NMR 
spectroscopy, the guanidine peak was prominent in the electrospray LC-MS spectrum. 
Guanidines are known to be very basic and readily protonated which explains the strong signal 
of the guanidine ions in the positive electrospray LC-MS. Two possible mechanisms could 
account for the formation of the guanidine (Scheme 50); either the carbodiimide had 
undergone nucleophilic attack by the diisopropylamine or the iminophosphorane had attacked 
the carbonyl of the urea. The latter is considered unlikely because ureas are notoriously weak 
electrophiles and there are no known examples of intermolecular aza-Wittig reactions with 
ureas. To examine the proposed pathway, pre-formed carbodiimide (32) was heated in the 
presence of three equivalents of diisopropylamine. Gratifyingly, this produced a concentration 
of guanidine (34) visible by 1H-NMR spectroscopy, verifying that nucleophilic attack is viable 
under the reaction conditions.  
 
Total conversion to carbodiimide (32) was not observed with the hindered urea but the 
reaction of the unprotected isocyanate is rapid and quantitative. It could be expected that as 
the hindered urea (27) dissociates (pathway a) and isocyanate is consumed, the concentration 
of diisopropylamine would increase (pathway b) trapping the small amount of carbodiimide 
(32) formed, as the guanidine (34) (pathway c). The increased concentration of 
diisopropylamine would also have the effect of driving the hindered urea-isocyanate 
equilibrium (pathway a) back towards the urea. In turn, this would keep the concentration of 
isocyanate low limiting the amount of carbodiimide formed; this may account for the sluggish 
nature of the dissociation of hindered urea (Scheme 51).  
Scheme 50: Possible routes to guanidine by-product (34). 
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As discussed above members of the Marsden group have utilised the catalytic aza-
Wittig reaction to produce imines from isocyanates (Scheme 43).52 This method has been 
employed to synthesise imines sporting N-aromatic groups; electron-deficient N-p-tosyl and 
N-ethoxycarbonyl imines; and azatrienes for electrocyclic ring formations.50, 66 After 
disappointing results for carbodiimide formation, the next step was to attempt the synthesis of 
imines from the novel isocyanate equivalents. It was hoped that by reacting the 
iminophosphorane with an aldehyde we would observe the desired imines. Heating a solution 
of diisopropyl urea (27) and benzaldehyde in the presence of the phospholene oxide catalyst 
(25) consistently led to the observation of the signal corresponding to imine (35a) in the 1H-
NMR spectrum of the crude reaction mixture. Imines are notoriously difficult to isolate due 
to a tendency to hydrolyse during silica column chromatography or other methods of 
purification. To quantify the reaction yields the crude reaction mixtures were analysed by 1H-
NMR spectroscopy to gauge conversion of aldehyde to the imine. Integration of the area under 
the characteristic aldehyde (10.00 ppm) and imine (8.46 ppm) proton signals gives a ratio of 
products as a proxy for conversion. With systems using 0.9 equivalents of benzaldehyde 
conversions of 57% were observed. Attempting to produce higher conversions, an excess of 
electron-deficient 3-nitrobenzaldehyde (36) was used as previous work had noted an increase 
in yields with this aldehyde. As expected, this provided higher conversions of aldehyde to 
imine (35b). When two equivalents of 3-nitrobenzaldehyde were used a 0.96:1.00 ratio of 
imine (8.57 ppm) to aldehyde (10.15 ppm) was observed by 1H-NMR spectroscopy, equating 
Scheme 2: Equilibria present in condensation reaction of diisopropyl ureas. 
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to a 95% yield of aza-Wittig product. Gratifyingly, with one equivalent of the aldehyde similar 
yields (89%) were observed suggesting an excess was not required (Scheme 52). A known 
quantity of internal standard (2,5-dimethylfuran) was added to the crude NMR sample to offer 
additional comparison allowing for a yield calculated in relation to the internal standard. 
 
 Diphenyl carbodiimide (32) was the only side product detected by 1H NMR 
spectroscopy accounting for loss of between four and nine percent of the isocyanate 
equivalent. We envisaged a possible water mediated process which would form the imine. 
This pathway could involve the hydrolysis of the phenyl isocyanate intermediate forming 
aniline which would undergo a condensation reaction with the aldehyde regenerating the 
water. A control reaction was run where a substoichiometric amount of water (10 mol%) was 
added to a stirring solution of phenyl isocyanate and imine in refluxing toluene under 
conditions similar to those used for the intermolecular catalytic aza-Wittig reaction. 
Gratifyingly, only a trace amount of imine (< 5% by crude NMR) was observed, while the 
major product was, as expected, the diphenyl urea formed from the nucleophilic addition of 
aniline to the phenyl isocyanate. 
Due to the success of the hindered ureas, the feasibility of the alternative methods for 
in situ isocyanate synthesis was assessed. Initially a one-pot reaction from the hydroxamic 
acid was attempted. Benzohydroxamic acid (26) was stirred with a slight excess of CDI (1.1 
eq.) in toluene at room temperature for an hour to form the active dioxazalone intermediate 
(28) before the catalyst (25) and 3-nitrobenzaldehyde (36) were added and the resulting 
mixture heated to reflux for 24 hours. With two equivalents of (36) a 1 : 1 ratio of imine to 
aldehyde was detected in the crude 1H NMR, indicating a near quantitative conversion. With 
one equivalent of aldehyde there was almost quantitative conversion to imine, with diphenyl 
urea as the major side product (97:3 ratio (35b):Urea). Simplifying the reaction further, the 
Scheme 52: Results of intermolecular catalytic aza-Wittig starting from hindered urea. 
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vessel was charged with all of the reagents in toluene before the mixture was heated to reflux 
giving the imine at conversions of 89% (Scheme 53). 
 
The intermediacy of the dioxazalone (28) was investigated using the isolated species as 
the starting point for the intermolecular catalytic aza-Wittig reaction (Scheme 54). It was 
reported that a nucleophile was required to activate the dioxazalone so imidazole and 
diisopropylamine were tested. Yields were calculated using a known concentration of 2,5-
dimethylfuran as an internal standard. Interestingly imidazole proved to be better than 
diisopropylamine (Table 2), probably due to the labile nature of the imidazolyl urea compared 
with the more stable diisopropyl urea. The imidazole was recovered at the end of the reaction 
suggesting it may be possible to use sub-stoichiometric quantities to initiate the rearrangement 
but this was not attempted.   
  
Scheme 53: Results of intermolecular catalytic aza-Wittig starting from hydroxamic acid. 
Scheme 53: Results of the intermolecular catalytic aza-Wittig reaction starting from 
hindered urea. 
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Scheme 54: Dioxazalone (28) as a starting material for the intermolecular catalytic aza-
Wittig reaction 
Equivalents (36) Amine 
Ratio 
(imine:aldehyde) 
Yield (35b)a (%)  
1 iPr2NH(1.0 eq.) 3 : 2 58% 
2 iPr2NH(1.0 eq.) 2 : 3 37% 
2 iPr2NH(0.5 eq.) 1 : 3 23% 
2 Imidazole (1.0 eq.) 1 : 1 86% 
Table 3: a) Yield based on (28) calculated by 1H-NMR using internal reference (2,5-
dimethylfuran). 
 
2.3. Conclusions 
 
A range of conditions have been developed for the intermolecular catalytic aza-Wittig 
reaction utilising alternative starting materials, avoiding the need for azides. The Lossen 
rearrangement offers an alternative to the Curtius reaction for the in situ formation of 
isocyanates. Hydroxamic acids and the associated intermediate from the CDI mediated Lossen 
rearrangement, dioxazalone (28), were successfully employed to produce imine (35b) from 
the aldehyde in excellent yields. Diisopropyl urea (27), a masked isocyanate could also be 
used as a starting material for the catalytic aza-Wittig reaction, giving comparable yields to 
the isocyanate. The self-condensation reactions failed to provide the expected carbodiimide 
product, which is usually a side-product of the intermolecular catalytic aza-Wittig reaction. 
This reduced tendency to self-condense proves advantageous in later works. 
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3. Application of the Azide Free Catalytic Aza-Wittig Reaction 
to the Synthesis of Heterocycles. 
 
3.1. Introduction to Intramolecular Catalytic Aza-Wittig 
Chemistry 
 
The most important application of aza-Wittig chemistry is the synthesis of N-
heterocycles for which it has been used extensively for the synthesis of 5- and 6-membered 
N-heterocycles.67 The strong driving forces associated with the formation of the P=O bond 
allow for the synthesis of otherwise difficult systems. Large rings and strained systems can be 
easily accessed as exemplified by the synthesis of benzomalvin A, a seven-membered 
benzodiazepine,68 and benzodiazocine, an eight-membered ring system.69 The intramolecular 
reaction can also be used to do condensation reactions on less active carboxyls like esters and 
amides, which in the case of amides is sometimes referred to as the Eguchi protocol. Mild 
reaction conditions also make the aza-Wittig reaction functional group tolerant making it a 
valuable tool for total synthesis. So robust and mild is this methodology that it has been applied 
to a particularly complex thirteen-membered ring system as part of the total synthesis of (-)-
ephedradine A.70 
 
The redox-neutral catalytic variant of the aza-Wittig reaction first saw use in cyclization 
reactions for the synthesis of phenanthridines and benzoxazoles (Scheme 55).52 Since then it 
has been utilized in the synthesis of benzimidazoles.50 Intramolecular reactions are an ideal 
application for the redox-neutral catalytic aza-Wittig reaction as the competing self-
condensation reaction of the isocyanates can be controlled with high dilutions which favour 
the cyclization. Difficulties arising from hydrolytic instability experienced during attempts to 
isolate carbodiimide and imine products from the intermolecular reactions, should not occur 
with the products of intramolecular methodologies. In contrast to imines, N-heterocycles are 
stable and can be easily isolated. This should allow for quantifiable results and isolation of 
analytically pure products.  
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Previous members of the group found the synthesis of phenanthridines via catalytic aza-
Wittig methodology to be robust and starting materials could be produced in two steps from 
commercially available materials. We therefore aimed to emulate McGonagle’s methodology, 
utilising novel methods for in situ isocyanate synthesis to produce phenanthridines (Scheme 
56). Utilising the catalytic aza-Wittig reaction five examples of phenanthridines were 
synthesised by McGonagle in good to excellent yields from the corresponding acyl azides with 
catalyst loadings as low as 1 mol% (Scheme 55).52 While the ester derivatives could be 
successfully cyclised with catalyst loadings of between 1 and 5 mol%, reactions with the 
amides required higher catalyst loadings of 25 mol%. It was hoped that comparable or 
improved results could be achieved using either one of the novel reaction pathways first 
explored with the intermolecular reaction. Both of these starting materials held the potential 
to remove the need for hazardous azides.   
Scheme 55: Previous results for the intramolecular catalytic aza-Wittig reaction.50,52 
Scheme 56: Novel methods for in situ isocyanate synthesis. 
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3.2. Results and Discussion 
3.2.1. Synthesis of Diphenyl Hydroxamic Acids 
 
Emulating McGonagle’s route, the first step was the synthesis of the diphenic acid 
esters/amides (40a-j). Nucleophilic addition of alcohols and amines to diphenic anhydride 
provided a simple route to the respective esters and amides (40a-j) in good yields (Table 3). 
These diphenic acid esters/amides were typically purified by acid-base work-up. Observed 
side products for this reaction were identified as the diphenic acid and diphenic diesters (or 
diamide) which were removed easily on acid-base work-up. 
 
RX Yield RX Yield 
OMe (40a) 98% OBn (40f) 57% 
OEt (40b) 52% NEt2 (40g) 64% 
OiPr (40c) 74% 
(40h) 
82% 
OnBu (40d) 88% 
(40i) 
75% 
OtBu (40e) 50% 
(40j) 
87% 
Table 4: Results from the synthesis of diphenic acid esters and amides. 
 
Initially, attempts were made to produce the hydroxamic acids following Usachova et 
al’s method employing CDI as activating agent, which had proven successful for the synthesis 
of N-hydroxybenzamide (26).71 Unfortunately, when this methodology was applied to the 
synthesis of hydroxamic acid (39a) only a small amount of the desired product was formed 
with the rest forming a complex mixture of unknown products. The addition of hydroxylamine 
hydrochloride and a base to the acid chlorides (41a-j) of the acids under Schotten-Baumann 
conditions proved the most successful method for the synthesis of the hydroxamic acids (39a-
j). Stirring a solution of the acid in dichloromethane with oxalyl chloride and a drop of 
dimethylformamide provided the desired acid chlorides crude, which were then concentrated 
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under reduced pressure to remove unreacted oxalyl chloride. The concentrated acid chlorides 
(41a-j) were then re-dissolved in ethyl acetate before the addition of an aqueous solution of 
hydroxylamine hydrochloride and base. During optimisation it was found that suspending the 
acid chloride in a biphasic system of ethyl acetate and hydroxylamine hydrochloride salt in 
aqueous potassium carbonate provided the biphenyl ester hydroxamic acid (39a-f) in low to 
excellent yields (Table 4) (method a). These conditions proved unreliable for the amide 
substrates (39g-j), which suffered from poor solubility in ethyl acetate. In order to circumvent 
solubility issues experienced during attempts to produce the amide substituted hydroxamic 
acids (39g-j) an alternative method was developed. Adding the crude acid chloride mixture in 
dichloromethane to a solution of hydroxylamine hydrochloride and triethylamine in 
acetonitrile resulted in the formation of the desired crude hydroxamic acids. This method was 
applied to the synthesis of a range of amide substituted hydroxamic acids (39g-j) (route b). 
RX Yield Route RX Yield Route 
OMe (39a) 81% A NEt2 (39g) 76% A 
OEt (39b) 69% A NEt2 (39g) 84% B 
OiPr (39c) 78% A 
 
 (39h) 
60% B 
OnBu (39d) 66% A 
 
 (39i) 
66% B 
OtBu (39e) 26% A 
 
 (39j) 
52% B 
OBn (39f) 38% A 
 
 
Table 5: Results of hydroxamic acid synthesis. 
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Similarities between the Rf of the starting acid and the hydroxamic acids made 
chromatograph separation troublesome. Normal silica column chromatography did not offer 
enough resolution to separate the desired hydroxamic acid (39a-j) from the starting acid (40a-
j). Both acids and hydroxamic acids streak on TLC. Eluting the column using a mixture of 
solvents and 1% acetic acid allowed for separation but removal of acetic acid from the 
fractions proved problematic even under reduced pressure. The difference in acidity between 
the carboxylic acid (pKa ~ 4) and hydroxamic acid (pKa ~ 9) was viewed as a possible handle 
for separation. At pH 7 it can be assumed that the majority of hydroxamic acid will be neutral 
(C(O)NHOH), while the majority of the carboxylic acid will be deprotonated (COO-). 
Acidification (pH = 1) of the reaction mixture removed excess hydroxylamine and neutralised 
left-over base. The product was then extracted from the organic phase with an aqueous 
solution of NaOH (1 M) and washed with organic solvent to remove neutral impurities such 
as the di-substituted esters/amides. Neutralising the basic aqueous phase allowed the 
hydroxamic acid to be extracted. Acid-base work-up aided purification but led to a low 
recovery of hydroxamic acid (39). After the work-up the product could be purified further by 
recrystallization from toluene. Further investigation found optimum conditions for separation 
to be column chromatography with a basic eluent, which allowed for the hydroxamic acid 
(39a-j) to be separated from the acid. A mixture of saturated aqueous ammonia (~ 18 M, pKa 
= 9.4) and ethanol in dichloromethane (1 : 8 : 50) was polar enough to cleanly elute the desired 
hydroxamic acid and basic enough to cause acidic impurities to elute slower.  
Of particular interest was the synthesis of the N-methylpiperazine amide (39k) which 
could be used for the synthesis of the biologically active N-methylpiperazine phenanthridine 
(41k).72 However, the desired hydroxamic acid (39k) could not be isolated, possibly due to 
zwitterion formation between the hydroxamic acid and tertiary amine of the piperazine 
complicating purification. The N-Boc protected piperazine (39l) offered a route to the core of 
this phenanthridine (41k) without a basic tertiary amine group, simplifying purification. This 
led to a different difficulty; the acidic conditions of the oxalyl chloride step de-protected the 
acid-labile Boc group. To rectify this, triethylamine was added before the addition of oxalyl 
chloride to neutralise the acid liberated during the reaction. 
Following on from the success of the hindered ureas as the starting materials for the 
intermolecular catalytic aza-Wittig (Scheme 52), attempts were made to produce biphenyl 
ureas for use in the intramolecular reaction. It was hoped that the Lossen rearrangement 
starting from the previously isolated hydroxamic acids (39a-j) could produce a range of 
hindered ureas providing alternative starting materials for the catalytic aza-Wittig reaction. 
Addition of a slight excess (1.2 eq.) of CDI to hydroxamic acid (39a) in acetonitrile and 
subsequent trapping with diisopropylamine on heating failed to produce the desired urea 
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(38a). Instead diisopropyl carboxamide phenanthridone (42) was isolated at a 90% yield 
(Scheme 57). Presumably, this arises from the condensation reaction of the urea secondary 
nitrogen with the ester, liberating methanol. This observation suggests that the desired Lossen 
rearrangement occurs producing the urea before forming the observed side product.  
 
While this may limit the application of hindered ureas as starting materials for the 
intramolecular aza-Wittig reaction it does demonstrate that these diphenic hydroxamic acids 
undergo Lossen rearrangement to produce the corresponding isocyanate intermediates which 
can then be trapped. It also offers insight into a possible side reaction for the CDI-mediated 
Lossen rearrangement which is worth consideration.  
 
3.3. Azide-Free Synthesis of Phenanthridines 
 
 
Initially, the conditions optimised by McGonagle for the catalytic aza-Wittig reaction 
starting from acyl azides were adapted for the reaction where the isocyanate starting material 
was produced via the CDI-mediated Lossen rearrangement (Scheme 59). Carbonyl 
diimidazole was added to a solution of hydroxamic acid (39a) in toluene and the mixture was 
stirred at room temperature for half an hour before being heated to reflux for an hour. After 
this time a solution of phospholene oxide (20 mol%) (25) in toluene (0.1 M) was added to the 
refluxing reaction mixture and was stirred at this temperature for a further 18 hours. It was 
hoped that using this stepwise approach the dioxazalone (43a) would form at room 
Scheme 58: Desired reaction for the azide free synthesis of phenanthridines. 
Scheme 57: Attempt to produce biphenyl diisopropyl urea (38a). 
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temperature, rearrange to the isocyanate on heating then undergo the catalytic aza-Wittig 
reaction on addition of catalyst (25) (Scheme 59). Unfortunately, this initial attempt failed to 
produce the desired product (41a), instead forming the phenanthridone (44) (90%). One 
suggestion for the mechanism responsible for the production of this species is a condensation 
reaction involving the imidazolyl urea (45) similar to that observed in the attempted synthesis 
of the hindered ureas described in Scheme 57. It is thought that the urea (45) would be formed 
by attack of imidazole on either the dioxazalone or isocyanate intermediates. The observed 
precipitation of the phenanthridone (44) would drive the equilibrium towards the by-products 
thus removing the imidazolyl urea (45) from the equation. Loss of the imidazolyl carboxamide 
on work-up would explain the absence of this pendant group on the observed by-product in 
the crude reaction mixture.  
 
In an attempt to reduce this competing condensation reaction, the phospholene oxide 
catalyst was added before addition of CDI. This time the reaction was stirred at room 
temperature for 2 hours before being heated to reflux for 18 and afforded 24% of the desired 
phenanthridine (41a) and 67% of the phenanthridone (44). To gain some mechanistic insight 
into the reaction, the dioxazalone (43a) was isolated in 80% yield by the addition of CDI (1.2 
eq.) to hydroxamic acid (39a) in dichloromethane (0.25 M) at 0 °C stirring for two hours 
(Scheme 60). Phenanthridone (44) was observed as a side product from this reaction, offering 
further evidence for the involvement of the imidazolyl urea intermediate (45) in the formation 
of this phenanthridone supporting the proposed mechanism, showing little/no involvement of 
the catalyst (25) or iminophosphorane intermediate in the formation of phenanthridone. When 
the dioxazalone (43a) was heated with catalytic imidazole and phospholene oxide the product 
Scheme 59: Mechanistic explanation for observed phenanthridone (44) 
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(41a) was isolated in 34% yield alongside the phenanthridone (44) as the major side product 
(47% yield) (Scheme 60).  
Scheme 60: Synthesis of phenanthridines starting from dioxazalone.  
 
The more hindered iso-propyl ester biphenyl hydroxamic acid (39c) was explored next, 
with the hope that a more hindered ester would reduce the amount of condensation product 
(44) formed. Subjecting (39c) to the same conditions used for the methyl ester (39a) (1.2 eq. 
CDI, 10 mol% catalyst (25) in toluene (0.25 M, 2 hours at room temperature, 18 hours at 110 
°C) yielded 59% of the desired phenanthridine (41c) and 12 % yield of phenanthridone (44). 
A range of conditions were screened to optimise the reaction (Scheme 61) (Table 5). 
 
Scheme 61: Azide free synthesis of isopropyl phenanthridine. 
Table 6: Table of results from optimisation. a) Carbodiimide (46c).  
 
Entry Concentration 
(39c) (mol.dm-3) 
Catalyst loading 
(25)  
(mol %) 
Ratio of  
(41c) : (44) 
in crude  
Isolated Yield 
(41c) 
1 0.25 5% 1.0 : 1.5 40% 
2 0.25 10% 1.0 : 0.2 59% 
3 0.25 20% 1.0 : 0.2 69% 
4 0.25 100% 1.0 : 0.1 79% 
5 0.50 10% 1.0 : 0.1 74% 
6 0.50 20% 1.0 : 0.1 87% 
7 1.00 20% 1.0 : 0.0 : 
2.2a 
40% 
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Doubling the concentration and catalyst loadings significantly improved reaction yields 
(Entry 6), this is presumably due to the increased frequency of interactions between the 
catalyst and isocyanate favouring the desired aza-Wittig reaction. At high concentrations 
(Entry 7) a side product was observed being formed during the reaction; presumably this was 
the carbodiimide (46c). It was found to contain the characteristic IR signal at 2140 cm-1 and 
was observed as the corresponding urea by LC-MS ([M+H] C33H33N2O5 m/z = 537.23). It can 
be expected that this intermolecular self-condensation reaction would be favoured at high 
concentrations. It is of note that catalyst loadings could be reduced to 5% without significant 
lowering of yield (Entry 1). Optimum conditions were found to involve heating the reaction 
mixture rapidly after the addition of CDI in the presence of the catalyst, allowing for complete 
formation of the dioxazalone intermediate before rapid formation of the isocyanate at 
temperatures where the rate of reaction for the catalytic aza-Wittig reaction is sufficient to 
compete with the condensation reaction. 
These optimum conditions were then utilised to produce a range of phenanthridines 
(41a-j) from the corresponding hydroxamic acids (39a-j) (Scheme 62). Substrates containing 
both esters and amides successfully underwent the aza-Wittig reaction. 
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The tert-butyl ester containing substrate (39e) failed to provide the desired product 
(41e), instead undergoing condensation to form the phenanthridone (44) in almost quantitative 
yield. Presumably the bulky tert-butyl group prevents the iminophosphorane intermediate 
from accessing the carbonyl. Steric bulk can also be assumed to be the cause of the lower yield 
for the diethylamide system (41g) compared with the cyclic amides. In the cyclic amides (41h-
j) the substituents are constrained in a ring, increasing access for the iminophosphorane to the 
carbonyl. Further investigation found the low yield for the benzyl ester (41f) system to be 
attributed to decomposition of the hydroxamic acid (39f); on heating, the starting hydroxamic 
acid (39f) decomposed producing the phenanthridone (44). This has been observed when on 
heated to reflux a solution of hydroxamic acid (39f) in toluene without CDI or phospholene 
oxide catalyst (25) give a quantitative yield of phenanthridone (44) as detected by 1H-NMR 
spectroscopy. Phenanthridine (41f) proved to be stable under the reaction conditions, since 
Scheme 62: Optimised reaction conditions and Yields for the CDI-mediated Lossen 
rearrangement initiated catalytic aza-Wittig. 
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stirring a solution of independently prepared benzyl phenanthridine (41f), phospholene oxide 
(25) and CDI in refluxing toluene led to total recovery of starting material. A further 
verification came from taking the acyl azide (47) and subjected it to the catalytic aza-Wittig 
reaction conditions optimised by McGonagle (5 mol% phospholene oxide (25), 0.1 M in 
toluene, 110 °C for 24 hours)52 which led to an isolated yield of 57% for the benzyl 
phenanthridine (Scheme 63). This supports the hypothesis that the hydroxamic acid is 
decomposing at elevated temperatures.  
 
Phenanthridone side product (44) was insoluble in most solvent systems and proved 
difficult to isolate by flash column chromatography. To reliably calculate the amount of 
phenanthridone (44) produced, the ratio of phenanthridine (41) to phenanthridone (44) could 
be calculated from integration of the proton NMR spectra in DMSO-d6. Conversions were 
calculated from the integration of phenanthridine (41) (two doublets at 8.65 and 8.55 ppm) 
and phenanthridone (44) (three doublets at 8.43, 8.39 and 8.32 ppm) signals compared with 
an internal standard (dimethylfuran, 5.80 and 2.20 ppm) with a known concentration are 
presented below (Table 6).  
Table 7: Conversion of hydroxamic acids (39a-f) to phenanthridine (41a-f) and 
phenanthridone (44) calculated by 1H-NMR. 
 
An alternative side product was observed for the amide systems (39g-l), which matched 
the carbodiimide side product observed by McGonagle. The carbodiimide product was not 
observed with the ester systems under normal conditions (39a-f) but was noted during 
optimisation when reactions carried out at high concentration. Amide carbonyls are more 
RX (41) (44) RX (41) (44) 
OMe (41a) 
OEt (41b) 
OiPr (41c) 
45% 
70% 
65% 
32% 
20% 
26% 
OnBu (41d) 
OtBu (41e) 
OBn (41f) 
44% 
0% 
13% 
33% 
77% 
87% 
Scheme 63: Synthesis of benzoxy phenanthridine (41f) via Curtius rearrangement. 
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electron rich and stable preventing the condensation reaction which would lead to the 
phenanthridone (44), but this also lowers electrophilicity meaning the desired intramolecular 
aza-Wittig reaction is slower, favouring the intermolecular condensation reaction involved in 
the self-condensation pathway. The carbodiimide can be observed by IR, 1H-NMR and as the 
urea by LC-MS. Unfortunately they are difficult to quantify by NMR due to similarities 
between the carbodiimides, products and starting materials. As previously mentioned, 
carbodiimides are unsuitable for column chromatography meaning isolation would prove 
difficult and is unlikely to be an accurate representation of the yield. 
To reassess the role of the dioxazalone as an intermediate or alternative starting material 
the more hindered iso-propyl ester dioxazalone (43c) was synthesised. This was used to test 
the effect of different amounts of imidazole in an attempt to understand the competing 
intramolecular acyl substitution giving rise to phenanthridone (44). Using the optimised 
conditions for the catalytic aza-Wittig step allowed for comparison with the one-pot reaction. 
With no imidazole present only a trace amount of product was observed in the crude 1H-NMR 
spectrum, with the majority of the mass balance being recovered starting material, reinforcing 
the idea that a nucleophile is required to initiate the CDI-mediated Lossen rearrangement. 
Substoichiometric amount of imidazole (20 mol%) leads to a yield comparable to the one pot 
reaction (79%) with trace amounts of the phenanthridone side-product (44) and other unknown 
by-products completing the mass-balance, but no observable starting material. This result 
supports the hypothesis that imidazole is catalytic and is required to initiate the Lossen 
rearrangement. With stoichiometric imidazole a high yield of the desired phenanthridine (41c) 
was isolated (66%). This yield was not as high as was isolated from the catalytic reaction 
which suggests that the imidazole also plays a role in the competing condensation reaction. It 
should be noted that in general yields are lower starting from the dioxazalone than for the one 
pot reaction due to the instability of starting dioxazalone (39c) which decomposes over time 
making it unsuitable as a starting material. 
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In conclusion, the Lossen rearrangement has been utilised as an in situ method for the 
synthesis of isocyanates for the catalytic aza-Wittig reaction with yields comparable to the 
Curtius variant (Scheme 64). It must be noted that higher catalyst loadings were required for 
the Lossen variant with esters, but lower catalyst loadings could be used for amide systems 
using the Lossen rearrangement rather than the Curtius. One possible explanation for this is 
differing side-reactions. When using the Curtius variant the carbodiimide side-product arises 
from the intermolecular dimerisation which occurs due to higher concentrations of the 
isocyanate. While with the Lossen rearrangement the isocyanate is possibly in equilibrium 
with the imidazolyl urea, meaning isocyanate concentration remain low throughout the 
reaction. The phenanthridine (44) side-product is possibly formed from a side reaction of the 
imidazolyl urea, which cannot occur in the Curtius system. 
Scheme 64: Comparison of Curtius and Lossen methodologies. 
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3.3.1. Starting Material Development for Substituted 
Phenanthridine Synthesis 
 
With a range of diphenic amides and esters (41a-l) explored, there remained the 
potential to place substituents on either of the two aryl rings. Cross-coupling reactions grant 
access to various substituted biaryls which could be used to explore the impact of electronic 
effects on the reaction. In the literature, Suzuki reactions are regularly employed to produce 
substituted biaryls with an aldehyde moiety in the 2-position which can then be oxidised to 
the corresponding carboxylic acids.73-76 There are no reports of cross-coupling reactions direct 
from the acid with an ester or amide substituted aryl bromides or boronic acids, so it was 
decided to use the two step process. To probe this route the simple ethyl ester biaryl aldehyde 
(48b) was synthesised in an adequate yield (58%) following literature conditions.74 
Tetrakis(triphenylphosphine) palladium(0) (5 mol%) was added to a mixture of commercially 
available bromide (49b) (1.0 eq.) and boronic acid (50) (1.0 eq.) in toluene (0.06 M) and 
aqueous K2CO3 (2.0 M, 6.7 eq.) then heated to reflux for 18 hours (Scheme 65). Oxidation 
with potassium permanganate yielded the carboxylic acid (40b) in an acceptable yield (50%). 
A large range of aryl bromides and boronic acids are commercially available meaning there is 
scope to produce many substituted biaryl carboxylic acids derivatives via this method. 
Scheme 65: Suzuki reaction and oxidation pathway to biaryl acid (40b). 
 
Microwave irradiation provides a much more rapid heating method for Suzuki 
reactions.73 Superheating the reaction mixtures in dioxane in a sealed reaction vessel to 120 
°C led to reactions reaching completion in 25 minutes. Due to the short reaction times and 
ease of use, the microwave-assisted method was applied to the synthesis of biaryl aldehyde 
(48b). Initial attempts using a slight excess of boronic acid (50) (1.1 eq.) yielded less of the 
desired product (48b) (47% yield) than the standard reaction (Scheme 66). Proton NMR 
spectroscopy of the crude reaction mixture found that while all boronic acid had been 
consumed, half of the bromide (49b) remained unreacted. It was found that the boronic acid 
had undergone proto-deboronation forming benzaldehyde, which could be observed in the 1H-
NMR of the crude reaction mixture. 
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The speed of the reaction allowed for rapid screening of a range of conditions. 
Integration of aryl bromide (49b) and product (48b) signals by 1H-NMR spectroscopy of the 
crude reaction mixture after work-up provided a rapid method for crudely quantifying 
conversions of bromides to biaryls (Table 7). Thorough degassing by bubbling nitrogen 
through the reaction solvents for half an hour improved the reaction yields (entry 1). Screening 
a series of commonly used bases led to no improvement in yields. While higher conversions 
were noted for sodium hydroxide (entry 3) and potassium phosphate (entry 5), less material 
was recovered after the reaction, suggesting that some mass balance might have been lost on 
work-up or under reduced pressure. Next, the effect of solvation was investigated. While polar 
protic (methanol, entry 7) and aprotic solvents (dioxane, entry 1, DMF, entry 8 and 
acetonitrile, entry 9) all gave comparable yields (60 − 68%), non-polar toluene led to poor 
conversion (entry 10) (8%), which is surprising given that the traditional method is performed 
in toluene. Using an alternative set of literature conditions (increased catalyst loading (5 
mol%) and an anhydrous solvent system of toluene and ethanol (10 : 1 ratio)) resulted in a low 
conversion to the desired product (48b) (entry 11).77 Fortunately, it was found that increasing 
the equivalents of boronic acid increased the conversion of bromide, with two equivalents of 
boronic acid providing complete conversion to the desired biaryl (entry 13). 
  
Scheme 66: Microwave assisted synthesis of biaryl (48b). 
68 
 
Table 8: Suzuki optimisation. 
 
 
 
Entry Base 
(eq.) 
Organic 
solvent 
(50) 
(eq.) 
Pd cat. 
loading 
Conversion 
of (49b) to 
(48b) 
1 Na2CO3 
(2.0 eq.) 
Dioxane 1.1 eq. 2 mol% 64% 
2 K2CO3 
(2.0 eq.) 
Dioxane 1.1 eq. 2 mol% 64% 
3 NaOH 
(2.0 eq.) 
Dioxane 1.1 eq.  2 mol% 84% (lost 
mass) 
4 NaHCO3 
(2.0 eq.) 
Dioxane 1.1 eq. 2 mol% 64% 
5 K3PO4 
(2.0 eq.) 
Dioxane 1.1 eq. 2 mol% 85% (lost 
mass) 
6 Na2CO3 
(4.0 eq.) 
Dioxane 1.1 eq. 2 mol% 54% 
7 Na2CO3 
(2.0 eq.) 
MeOH 1.1 eq. 2 mol% 66% 
8 Na2CO3 
(2.0 eq.) 
DMF 1.1 eq. 2 mol% 68% 
9 Na2CO3 
(2.0 eq.) 
MeCN 1.1 eq. 2 mol% 60% 
10 Na2CO3 
(2.0 eq.) 
PhMe 1.1 eq. 2 mol% 8% 
11 K2CO3 
(6.7 eq.) 
PhMe: 
EtOH 
1.1 eq. 5 mol% 30% 
12 Na2CO3 
(2.0 eq.) 
Dioxane 1.5 eq. 2 mol% 85% 
13 Na2CO3 
(2.0 eq.) 
Dioxane 2.0 eq. 2 mol% 99% 
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The optimised conditions were found to be addition of the bromide (1.0 eq.) to a 
suspension of boronic acid (2.0 eq.), Pd(PPh3)4 (2 mol%) and sodium carbonate (2.0 eq.) in a 
mixture of dioxane (1.7 M) and water (2.5 M) which was degassed and flushed with nitrogen 
for an additional 20 minutes before being heated with stirring to 120 °C for 25 minutes in a 
microwave (100 W) (Scheme 67). After cooling to room temperature the reaction mixture was 
washed with brine and extracted with ethyl acetate before being dried with sodium sulphate 
and concentrated under reduced pressure. 
Optimised conditions provided a route to the desired aldehydes in excellent yields, but 
for more expensive substituted boronic acids using two equivalents of boronic acid was 
undesirable and limited the scale reactions could be run on. For these systems we turned to 
conditions reported by Moseley et al. using a more active palladium catalyst, Pd(dbpf)Cl2, 
colloquially known as “Pd-118”.78 With the palladium species at the (II) oxidation state it is 
resistant to oxidation, a process which poses a problem for palladium(0) species such as 
tetrakis(triphenylphosphine) palladium(0) (Pd(PPh3)4). To produce the active palladium(0) 
species the starting palladium(II) species is initially reduced in situ by a slight excess of 
boronic acid. While Moseley’s conditions originally used traditional heating, they were easily 
adapted for microwave heating with a simple solvent swap from acetonitrile to dioxane. The 
adapted conditions were similar to those previously used. Addition of the bromide (1.0 eq.) to 
a suspension of boronic acid (1.2 eq.), “Pd-118” (1 mol%) and potassium carbonate (1.5 eq.) 
in a mixture of dioxane (0.5 M) and water (0.5 M), degassed by flushing with nitrogen for an 
additional 20 minutes before being heated with stirring to 120 °C for 25 minutes in a 
microwave (100 W) (Scheme 68). After cooling to room temperature the reaction mixture was 
washed with brine and extracted with ethyl acetate before being dried with Na2SO4 and 
concentrated under reduced pressure. 
Scheme 67: Optimised conditions for Suzuki cross-coupling reaction. 
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The methods furnished us with the aldehyde starting materials (48a-h) in good to 
excellent yields (56 – 99%) from the corresponding bromides and (2-formyl)phenylboronic 
acids on gram scale. Both sets of conditions gave similar yields, with the optimised conditions 
with two equivalents of boronic acids providing slightly higher yields in cases with (2-
formyl)phenylboronic acid, and Moseley’s conditions giving higher yields for the more 
difficult functionalised boronic acids (48e + 48f). Under the forcing reaction conditions the 
chlorides on (48c) and (48d) have undergone a small degree of cross-coupling, yielding a 
noticeable amount of compounds believed to be triaryl ((51) 8% and (52) 7%) based on the 
integration of signals for the aldehyde and methyl ester at a 2:3 ratio in the crude 1H-NMR 
spectrum. This would explain the lower isolated yield for the desired products.  
 
Scheme 68: Results of Suzuki reaction for the formation of biaryls. Percentages in 
parenthesis are yields using conditions of Moseley et al.. 17 
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Heterocycles are well known to react sluggishly in the Suzuki reaction.78 Indeed 
Moseley et al. report that the formation of thiophenyl biaryl (53) took 24 hours to reach 
completion, rather than the usual 2 hours.78 Even with superheating and the more active “Pd-
118” catalyst a third of the starting (formyl)thiophenyl boronic acid (50f) and a third of the 
ethyl 2-bromobenzoate (49b) were recovered after 25 minutes, explaining the poor yield for 
these reactions. Moseley et al. report that the use of hydrochloride salts of the pyridyl bromides 
allowed them to undergo cross-coupling reactions. Cross-couplings were attempted with two 
pyridyl bromides (methyl 3-bromopyridine 4-carboxylate (54) and methyl 2-bromopyridine 
3-carboxylate (55)). While the reaction of methyl 2-bromopyridine 3-carboxylate (55) with 
formylphenyl boronic acid yielded an adequate amount of the desired product (48l) (59% 
yield), 3-bromopyridine-4-carboxylate (54) only produced a complex mixture of products, 
none of which could be identified. Although (48l) was isolated it could not be recovered after 
the oxidation step, presumably due to the zwitterionic nature of the acid (40l).  
 
Aldehyde (48g) was prepared as the first step in a proposed synthesis of biologically 
active benzophenanthridine (56) which has been found to be a potent 5-HT3 receptor 
antagonist (Scheme 70).79 
Scheme 69: Attempt at synthesis of pyridine derived biaryl acid (40l). 
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To convert the isolated aldehydes into the required acids an oxidation step had to be 
performed. Originally a potassium permanganate method was used but often resulted in 
complex mixtures which may be attributed to the indiscriminate nature of potassium 
permanganate. Alternative oxidation techniques were explored in an attempt to allow for the 
incorporation of less robust functional groups in the biaryl products. A literature precedent 
has been set for the Pinnick oxidation to work selectively with similar systems.76 The 
conditions reported by Miura et al. were adapted to use 1-methylcyclohexene rather than the 
low boiling 2-methyl-2-butene which would be difficult to handle. A range of acids were 
prepared by the addition of sodium chlorite (NaClO2) (4.0 eq.) to a stirred solution of aldehyde, 
1-methylcyclohexene (5.0 eq.) and monosodium phosphate (1.0 eq.) in a mixture of (6 : 2 : 1) 
tBuOH, water and acetonitrile for 16 hours at room temperature in good to excellent yields 
(58 − 99%) (Scheme 71).  
 
  
Scheme 70: Retro-synthetic analysis of biologically active benzophenanthridine (56). 
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The role of 1-methylcyclohexene is as a scavenger of hypochlorous acid (HOCl) which 
is formed as a by-product throughout the reaction and can consume the active sodium chlorite 
to produce the hazardous chlorine dioxide (ClO2). The tertiary alkene is sacrificially oxidised 
by HOCl, a more powerful oxidant than the sodium chlorite (NaClO2). The problem associated 
with using methyl cyclohexene as a scavenger is the production of aliphatic alcohol chloride 
products (Scheme 72). These oxidation products proved difficult to separate from the desired 
acids, so the use of hydrogen peroxide as a scavenger was investigated. Hydrogen peroxide 
reacts with the hypochlorous acid (HOCl) to produce HCl and water which are removed on 
work-up and O2 which is lost as a gas.80 
 
Using hydrogen peroxide as a chlorite scavenger gave vastly cleaner reactions and 
provided pure acids from the corresponding aldehydes after an acidic work-up (4 M HCl). 
This method was used to produce a range of acids in excellent yields (71 – 99%) (Scheme 73). 
Scheme 71: Pinnick oxidation of biaryl aldehydes with 1-methyl cyclohexene scavenger. 
Scheme 72: Role of scavengers in the Pinnick oxidation.80 
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Scheme 73: Yields for Pinnick oxidation step. Percentages in parentheses are yields using 
hydrogen peroxide conditions. 
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Following the reaction conditions optimised for the synthesis of unsubstituted 
hydroxamic acids (Table 4), the acids were transformed into the hydroxamic acids using the 
previously developed Schotten-Baumann conditions (Scheme 43). As detailed previously, 
triethylamine was added to the synthesis of N-Boc piperazine acid chlorides (39m + 39t) with 
the purpose of neutralising acid liberated throughout the reaction. Yields were found to be 
comparable to the unsubstituted systems (Scheme 74).  
 
  
Scheme 74: Results from the synthesis of substituted biaryl hydroxamic acids. 
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3.4. Azide-Free Synthesis of Substituted Phenanthridines 
 
Subjecting the substituted hydroxamic acids (39m-t) to the conditions optimised for the 
synthesis of the simple phenanthridines (Scheme 62) provided the expected substituted 
products (41m-t). Substituted phenanthridines suffered from lower yields (48 – 62%) than the 
simple methoxy-phenanthridine (41a) which was isolated in a 68% yield. The difference in 
yields was more marked in the ethoxy systems (41r 49% yield and 41s 43%) wherein the 
simple systems was isolated in an 83% yield. Since it can be envisaged that the aza-Wittig 
reaction is the nucleophilic addition of an iminophosphorane onto a carbonyl, it could be 
expected that electron-donating substituents on the ring sporting the carbonyl would lead to 
lower yields. Electron-withdrawing substituents would be expected to increase the yield of the 
aza-Wittig reaction. Experimental results seem to disagree with the expected hypothesis, since 
electron-rich systems (41n + 41o) were isolated in higher yields than the electron-poor 
chlorides (41p + 41q) (Scheme 75). 
 
Scheme 75: Results of the azide free catalytic aza-Wittig reaction of substituted 
phenanthridines. 
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Steric effects may explain the lowest yield of the set. The naphthyl system (41m) had 
the lowest yield of all the phenanthridines, presumably because of the steric hindrance 
involved in aligning the iminophosphorane and the amide with two protons clashing in the 
planar product (Scheme 76).  
 
3.5. Conclusions 
 
A range of phenanthridines have been synthesised using the CDI-mediated Lossen 
rearrangement to produce isocyanates from hydroxamic acids in situ. Yields are comparable 
to the catalytic aza-Wittig reaction utilising the Curtius rearrangement. Unfortunately catalyst 
loadings were higher for the Lossen mediated reaction where high loadings are required to 
prevent the alternative side-reaction observed for the CDI mediated Lossen rearrangement. 
Hydroxamic acids can be isolated in good to excellent yields starting from the corresponding 
acid on a gram scale. 
Novel phenanthridines with various pendant amines and ethers have been produced 
using this new method, many in good yields. The reaction has also been used to synthesise 
phenanthridines sporting various functional groups on the aromatic rings. The first example 
of a thienoisoquinoline being synthesised via the catalytic aza-Wittig reaction is also reported. 
  
Scheme 76: Steric clash involved in naphthyl derivative 
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4. Organocatalytic Aza-Wittig Reaction of Seven-Membered 
Heterocycles 
4.1. Introduction to Benzodiazepine Synthesis 
 
Having explored the synthesis of the six-membered heterocyclic phenanthridines it 
seemed prudent to explore a larger ring system. Benzodiazepines seemed to be the perfect 
system to apply the developed methods for the azide-free catalytic aza-Wittig reaction. This 
seven-membered ring is an important moiety in a large number of pharmaceutically active 
compounds; indeed benzodiazepines are synonymous with sedatives due to the importance of 
diazepam (Vallium) (Scheme 77). The benzodiazepine binds to the GABAA receptor, acting 
as a GABA agonist enhancing the effect of the neurotransmitter, suppressing excitation in the 
central nervous system.81 Due to this behaviour benzodiazepines are used in the treatment of 
epilepsy, delirium, psychosis, anxiety, alcohol withdrawal, seizures and insomnia. Due to the 
importance of these compounds the classical aza-Wittig reaction has been applied to their 
synthesis. 
 
Scheme 77: Important benzodiazepines 
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Various groups have devised methods incorporating the aza-Wittig reaction for the 
synthesis of benzodiazepines (Scheme 78). The original example was a publication by Eguchi 
et al. which took an azidobenzoic acid, formed the acid chloride and added this to amino acid 
esters to form the azide-containing starting materials which underwent the Staudinger/aza-
Wittig reaction to give the benzodiazepines in good yield.82 Grieder et al. adapted this work 
to produce a library of benzodiazepine-quinazolinone alkaloids (circumdatins) using a 
polymer-supported-phosphine-mediated intramolecular aza-Wittig reaction. By using 
polymer-supported phosphine reagents it is possible to circumvent the issues associated with 
the removal of phosphine oxide by-products after the aza-Wittig reaction, allowing for the 
rapid synthesis of benzodiazepines. Over 120 examples were prepared in acceptable to good 
yields (40 - 60%) and high purity.83 Similarly, Gil and Bräse used polymer-supported 
phosphine reagents to carry out the synthesis of benzodiazepines via the aza-Wittig reaction. 
Polymer-supported reagents were also employed in the amide bond formation reaction.84 By 
utilising the Ugi reaction Torroba et al. managed to produce the starting materials for the 
Staudinger/aza-Wittig reaction in one step allowing them to synthesis a range of 
benzodiazepines.85 Another example of the synthesis of benzodiazepines using an alternative 
set of reagents for the Ugi reaction to produce starting materials have been developed by Ding 
et al..86 This group has also produced a temperature dependant aza-Wittig cyclization, at 80 °C 
the benzodiazepines are formed, at room temperature, 1,2,4-triazino[2,3]indazoles are 
produced (Scheme 79).87 Scifinder finds 21 publications involving the synthesis of 
benzodiazepines using aza-Wittig protocols producing 171 different benzodiazepines.88 
Scheme 78: Solid Supported Synthesise of Benzodiazepines.82,83 
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The most recent method reported involves the catalytic Staudinger/aza-Wittig reaction 
mediated by in situ reduction detailed above (Scheme 80). van Delft et al. developed a protocol 
where the phosphine oxide (57) is reduced back to the phosphine using diphenylsilane.19 While 
the proline derivatives (58a) and (58b) worked well, other systems suffered from low yields 
arising from the competing reduction of the iminophosphorane intermediate which led to 
recovery of the anilines. This method also required the use of hazardous azide starting 
materials, an issue we wished to address with the redox neutral catalytic aza-Wittig reaction. 
  
Scheme 79: Ugi reaction for the synthesis of starting materials for the synthesis of 
Benzodiazepines.83-86 
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It was our aim to produce a comparison between the redox neutral catalytic aza-Wittig 
reaction and the redox mediated catalytic aza-Wittig methodology. Due to the success of the 
proline derived benzodiazepines reported by van Delft it was decided to use this for 
preliminary investigations into the application of azide free methods for the synthesis of 
benzodiazepines. Initial attempts were focused on producing the hydroxamic acid starting 
materials. 
  
Scheme 80: Results from redox mediated catalytic aza-Wittig.19 
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4.2. Results and Discussion 
4.2.1. Hydroxamic Acids as Potential Starting Materials for 
Synthesis of Benzodiazepines 
 
Inspired by the success of hydroxamic acids as starting materials for the synthesis of 
phenanthridines, the first target was to produce the corresponding hydroxamic acid for the 
synthesis of the benzodiazepine. To produce the required carboxylic acid (59) initial attempts 
looked to emulate previous work on the phenanthridines by opening the corresponding 
anhydride, in this case phthalic anhydride, with the desired nucleophile L-proline methyl ester. 
By following the literature preparation reported by Jarho et al.89 multiple grams of the starting 
acid (59) were produced in good yields. Addition of phthalic anhydride to a solution of L-
proline methyl ester hydrochloride and triethylamine in DCM at 0 °C with subsequent 
warming to room temperature over 2 hours furnished us with 5 grams (70% yield) of the pure 
starting acid (59). With this acid in hand the aim was to form the acid chloride and react it 
with the hydroxamic acid in similar conditions to those used for the synthesis of diphenyl 
hydroxamic acids (39) used previously. Unfortunately this methodology failed to produce the 
desired hydroxamic acid (60a); instead starting acid was recovered after every attempt 
(Scheme 81). 
 
Thinking this may be an issue associated with the acid chloride, other carboxylic acid 
activating agents were tested. Carbonyl diimidazole (CDI) and the triazole peptide coupling 
reagent HATU were tried and again led only to the recovery of starting acid (59). Next, a 
range of O-protected hydroxylamines were tested with CDI as the coupling partner. It was 
hoped that the mildly basic conditions expected from the liberation of imidazole would prevent 
deprotection of the acid labile groups. Silyl protecting groups (trimethylsilyl (TMS) and the 
more stable tert-butyldimethylsilyl (TBDMS)) were initially tried but again failed to produce 
the desired protected or deprotected hydroxamic acids. Next the more stable tetrahydropyryl 
Scheme 81: Initial attempts to produce hydroxamic acid (60a). 
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(THP) protecting group was used. It was hoped that because it was more acid stable than the 
silyl protecting groups it would survive the coupling process. Unfortunately, again none of the 
desired products were observed (Scheme 85). It is possible that the activated acid undergoes 
coupling with the adjacent carbonyl to form an anhydride like species (61) which is not 
susceptible to attack by hydroxylamine but on work up or acidification inside the LC-MS 
returned to the starting acid (Scheme 82). 
 
An alternative method was devised which incorporated the hydroxamic acid prior to the 
addition of the proline. It was hoped that by protecting N-hydroxyphthalamide with para-
methoxy benzyl ether (PMB) it would behave similarly to the anhydride and allow for addition 
of the proline methyl ester. Gratifyingly, the desired product (60e) was isolated and 
deprotected by hydrogenolysis. This hydroxamic acid (60a) was then subjected to the same 
conditions as those used previously in the synthesis of the phenanthridines, but this time 
stoichiometric phospholene oxide was added to increase the likelihood of forming the desired 
reaction (Scheme 83). While small amounts of the desired benzodiazepine product (58a) were 
observed by LC-MS, no product could be isolated. This discouraging result directed research 
into alternative starting materials for the synthesis of benzodiazepine via the catalytic aza-
Wittig. 
 
Scheme 82: Variations in method for hydroxamic acid (60a-d) synthesis. 
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4.2.2. Hindered Ureas as Potential Starting Materials for 
Synthesis of Benzodiazepines 
 
Keeping to the premise of azide-free aza-Wittig reactions, it was decided to investigate 
hindered urea (62) as the starting material. Commercially available isocyanate (63) provided 
the perfect starting point for the synthesis of the hindered urea. The first step was protection 
of the isocyanate as the diisopropyl urea (64) which was performed by the addition of 
diisopropylamine to a stirring solution of the isocyanate. Next was the saponification of the 
methyl ester to produce the carboxylic acid (65) using sodium hydroxide. Finally the amide 
bond was formed between the acid and the proline methyl ester. Initial attempts using CDI 
produced low quantities of the desired product (62) with the rest forming the benzoxazinone 
(66). There was no reaction between the benzoxazinone and proline methyl ester at room 
temperature. On heating the proline methyl ester reacted with (66) forming the amide bond 
but the product also underwent deprotection of the isocyanate, forming the diproline urea (67) 
(57% yield). The more active coupling reagent, HATU, successfully produced the desired urea 
(62) in good yields at room temperature (53% yield) (Scheme 84). 
Scheme 83: Initial attempts at an azide-free synthesis of benzodiazepine (58a). 
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To produce the starting materials on a multigram scale the use of HATU would be costly 
and hazardous, so alternative methods were sought. Since installing the diisopropyl urea 
moiety before the proline had previously resulted in the formation of the anhydride 
benzoxazinone (66) attempts were made to change the order of addition. Starting with 
anthranilic acid, the aim was to form the amide bond between the acid and the proline then 
use diisopropylcarbamoyl chloride to install the urea. Interestingly, the activated anthranilic 
acid coupled with the proline, but this product then underwent a condensation reaction 
between the aniline nitrogen and the methyl ester to produce the benzodiazepinone (68) and 
none of the desired product (69) was isolated (Scheme 85). This illustrates how readily the 
system cyclises, boding well for the success of the aza-Wittig reaction. 
 
It was decided to resort to the Curtius rearrangement for the synthesis of the starting 
material (62) on scale as synthesis of grams of the acid (65) had already been demonstrated. 
To offset the hazards associated with the use of acyl azides, continuous flow protocols were 
Scheme 84: Synthesis of hindered urea (62). 
Scheme 85: Failed alternative starting material synthesis method. 
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used to ensure that quantities of azide remained low. Using the method reported by Ley et al. 
for the Curtius rearrangement in flow, 10 grams of pure urea (62) was synthesised (Scheme 
86).90  
 
With the hindered urea in hand it was possible to investigate the application of 
diisopropyl ureas as masked isocyanates for the intramolecular catalytic aza-Wittig reaction. 
To compare the urea (62) with the simple isocyanate, the acyl azide (70) was subjected to the 
conditions optimised by McGonagle for the intramolecular catalytic aza-Wittig reaction. The 
isolated acyl azide was heated to reflux in toluene with the phospholene oxide catalyst. With 
catalyst loadings of 10 mol% phospholene oxide the reaction was complete within 24 hours 
yielding 87% of the pure desired benzodiazepine and the remainder appearing to be the 
dimerisation product, carbodiimide (71). Lowering catalyst loadings to 5 mol% led to longer 
reaction times, with the reaction taking 48 hour to reach completion, but a higher yield of the 
benzodiazepine was observed (99% yield) (Scheme 87). These yields were satisfying 
especially with such low catalyst loadings, and compare very favourably to the redox-
mediated catalytic aza-Wittig reaction. The aim was now to replicate those impressive yields 
using the diisopropyl masked isocyanates. 
Scheme 86: Large scale synthesis of hindered urea (62) by continuous flow protocol. 
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Initial results for the reaction of hindered urea (62) were far less impressive, yields of 
the benzodiazepine between 36% and 47% were observed with the remaining mass balance 
(53 − 64%) being made up of recovered starting materials (Scheme 88). Results were highly 
variable, with a general trend that yields increased when less solvent remained, due either to 
increased flow of nitrogen, vented reaction vessel, increased reaction temperatures or 
deliberate removal of solvent on condensation. Reactions which were actively boiled dry by 
bubbling nitrogen throughout the reaction led to near quantitative conversions (90 – 100%). 
The use of solid supported reagents was also investigated as a method of increasing yields. 
When solid supported acids were placed in the reaction mixture the observed yield decreased 
and a complex mixture of by-products were observed. Solid-supported reagents were 
suspended such that they were held above the reaction mixture exposing the refluxing solvent 
and diisopropylamine to the reagents. It was hoped that the solid-supported acids would trap 
the diisopropylamine driving the equilibrium towards the desired isocyanate. Indeed, it was 
found that yields increased when reagents were held like this, with complete conversion 
observed by 1H-NMR for a number of reagents, PS-tosyl chloride, Amberlyst, Dowex and 
most surprisingly 4Å MS (Scheme 88). The use of solid-supported reagents also led to 
reactions going to dryness, a fact which would explain the indiscriminate behaviour of the 
reagents, suggesting that the increased conversions might be due to the physical properties of 
the solid supported reagents rather than their chemistry. The observation that reactions going 
to dryness had increased conversion can be attributed to removal of diisopropylamine by the 
azeotrope effect throughout the reaction. By removing the diisopropylamine from the reaction 
mixture the equilibrium between the urea and the isocyanate shifts towards the isocyanate, 
leading to more of the aza-Wittig reaction and the formation of benzodiazepine (58a). Without 
this shift in equilibrium the amount of diisopropylamine builds up as the reaction progresses 
Scheme 87: Application of the Curtius rearrangement for the synthesis of benzodiazepines 
via the catalytic aza-Wittig reaction. 
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meaning that rate of benzodiazepine (58a) formation drops and conversions remain low. 
Unfortunately, the removal of solvent during the reaction would be unfavourable on industrial 
application. Due to this, the reaction was not examined further as it was impractical. This was 
a highly disappointing outcome for a promising area of research.  
 
  
Scheme 88: The use of hindered ureas as starting materials for the benzodiazepine (58a). 
Figure 3: 1H-NMR of crude reaction mixtures for the synthesis of benzodiazepine (58a) 
comparing the use of solid-supported reagents. 
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4.3. Conclusions 
 
The redox neutral catalytic aza-Wittig reaction has been applied to the synthesis of a 7-
membered ring system namely the benzodiazepines. While only a single example was 
synthesised, there is the potential to produce a wide variety of benzodiazepines using this 
methodology. Trace amounts of the desired product were produced from the reaction starting 
from hydroxamic acids, offering proof of concept. Hindered ureas behaved as masked 
isocyanates but yields were found to be highly variable and dependant on the removal of 
diisopropylamine. The Curtius rearrangement was found to be the most reliable method for 
the in situ formation of isocyanate starting materials for intramolecular catalytic aza-Wittig 
chemistry of seven member rings. Starting from acyl azide (70) the benzodiazepine (58a) was 
synthesised with 10 mol% of phospholene oxide yielding 86% of product. Catalyst loadings 
could be reduced to 5 mol% with an increased yield (99%) but longer reaction times. These 
results were an improvement on those reported by van Delft which relied on the redox 
mediated catalytic aza-Wittig reaction.19  
 
4.4. Future Work 
 
This area of research holds a lot of potential since benzodiazepines are an important 
moiety in a large range of pharmaceutically active compounds. The scope of the application 
of catalytic aza-Wittig chemistry in this area should be expanded to incorporate more amino-
acid derivatives and possibly some other seven membered ring systems. Use of hindered urea 
and hydroxamic acid starting materials should be optimised so the reaction is more reliable 
and yields higher. By focusing on this area it would be possible to become less reliant on 
hazardous azides. 
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5. Organocatalytic Aza-Enyne Metathesis Cascade Reaction 
 
5.1. Introduction to the Aza-Enyne Metathesis Cascade 
Reaction 
 
Iminophosphoranes can be viewed as analogous to metallocarbenes in metathetical 
reactions. The aza-Wittig reaction can be viewed as metathetical in nature as it involves a 
transfer of groups, in this case the transfer of the NR moiety from the iminophosphorane to 
the carbonyl carbon. The intermolecular aza-Wittig reaction can be viewed as being similar to 
cross-metathesis and the intramolecular reaction as being a ring closing metathesis. 
Computational studies of the aza-Wittig reaction also predict that the reaction goes via two 4-
membered oxazaphosphetane cycles, similar to the metallocyclobutene intermediates 
observed in the metathesis reaction.91 Another form of metathesis, enyne metathesis, also has 
an aza-Wittig analogue, the cyclization of iminophosphoranes with alkynes (Scheme 89).  
 
In 1964 Brown et al. proposed a mechanism for the reaction of iminophosphoranes with 
dimethyl acetylenedicarboxylate (DMAD) to give the 1 : 1 adduct (72) where the reaction 
proceeds via a phosphazacyclobutene intermediate (73) (Scheme 90).92 In most cases 
intermediates like (73) cannot be isolated as it is highly strained and rapidly rearrange on the 
slightest input of energy. However, Kawashima set out to produce a thermally stable 
Scheme 894: Analogies between metathesis and aza-Wittig reactions. 
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azaphosphetine and succeeded, isolated (74) and analysed the structure through X-ray 
crystallography. It is thought that the electron-deficient nature of this azaphosphetine and the 
bulky 2,4,6-triisopropylphenyl (Tip) group prevent rearrangement. Surprisingly, this 
azaphosphetine (74) proved to be stable up to 180 °C and was chemically inactive towards 
both benzaldehyde and phenyl isocyanate.93  
 
Since 1985, Barluenga et al. have been exploiting aza-enyne metathesis chemistry by 
reacting iminophosphoranes with DMAD to create substituted phospholes and aza-
phosphinines (Scheme 94).94-96 It was found that electron-deficient iminophosphoranes, such 
as N-2,4-dinitrophenyl, N-benzoyl, N-ethoxycarbonyl and N-tosyl-triphenylphosphimine 
would not undergo addition with DMAD, suggesting the nitrogen of the iminophosphorane 
usually acts as a nucleophile.92 Barluenga et al. exploit this by cyclising an enamine attached 
to the phosphine end of an iminophosphorane with DMAD; in this way a range of 2-pyridones 
sporting a pendant iminophosphorane could be formed (Scheme 91).95 To offset the 
deactivating effect of electron withdrawing groups, the P-phenyl groups could be substituted 
by an aliphatic group, increasing activity to the point that N-benzoyl and N-ethoxycarbonyl 
undergo addition to alkynes.94 Palacios continued Barluenga’s work, increasing the scope to 
include iminophosphoranes bearing N-phosphonate, N-iminophosphorane and N-vinyl 
groups.97  
 
 
Scheme 90: Brown et al. findings and Kawashima et al. thermally stable azaphosphetine 
(74).92,93 
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Other metathesis-like phosphorus-based reactions have been reported, suggesting that 
this behaviour could be general to iminophosphoranes.98 Serendipity led to the discovery that 
the reverse reaction could be used to synthesise aryl iminophosphoranes in a fashion 
reminiscent of the aza-enyne metathesis. When an aniline and triphenylphosphine were mixed 
with a solution of dimethyl acetylenedicarboxylate (DMAD) in dichloromethane, an ylide (75) 
formed. On heating to reflux in toluene or xylene the ylide undergoes a proton shift to form a 
betaine (76), then aza-phosphetane (77) which fragments to form the iminophosphorane and 
a mixture of dimethyl fumarate and dimethyl maleate (Scheme 92).98 While it is assumed that 
the formation of the betaine is a stepwise process, the fragmentation of the azaphosphetane is 
likely to involve a reverse [2+2] cycloaddition similar to aza-enyne metathesis. 
Scheme 91: Application of aza-enyne chemistry for the synthesis of P-heterocycles.94-97 
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Another example of the reverse metathesis-like nature of imines and phosphines being 
used to form iminophosphoranes is the Wittig reaction of electronically stabilized 
phosphonium ylides with N-sulfonyl imines. As predicted, this produces an alkene 
stereoselectively and an iminophosphorane, via an aza-phosphetane intermediate (Scheme 
93).99 
 
Analogous to the aza-enyne metathesis of iminophosphoranes, phosphine oxides can 
undergo a metathetical reaction with DMAD to form a stabilised phosphonium ylide (78). 
Luckily, this reaction is sluggish even in refluxing xylenes, requiring more energy input than 
the reaction with iminophosphoranes (154 °C for 8-14 days)100, 101-102 (Scheme 94). This 
reaction may prove an issue for the development of a catalytic aza-enyne cascade reaction. If 
the addition of phosphine oxide (25) occurred under the same conditions as the desired 
iminophosphorane metathesis, the phospholene oxide catalyst would be consumed, shutting 
down the reaction. 
Scheme 94: Phosphine oxide analogue of aza-enyne metathesis reaction with DMAD.100-102 
Scheme 93: Wittig reaction with N-sulfonyl imine.99 
Scheme 92: Reverse aza-enyne metathesis-like synthesis of iminophosphoranes.98 
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The aim of this chapter is to explore the possibility of developing a phosphorane 
catalysed aza-enyne metathesis cascade reaction. It is hoped that an iminophosphorane formed 
catalytically from a commercially available isocyanate and phospholene oxide catalyst (25) 
can react with an alkyne in a metathetical manner to produce N-heterocycles. The 
stoichiometric cascade reaction would be also be investigated with the aim of aiding 
mechanistic understanding.  
 
5.2. Results and Discussion 
5.2.1. Developing Organocatalytic Aza-Enyne Metathesis Cascade 
Reaction 
 
Previous attempts by the Marsden group indicated that aza-enyne metathesis could be 
successfully catalysed by phospholene oxide (25).50, 103 Initial results found that quinolines 
could be synthesised from commercially available isocyanato ester (63) through a metathetical 
reaction with electron deficient alkyne, dimethyl acetylenedicarboxylate (DMAD). It was 
found that slow addition of a dilute solution of the isocyanate (63) into a concentrated solution 
of the alkyne (DMAD) and phospholene oxide catalyst (25) (Scheme 95) gave the highest 
conversions. Slow addition was used to limit the concentration of isocyanate in the reaction 
in an attempt to control dimerization to the carbodiimide (80). Using three equivalents of 
DMAD favoured the aza-enyne metathesis over carbodiimide formation. The previous best 
recorded conversion to desired product (79) was 60% by 1H NMR.50, 103 Removal of DMAD 
and related impurities from the reaction mixture proved to be problematic, preventing 
isolation. Application of ion exchange column SCX-2 allowed the isolation of the pure 
quinoline product in 25% yield. 
Scheme 95: Organocatalytic aza-enyne metathesis cascade reaction. 
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Expanding upon previous work, attempts were made to further optimise the 
organocatalyzed aza-enyne metathesis cascade reaction. Previous work had identified the 1H-
NMR signals for each of the commonly observed products. Quinoline (79) has a characteristic 
set of aromatic protons forming two doublets between 8.26 – 8.19 ppm. The methoxy signal 
at 4.17 ppm is also characteristic of this product. Carbodiimide (80) can be observed as a 
doublet of doublets at 7.90 ppm and urea (81) as a doublet at 8.55 ppm. The rate of isocyanate 
addition has been shown to have a substantial effect on the distribution of products, so this 
was the first variable investigated. Previous results found addition of a 0.5 M solution of 
isocyanate to a 6.0 M solution of 3 equivalents of DMAD and 10 mol% phospholene oxide 
gave the best ratio of products (60% quinoline : 26% carbodiimide : 14% urea) (Table 8) 
(Entry 2). Addition of a dilute solution of isocyanate (0.25 M) over 16 hours resulted in a 1:1 
ratio of quinoline (79) to carbodiimide (80) in the crude reaction mixture; while no better than 
previous results, this is the best ratio of products from this set of experiments (Entry 5). 
Purification with SCX ion exchange column allowed the quinoline to be isolated in a 25% 
yield, the highest isolated yield to date for this system. According to the ratio of products in 
the crude reaction mixture, the self-condensation reaction would account for the consumption 
of 66% of the starting isocyanate, while the rest of the mass balance was found to be a complex 
mixture of DMAD-related by-products, the urea and methyl anthranilate. These results 
suggest that iminophosphorane has a substantial preference for the aza-Wittig self-
condensation reaction over the desired aza-enyne metathesis which is favoured by limiting 
isocyanate concentration. 
  
Scheme 96: Proposed ylide intermediate. 
96 
 
 
Entry Conditions 1H NMR ratios 
((79) : (80) : (81)) 
Isolated 
yield 
(79) 
1a 1.5 eq. DMAD, 10 mol% Cat., (0.3 M) PhMe 22 : 74 : 4  – 
2a 3 eq. DMAD, 10 mol% Cat., (2 M) PhMe, 7 hr 
add. (0.5 M)  
60 : 26 : 14 – 
3 3 eq. DMAD, 5 mol% Cat., (2 M) PhMe, 6 hr add. 
(0.5 M)  
30 : 32 : 38 - 
4 3 eq. DMAD, 10 mol% Cat., (2 M) PhMe, 6 hr 
add. (0.5 M) 
20 : 57 : 23 13% 
5 3 eq. DMAD, 10% Cat., (2 M) PhMe, 16 hr add. 
(0.25 M) 
49 : 50 : 1 25% 
6 3 eq. DMAD, 100% Cat., (2 M) PhMe, 7 hr add. 
(0.5 M) 
68 : 0 : 10 : 22b - 
Table 9: Results from aza-enyne metathesis cascade reaction. a previous unpublished work, b 
adduct (83)  
 
Intriguingly, little to none of the characteristic phospholene oxide alkene doublet at 6.96 
ppm was observed by 1H-NMR in the crude reaction mixtures, which might justify the low 
yields. Consumption of phospholene oxide would explain the low yield observed. Heating a 
mixture of phospholene oxide (25) (1 eq.) and DMAD (3 eq.) in toluene at reflux for 24 hours 
led to an interesting observation, a small amount of phospholene oxide reacted with DMAD 
to form an observable amount of an adduct. Similarities between the 1H-NMR and LC-MS 
spectra of this unknown adduct and the ylide (78) previously reported by Kegelvich (Scheme 
94)100 supports the theory that this is the phospholene oxide adduct (83) (Scheme 97). 
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Unfortunately (83) could not be isolated from the crude reaction mixture of phospholene oxide 
and DMAD by-products. 
 
In an attempt to understand the reaction in greater detail the reaction was run with 
stoichiometric phospholene oxide. Using slow addition of isocyanate into a concentrated 
solution of stoichiometric phospholene oxide and DMAD the effective concentration of 
catalyst was very high, meaning that there would be many more equivalents of phospholene 
oxide compared with the isocyanate. The hope was that the effective concentration of 
phospholene oxide would remain high throughout the reaction driving the formation of the 
iminophosphorane which would undergo metathesis with the acetylene rather than with the 
relatively low concentration of isocyanate. The idea was that the isocyanate would be trapped 
as the iminophosphorane before the dimerization reaction could occurred. While this 
successfully reduced the amount of carbodiimide produced, some of the adduct (83) was 
observed by LC-MS contaminating the desired quinolone product (Table 8, entry 6). 
  
Scheme 97: Addition of phospholene oxide to DMAD. 
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5.2.2. Stoichiometric Aza-Enyne Metathesis Cascade Reaction 
 
To further probe the mechanism of the reaction, the known methyl anthranilate-derived 
iminophosphorane (84)104 was prepared following the literature procedure105 and reacted with 
the alkyne DMAD. Studying the reaction of pre-formed iminophosphorane with DMAD 
avoided the added complication of the self-condensation reaction, potentially allowing 
weaknesses in the addition step to be highlighted. These weaknesses could then be addressed 
for application in the catalytic aza-enyne metathesis reaction. We prepared the 
iminophosphorane (84) by an Appel-modified Kirsanov reaction utilising triphenylphosphine, 
hexachloroethane and triethylamine to form the reactive dichlorotriphenylphosphine 
intermediate which reacts with a methyl anthranilate to produce the iminophosphorane (84) 
(Scheme 98).105 Using this method the iminophosphorane (84) could be produced at yields of 
85% from simple, inexpensive starting material in one step. The fact that there was a literature 
precedent for the formation of (84) made this a useful starting material for investigations into 
the stoichiometric reaction. Although it should be noted that triphenylphosphine oxide is a 
poor catalyst for the redox-neutral catalytic aza-Wittig reaction with isocyanates and would 
behave differently to the phospholene oxide in the aza-enyne metathesis reaction 
 
To emulate the optimised catalytic reaction conditions used, the iminophosphorane was 
stirred with three equivalents of DMAD in refluxing toluene over 18 hours. The desired 
quinoline (79) product was isolated in 24% yield, which was lower than expected. Alongside 
this, there was 37% yield of what 1H, 13C, 31P NMR spectroscopy and HRMS analysis 
suggested to be the ylid intermediate (85). X-ray crystallography confirmed the ylid 
intermediate as the (E) isomer of the imine (85) (Figure 4). Surprisingly, the (E)-ylid (85) 
remained stable under further heating at reflux in toluene and at higher temperatures in a 
microwave, not forming the expected quinoline (79) (Scheme 99). This result suggests that 
the barrier of rotation for the imine is too high for this isomer to adopt the active (Z)-
Scheme 98: Appel modified Kirsanov for the synthesis of iminophosphorane (84). 
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configuration in which the phosphorus ylid could interact with the carbonyl of the ester to 
carry out the Wittig step.  
 
 
It was thought that an inactive species, such as ylid (60)-(E), formed in the catalytic 
reaction explaining the low yields experienced. Such a species would trap the catalyst, 
preventing the regeneration of the phospholene oxide and would prevent the turnover of the 
catalytic cycle. Further examination of the catalytic aza-enyne metathesis crude reaction 
mixture failed to find any evidence that a similar species had been formed during the catalytic 
aza-enyne reaction. Differences between the cyclic phospholene (25b) and triphenylphosphine 
in the isolated iminophosphorane (85) may explain why none of the intermediate was 
observed. Cyclic phosphines such as phospholene catalyst (25) are known to adopt four 
Scheme 99: Stoichiometric aza-enyne metathesis with iminophosphorane and DMAD. 
Figure 4: Molecular structure of (85)-(E). Displacement ellipisoid are at the 50% probablity 
level. 
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membered rings, such as oxazaphosphetane, more readily than acyclic phosphines such as 
triphenylphosphine due to bond angle reducing ring strain, which is used as an explanation for 
the enhanced reactivity of cyclic phosphines in the catalytic aza-Wittig reaction as explained 
by Campbell.44, 46 Increased stability of the four membered ring intermediate potentially allows 
for an equilibrium between (E)-(85) and the intermediate established. Irreversible formation 
of the quinoline would drive the reaction towards the desired product and the consumption of 
the (E)-isomer. Alternatively, it can be envisaged that the phospholene derived adduct (86) 
may have a weaker imine bond resulting in more rotation between the configurations (Scheme 
100). A third possibility is that the inactive (E)-adduct is formed during the reaction, but then 
consumed in some other unobserved pathway. The aim was to synthesise and test the 
iminophospholene (87) to provide experimental evidence to prove or disprove these 
hypotheses. 
 
Many methods were used in an attempt to produce the iminophospholene (87). Initially, 
the Appel-modified Kirsanov reaction, which proved so successful for the triphenyl phosphine 
based iminophosphorane, was attempted. It was envisaged that reduction of the phospholene 
oxide would provide the corresponding phosphine, which would react with hexachloroethane 
and methyl anthranilate to give the iminophospholene. A range of reductants were explored 
(Scheme 101); diphenylsilane, reducing agent of choice for the reductive catalytic aza-Wittig 
reaction employed by van Delft et al.;19 trichlorosilane, known to reduce phosphine oxides 
Scheme 100: Possible method for the conversion of (Z) to (E) ylid. 
101 
 
effectively;106 a number of borane reagents were explored as there is a literature precedent for 
their use in the synthesis of phosphine-borane complexes from phosphine oxides.106 
Unfortunately, none of the reduced phospholene or phosphine-borane complex could be 
isolated or observed by 31P-NMR spectroscopy, with complete recovery of starting 
phospholene oxide observed.  
 
The next method attempted was a modification to Kirsanov reaction inspired by Denton 
et al. and Fukui.35, 36 Oxalyl chloride was added to phospholene oxide to produce 
dichlorophosphine, which were added to methyl anthranilate in an attempt to produce the 
iminophosphoranes. This method was inspired by the work of Denton et al. who utilised oxalyl 
chloride to produce dichlorophosphines catalytically for use in the Appel reaction.36-38 Similar 
methodology has been employed by Yano et al. for the one-pot reduction of phosphine 
oxides.107 It was hoped that this method would allow for a range of phosphine oxides to 
undergo the dichlorination reaction and be trapped with methyl anthranilate. The phospholene 
dichloride (88) was observed by 31P and 1H NMR spectroscopy matching the literature values 
(31P 98.8 ppm).108 Additionally the dichloride was produced by the addition of dichlorophenyl 
phosphine to isoprene, a method commonly used for the synthesis of the phospholene oxide 
catalyst (25) (Scheme 102). While these methods did provide a successful route to the 
phospholene dichloride, they failed to produce the desired iminophosphorane, instead leading 
to the recovery of the phospholene oxide and methyl anthranilate. 
  
Scheme 101: Attempts to reduce phospholene oxide (25). 
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The final method attempted involved the commercially available azide (89). The 
Staudinger reaction between azides and phosphines are well studied2, 3 and though no 
examples have utilised this particular phospholene, reactions with the azido methyl benzoate 
(89) are known.109 Stirring the azide with triphenylphosphine in methyl tert-butyl ether 
(TBME) provided the iminophosphorane (84) in excellent yield (85%) (Scheme 103). In order 
to investigate the effect of phosphine on the chemistry of the iminophosphorane the Staudinger 
reaction was attempted with a range of phosphines. Replacing a phenyl group with a methyl 
group was expected to increase reactivity. Disappointingly, the corresponding reaction with 
diphenylmethylphosphine failed to produce the iminophosphorane, instead yielding the 
phosphine oxide and methyl anthranilate, as expected of the reduction in the presence of water. 
Following the method employed by Barluenga et al. using more stringent anhydrous 
procedures also failed to result in the isolation of desired iminophosphorane.109 The same was 
true for attempts to trap the azide with the dibenzophosphole (6) favoured by van Delft 
(Scheme 104). No attempts were made to produce the azide or to investigate other azides as 
(89) was commercially available and matched the desired product.18 
 
Scheme 102: Attempt to form iminophosphorane (87) using modified Kirsanov reaction. 
Scheme 103: Staudinger reactions with triphenylphosphine. 
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It is possible that the desired iminophosphorane is too hydrolytically unstable to be 
isolated when incorporating more active phosphines such as diphenylmethylphosphine and 
the phospholene. With this in mind attempts were made to avoid the isolation of the 
iminophosphorane and to form it (87) in the presence of DMAD so that the iminophosphorane 
would be trapped rapidly by DMAD forming the corresponding ylid. Disappointingly, this 
also failed to provide the desired product, leading to the isolation of methyl anthranilate, 
phospholene oxide and polymerised DMAD. 
While the results for the stoichiometric aza-enyne reaction of iminophosphorane with 
DMAD were disappointing, initial results gave important mechanistic insight into the catalytic 
reaction. It also suggests that the nature of the phosphine plays an important role in the stability 
of iminophosphoranes, especially with an electron-deficient N-aryl group which would 
enhance the rate of hydrolysis of the iminophosphorane as expected of the Staudinger 
reduction. 
  
Scheme 104: Staudinger reaction for the synthesis of iminophosphoranes. 
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5.3. Aza-enyne Metathesis Conclusions 
 
Conditions for the first phosphine oxide catalysed aza-enyne metathesis were optimised 
and the mechanism involved probed. It was shown that phospholene oxide can be utilised in 
a cascade reaction involving the addition of catalytically produced iminophosphine across an 
alkyne for the synthesis of tri-substituted quinoline (79). Unfortunately isolated yields were 
low (25%) and the majority of starting material was consumed by the self-condensation 
reaction to give the carbodiimide.  
The stoichiometric reaction offered some mechanistic insight and offered a potential 
explanation for the low yields experienced. It was found that the stoichiometric reaction with 
an iminophosphorane derived from triphenylphosphine led to 60% isolated yield of addition 
products with 24% yield of the desired quinoline (79) and 37% yield of the novel (E)-ylid 
(85). This inactive ylid species (85) did not undergo the expected Wittig reaction even under 
forceful heating, which suggests it could possibly be a unobserved pathway producing by-
product in the catalytic aza-enyne metathesis cascade reaction. Attempts to vary the phosphine 
moiety failed to provide the desired iminophosphorane starting materials. 
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5.4. Future Work 
 
Given more time it may have been possible to screen a range of phosphine oxides and 
find alternative which would favour the aza-enyne cascade reaction over the self-condensation 
reaction. Alternatively, an iminophosphorane could have been found to limit the formation of 
the undesired stable (E)-isomer which was observed in the stoichiometric reaction. Another 
area of modification is the N-aryl portion of the iminophosphorane substituents on the ring 
may have affected reactivity and the use of amides could have been investigated, possibly 
producing a range of quinolines bearing the amine moiety. Corresponding ortho- 
isocyanatobenzamides might also undergo the catalytic aza-enyne metathesis cascade reaction 
infavor of the self-condensation reaction.  
Another area of interest is the possibility of an intramolecular cascade reaction whereby 
a pendant alkyne group undergoes intramolecular addition of an iminophosphorane to form a 
heterocycle. The advantage of this method is that the undesired dimerisation reaction could be 
controlled using high dilution conditions. 
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Experimental 
Novel Applications of Organocatalytic Aza-Wittig 
Chemistry 
  
107 
 
6. Experimental 
 General Experimental Techniques 
 
All reactions were carried out under an atmosphere of dry nitrogen using oven-dried 
glassware and dried solvent unless stated. Dried solvents dispensed from Innovate Technology 
Pure Solv MD solvent purification system. Triethylamine, pyridine and morpholine were 
distilled from KOH onto 4Å molecular sieves before use. Isopropanol was distilled from 3Å 
molecular sieves onto 4Å molecular sieves before use. The phospholene oxide catalyst was 
distilled by Kugelrohr before use to remove trace water, DCM and other impurities. All 
solvents used for analysis were analytical grade solvents. All other solvents and reagents were 
purchased from commercial sources and were used without purification. Petrol refers to light 
petroleum (b.p. 40-60 ºC). 
Flash column chromatography was performed using Fischer Matrix silica gel (35-70 
m) or pre-packed Biotage or Redisep silica cartridges running on Biotage Isolera machine. 
Thin layer chromatography was conducted using pre-coated silica plates (Merck silica 
Kieselgel 60F254). Spots were visualized using UV fluorescence (max = 254 nm), then stained 
and heated with potassium permanganate and in the case of hydroxamic acids FeCl3 in 
methanol. All chromatography eluents were BDH GPR grade and used without purification. 
1H NMR spectra were recorded at 300 MHz on a Bruker DPX 300 or 500 MHz on a 
Bruker Avance 500 spectrometer, using an internal deuterium lock. 1H NMR chemical shifts 
() are quoted in parts per million with respect to the standard tetramethylsilane at 0 ppm and 
coupling constant (J) values are quoted in Hz. Estimated purity calculated using integration 
of 1H NMR taking difference between total spectra and accounted signals, assume >95% 
unless otherwise stated. 13C NMR spectra were recorded with broadband proton decoupling at 
75 or 125 MHz. Assignments were made on the basis of chemical shift and coupling data, 
using 1H-13C HMQC, DEPT, HMBC and nOe experiments where necessary. 31P NMR spectra 
were recorded with broadband proton decoupling at 121 MHz. Infra-red spectra were recorded 
on a Perkin Elmer Spectrum One FT-IR spectrometer, with absorption reported in 
wavenumbers (cm-1) Mass Spectra were recorded on a Bruker HCT Ultra LC-MS instrument 
or a Bruker MicroTOF spectrometer (using electrospray techniques). Accurate molecular 
weights were obtained by peak matching using perfluorokerosene as a standard. Melting 
points were determined on a Reichert hot stage apparatus and are uncorrected. Specific 
rotation was determined using Optical Activity AA-10 polarimeter on sodium D line (589 
nm), with concentrations giving in g/100ml. 
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 Experimental Procedures from Chapter 2 
3-Phenyl-1,4,2-dioxazol-5-one (28)64 
To a stirred suspension of N-hydroxybenzamide (26) (137 mg, 1.00 mmol, 1.00 eq.) 
in CH2Cl2 (10 mL, 0.10 M) at 0 °C was added CDI (162 mg, 1.00 mmol, 1.00 eq.). The reaction 
mixture was allowed to warm to room temperature over an hour, after which time the mixture 
was treated with 0.5 M HCl (10 mL). Aqueous phase extracted with CH2Cl2 (2  10 mL). The 
combined organic phases were then dried (MgSO4) and concentrated under reduced pressure. 
Crystallisation from CH2Cl2 and petroleum ether provided 3-phenyl-1,4,2-dioxazol-5-one (28) 
(110 mg, 0.68 mmol, 68% yield) as a colourless amorphous solid. Data agrees with literature 
values.64 
M.p. (Petrol/CH2Cl2; colourless amorphous solid): 63 – 64 °C (lit.64 63 °C); 1H NMR (300 
MHz, DMSO-d6) δ 7.87 (2H, dd, J = 7.2, 1.2 Hz, ArH), 7.66 (1H, td, J = 7.2, 1.2 Hz, ArH), 
7.56 (2H, td, J = 7.2, 1.2 Hz, ArH); 13C NMR (100.6 MHz, CDCl3) δ 164.0 (C), 154.3 (C), 
134.6 (2 × CH), 130.1 (CH), 127.0 (2 × CH), 120.5 (C); IR (νmax, solid, cm-1) 3074, 2922, 
2245, 2101, 2058, 1955, 1941, 1900, 1858, 1817, 1613, 1753, 1498, 1448, 1396, 1367, 1177, 
1072, 973, 752; Data in accordance with literature values.64 
 
1,1-Diisopropyl-3-phenyl urea (27)62  
Method A) To a stirred solution of N-hydroxybenzamide (26) (41 mg, 0.30 mmol, 
1.00 eq.) in acetonitrile (0.50 mL, 0.60 M) was added CDI (65 mg, 0.40 mmol, 1.20 eq.). After 
stirring for 30 minutes the reaction mixture was heated to 60 °C then diisopropylamine (0.13 
mL, 0.92 mmol, 3.00 eq.) was added. After 90 minutes of stirring the reaction was cooled to 
room temperature. The reaction mixture was diluted with ethyl acetate and the reaction was 
quenched with saturated ammonium chloride solution (2 × 10 mL), water (10 mL) and brine 
(10 mL). The organic phase was dried (Na2SO4) and concentrated under reduced pressure. 
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Crystallisation from boiling toluene provided 1,1-diisopropyl-3-phenyl urea (27) (56 mg, 0.26 
mmol, 85% yield) as a colourless solid. 
Method B) To a stirred solution of 3-phenyl-1,4,2-dioxazol-5-one (28) (49 mg, 0.30 
mmol, 1.00 eq.) in acetonitrile (0.50 mL, 0.60 M) was added diisopropylamine (0.13 mL, 0.92 
mmol, 3.00 eq.), then heated to 60 °C. After 90 minutes of stirring the reaction was cooled to 
room temperature. The reaction mixture was diluted with ethyl acetate and the reaction was 
quenched with saturated ammonium chloride solution (2 × 10 mL), water (10 mL) and brine 
(10 mL). The organic phase was dried (Na2SO4) and concentrated under reduced pressure. 
Crystallisation from boiling toluene provided 1,1-diisopropyl-3-phenyl urea (27) (56 mg, 0.26 
mmol, 85% yield) as colourless needles. 
Method C) To a stirred solution of diisopropylamine (5.80 mL, 41.0 mmol, 1.20 eq.) 
in CH2Cl2 (150 mL, 0.27 M) at 0 °C was added phenyl isocyanate (30) (6.50 mL, 34.0 mmol, 
1.00 eq.). The reaction mixture was allowed to warm up to room temperature before the 
reaction was quenched with 2 M aqueous HCl (2  100 mL). The organic mixture was dried 
(Na2SO4), concentrated under reduced pressure and crystallised from toluene to provide 1,1-
diisopropyl-3-phenyl urea (27) (7.50 g, 34.0 mmol, 99% yield) as colourless needles. 
M.p. (PhMe; colourless needles): 123 °C (lit.110: 123 – 124 °C); 1H NMR (300 MHz, CDCl3) 
δ 7.39 – 7.22 (4H, m, ArH), 7.03 – 6.95 (1H, m, ArH), 6.17 (1H, br. s, NH), 4.00 (2H, septet, 
J = 7.0 Hz, N(CH)2), 1.32 – 1.34 (12H, d, J = 7.0 Hz, 4 × CH3); 13C NMR (100.6 MHz, 
CDCl3) δ 154.5 (C), 139.3 (C), 128.6 (CH), 122.4 (CH), 119.6 (2 × CH), 45.4 (2 × CH), 21.3 
(4 × CH3); IR (νmax, solid, cm-1) 3271, 2970, 1631, 1594, 1526, 1447, 1333. Data agrees with 
literature values.110  
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N-[(3-Nitrophenyl)methylene]benzenamine (35b) 111 
Method A) To a stirred mixture of 1,1-diisopropyl-3-phenyl urea (27) (132 mg, 0.600 
mmol, 1.00 eq.) and 3-methyl-1-phenyl-2-phospholene oxide (25) (12 mg, 0.060 mmol, 1.00 
eq.) in toluene (0.6 mL, 0.10 M) was added 3-nitrobenzaldehyde (36) (91 mg, 0.60 mmol, 
1.00 eq.). After refluxing at 110 °C for 18 hours the mixture was concentrated under reduced 
pressure and a 1H-NMR spectrum of a sample taken from the crude reaction mixture. The 
product, N-[(3-nitrophenyl)methylene]benzenamine (35b) was crystallised from dry diethyl 
ether and hexanes for spectroscopic analysis. Conversions were calculated using 1H-NMR of 
the crude reaction mixture looking at the ratio between the CHO signal (10.00 ppm) of the 
aldehyde and CHNPh signal of the imine (8.55 ppm). 
Method B) To a stirred mixture of 3-phenyl-1,4,2-dioxazol-5-one (28) (0.15 mmol, 
1.00 eq.), imidazole or diisopropylamine (0.15 mmol, 1.00 eq.) and 3-methyl-1-phenyl-2-
phospholene oxide (25) (3.0 mg, 0.02 mmol, 10 mol%) in toluene (0.25 mL, 0.60 M) was 
added 3-nitrobenzaldehyde (36 (45 mg, 0.30 mmol, 2.00 eq.). After refluxing at 110 °C for 18 
hours the mixture was concentrated under reduced pressure and a 1H-NMR spectrum of a 
sample taken from the crude. The product, N-[(3-nitrophenyl)methylene]benzenamine (35b) 
was crystallised from dry diethyl ether and hexanes for spectroscopic analysis. Conversions 
were calculated using 1H-NMR of the crude reaction mixture looking at the ratio between the 
CHO signal (10.00 ppm) of the aldehyde and CHNPh signal of the imine (8.55 ppm). 
Method C) To a stirred mixture of N-hydroxybenzamide (26) (0.60 mmol, 1.00 eq.) 
in toluene (1.00 mL, 0.60 M) was added CDI (117 mg, 0.720 mmol, 1.20 eq.). After an hour 
at room temperature 3-methyl-1-phenyl-2-phospholene oxide (25) (3.0 mg, 0.02 mmol, 10 
mol%) and 3-nitrobenzaldehyde (36) (45 mg, 0.30 mmol, 2.00 eq.) were added and the 
reaction mixture heated to reflux for 18 hours. The mixture was concentrated under reduced 
pressure and a 1H-NMR spectrum of a sample taken from the crude. The product, N-[(3-
nitrophenyl)methylene]benzenamine (35b) was crystallised from dry diethyl ether and 
hexanes for spectroscopic analysis. Conversions were calculated using 1H-NMR of the crude 
reaction mixture looking at the ratio between the CHO signal (10.00 ppm) of the aldehyde and 
CHNPh signal of the imine (8.55 ppm). 
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1H NMR (300 MHz, CDCl3) δ 8.76 (1H, t, J = 2.0 Hz, ArH), 8.55 (1H, s, N=CH), 8.33 (1H, 
ddd, J = 8.0, 2.5, 1.0 Hz, ArH), 8.25 (1H, dt, J = 7.5, 1.0 Hz, ArH), 7.67 (1H, t, J = 8.0 Hz, 
ArH), 7.46 (2H, t, J = 7.5 Hz, ArH), 7.32 – 7.24 (3H, m, ArH); 13C NMR (75.5 MHz, CDCl3) 
δ 157.2 (CH), 150.9 (C), 148.7 (C), 137.9 (C), 134.1 (CH), 129.8 (CH), 129.3 (CH), 126.9 
(CH), 125.6 (CH), 123.5 (CH), 120.9 (CH); IR (νmax, solid, cm-1) 3084, 3058, 2885, 1614, 
1532, 1353, 1321, 1192, 1092, 1077, 811. Data agrees with literature.111 
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 Experimental Procedures from Chapter 3 
6.3.1. General procedure A 
 
A microwave vial was charged with Pd(PPh3)4 (120 mg, 0.10 mmol, 0.02 eq.), the boronic 
acid (10.00 mmol, 2.00 eq.), sodium carbonate (1.06 g, 10.0 mmol, 2.0 eq.) and, if solid, the 
bromide (5.00 mmol, 1.00 eq.) before being sealed and flushed with nitrogen. The solids were 
then dissolved in a mixture of dioxane (3.0 mL, 3.3 M) and water (2.0 mL, 5.0 M) with stirring; 
if liquid, the bromide was added after addition of solvent. The reaction mixture was then 
degassed by bubbling dry nitrogen for 20 minutes before being placed in the microwave. The 
reaction mixture was stirred and heated to 120 C at 100 W for 25 minutes, after which time 
the reaction mixture was allowed to cool to room temperature and was extracted from brine 
(10 mL) with ethyl acetate (2 × 10 mL). The combined organics were washed with brine (20 
mL) and dried over Na2SO4 before being concentrated under reduced pressure. The crude was 
purified by silica column chromatography (20% ethyl acetate in hexane). 
Alternatively, the Pd(PPh3)4 could be replaced with 1,10-bis(di-tert-butylphosphino) 
ferrocene palladium dichloride (Pd(dbpf)Cl2, “Pd-118”) employing the conditions optimised 
by Moseley et al. requiring fewer equivalents of boronic acid.78 A microwave vial was charged 
with Pd-118 (22 mg, 0.04 mmol, 0.01 eq.), the boronic acid (4.20 mmol, 1.20 eq.), potassium 
carbonate (724 mg, 5.25 mmol, 1.50 eq.) and the bromide (3.50 mmol, 1.00 eq.). The solids 
were then dissolved in dioxane (7 mL, 0.5 M) and water (7 mL. 0.5 M). The reaction mixture 
was then degassed by bubbling dry nitrogen through the mixture for 20 minutes before being 
placed in the microwave. The mixture was stirred and heated to 120 C at 100 W for 25 
minutes, after which time the reaction mixture was allowed to cool to room temperature and 
was extracted from water (15 mL) with ethyl acetate (2 × 15 mL). The combined organics 
were washed with brine (20 mL) and dried over Na2SO4 before being concentrated under 
reduced pressure. The crude was purified by silica column chromatography (20% ethyl acetate 
in hexane). 
 
6.3.2. General procedure B 
 
A mixture of 4-dimethylaminopyridine (2.69 g, 12.0 mmol, 1.00 eq.), diphenic 
anhydride (2.69 g, 12.0 mmol, 1.00 eq.), nucleophile (12.0 mmol, 1.00 eq.) and pyridine (0.96 
mL, 12 mmol, 1.0 eq.) in THF (30 mL, 0.40 M) was heated to reflux with stirring for 2 hours. 
After this time the reaction mixture was cooled to room temperature before being quenched 
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with 2M HCl (20 mL) and extracted with ethyl acetate (3 × 20 mL). The combined organics 
were washed with brine (20 mL) and dried over Na2SO4 before being concentrated under 
reduced pressure. If required, the crude was purified by flash column chromatography (silica, 
30% ethyl acetate in hexane). 
 
6.3.3. General procedure C 
 
To a stirred solution of aldehyde (48a-h) (1.00 mmol, 1.00 eq.) in a mixture of tert-
butyl alcohol (3 mL), water (1 mL) and acetonitrile (0.5 mL), (6 : 2 : 1 ratio, 0.28 M) was 
added monosodium phosphate (156 mg, 1.00 mmol, 1.00 eq.) and 1-methyl-cyclohexene (590 
L, 5.00 mmol, 5.00 eq.). Sodium chlorite (360 mg, 4.00 mmol, 4.00 eq.) was added 
portionwise to the reaction mixture. After 16 hours stirring at room temperature the reaction 
mixture was partitioned between ethyl acetate (10 mL) and water (10 mL). The organics were 
washed with brine and dried (Mg2SO4) before being concentrated under reduced pressure. The 
desired products were purified by flash column chromatography (0 − 100% gradient of ethyl 
acetate in hexane) and crystallised if required.  
Alternatively, hydrogen peroxide could be used instead of 1-methylcyclohexene for a 
reaction with fewer by-products. To a stirred solution of aldehyde (48a-h) (0.85 mmol, 1.0 
eq.) in a mixture of acetonitrile (8.5 mL) and water (3.5 mL) (2.4 : 1, 0.07 M) was added 
monosodium phosphate (265 mg, 1.70 mmol, 2.00 eq.) and aqueous hydrogen peroxide (35% 
wt., 0.70 mL, 1.0 mmol, 1.2 eq.). A solution of sodium chlorite (90 mg, 1.0 mmol, 1.2 eq.) in 
water (10 mL, 0.10 M) was added dropwise to the reaction mixture over an hour resulting in 
the evolution of gas. After an additional 3 hours stirring at room temperature the reaction 
mixture was quenched with 4M HCl (aq) (10 mL) and extracted with ethyl acetate (10 mL). 
The combined organics were washed with brine and dried (Mg2SO4) before being concentrated 
under reduced pressure. The crude reaction mixture was pure enough after extraction to take 
through to the next step without further purification. 
 
6.3.4. General procedure D 
 
To a stirred solution of biphenyl-2,2’-dicarboxylic acid 2-ester (40a-t) (8.00 mmol, 
1.00 eq.) in CH2Cl2 (60 mL, 0.13 M) was added DMF (10 mol%) then oxalyl chloride (850 
μL, 10.0 mmol, 1.20 eq.). The reaction mixture was stirred for an hour before the volatiles 
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were removed under reduced pressure before being re-dissolved in ethyl acetate (120 mL, 0.06 
M) and cooled to 0 °C. To this solution hydroxylamine hydrochloride (1.11 g, 16.0 mmol, 
2.00 eq.) and potassium carbonate (4.42 g, 32.0 mmol, 4.00 eq.) were added portionwise over 
5 minutes to the reaction mixture followed by the addition of water (24 mL). Once the addition 
was complete the reaction was allowed to warm up to room temperature. After 2 h of stirring, 
2M HCl (20 mL) was added and extracted with ethyl acetate (2  30 mL). The organic phase 
was washed with brine (60 mL), dried (Na2SO4) and concentrated under reduced pressure. The 
crude was purified by flash column chromatography (silica, CH2Cl2 : EtOH : NH4.OH(aq) (50 
: 8 : 1)). The product was crystallised with either ethyl acetate and hexane or toluene. 
 
6.3.5. General procedure E 
 
To a stirred solution of biphenyl-2,2’-dicarboxylic acid 2-amide (40a-t) (8.00 mmol, 
1.00 eq.) and oxalyl chloride (850 μL, 10.0 mmol, 1.20 eq.) in CH2Cl2 (60 mL, 0.13 M) was 
added DMF (10 mol%). The reaction mixture was stirred for an hour before being added to a 
solution of hydroxylamine hydrochloride (1.11 g, 16.0 mmol, 2.00 eq.) and triethylamine 
(4.50 mL, 32.0 mmol, 4.00 eq.) in acetonitrile (30 mL, 0.26 M) at 0 °C. Once the addition was 
complete the reaction was allowed to warm up to room temperature. After 16 hours of stirring, 
the mixture was quenched with 1M NaOH (30 mL) and washed with ethyl acetate (2 × 30 
mL), neutralised with 2M HCl (15 mL) to pH 7 and extracted with ethyl acetate (2 × 30 mL). 
The organic phase was washed with brine (60 mL), dried (Na2SO4) and concentrated under 
reduced pressure. The crude was purified by flash column chromatography (silica, CH2Cl2 : 
EtOH : NH4.OH(aq) (50 : 8 : 1)). The product could be crystallised from either ethyl acetate 
and hexane or toluene. 
 
6.3.6. General procedure F 
 
To a stirred mixture of 2’-hydroxycarbamoyl-biphenyl-2-carboxylic acid ester (39a-
t) (1.00 mmol, 1.00 eq.) and 3-methyl-1-phenyl-2-phospholene oxide (41 mg, 0.20 mmol, 20 
mol %) in toluene (2 mL, 0.5 M) was added CDI (196 mg, 1.20 mmol, 1.20 eq.) reaction was 
heated from room temperature to reflux over 20 minutes and maintained at reflux for a further 
24 hours, after which time the reaction was cooled to room temperature and the crude reaction 
mixture was concentrated under reduced pressure and purified by flash column 
chromatography (silica, 20% ethyl acetate in petrol).  
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 Experimental Results from Chapter 3 
 
Methyl 2-bromo-5-methylbenzoate (49a) 112 
To a stirred solution of 2-bromo-5-methyl benzoic acid (2.15 g, 10.0 mmol, 1.00 eq.) 
in CH2Cl2 (125 mL, 0.800 M) was added oxalyl chloride (1.28 mL, 15.0 mmol, 1.50 eq.) and 
DMF (0.50 mL). This mixture was stirred at room temperature for an hour before being 
concentrated under reduced pressure and dissolved in methanol (12 mL, 0.30 mol, 30.0 eq.). 
After stirring at room temperature for 16 hours the reaction mixture was diluted with ethyl 
acetate (50 mL) and quenched with water (2 × 50 mL) and 2 M NaOH (50 mL). The organics 
were washed with brine (20 mL) and dried over Na2SO4 before being concentrated under 
reduced pressure. The crude was purified by flash column chromatography (silica, 30% ethyl 
acetate in hexane). Isolated the desired product, methyl 2-bromo-5-methylbenzoate (49a) 
(2.06 g, 9.00 mmol, 90% yield), as a colourless oil. 
1H NMR (501 MHz, CDCl3) δ 7.60 (1 H, d, J = 1.9 Hz, H6), 7.52 (1 H, d, J = 8.2 Hz, H3), 
7.13 (1 H, dd, J = 8.2, 1.9 Hz, H4), 3.93 (3 H, s, OCH3), 2.33 (3 H, s, ArCH3); 13C NMR (126 
MHz, CDCl3) δ 167.3 (COOMe), 137.7(CCH3), 134.6 (CH), 133.9 (CH), 132.4 (CH), 132.3 
(C1), 118.7 (C2), 52.9 (COOCH3), 21.2 (CH3); IR (νmax, thin film (neat), cm-1) 3448, 2996, 
2951, 2924, 1734, 1598, 1574, 1471, 1434, 1393, 1300, 1252, 1205, 1113, 1030; HRMS (ESI) 
Calcd. for C9H1079BrO2 [M+H]+ 228.9858; Found 228.9852. Data agrees with literature 
values.112 
 
tert-Butyl 4-(2-bromo-5-methylbenzoyl)piperazine-1-carboxylate 
(49h) 
To a stirred solution of 2-bromo-5-methyl benzoic acid (430 mg, 2.00 mmol, 1.00 eq.) 
in CH2Cl2 (25 mL, 0.08 M) was added oxalyl chloride (257 µL, 3.00 mmol, 1.50 eq.) and 
DMF (0.10 mL). This mixture was stirred at room temperature for an hour before being 
concentrated under reduced pressure and dissolved in diethyl ether (25 mL, 0.08 M). To this 
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solution was added dropwise a mixture of 1-Boc piperazine (558 mg, 3.00 mmol, 1.50 eq.) 
and diisopropylethylamine (523 µL, 3.00 mmol, 1.50 eq.) in diethyl ether (10 mL, 0.30 M). 
After stirring at room temperature for 16 hours the reaction mixture was diluted with diethyl 
ether (10 mL) and quenched with water (2 × 10 mL). The combined organics were washed 
with brine (20 mL) and dried over Na2SO4 before being concentrated under reduced pressure. 
The crude was purified by flash column chromatography (silica, 30% ethyl acetate in hexane). 
Isolated the desired product, tert-butyl 4-(2-bromo-5-methylbenzoyl)piperazine-1-
carboxylate (49h) (720 mg, 1.90 mmol, 94% yield), as a colourless solid. 
M.p. (hexane/CHCl3; colourless needles): 147 – 148 °C; 1H NMR (500 MHz, CDCl3) δ 7.44 
(1 H, d, J = 8.8 Hz, H3), 7.06 (1 H, d, J = 8.8 Hz, H4), 7.06 (1 H, br. s, H6), 3.88 – 3.79 (1 
H, m, N(CH2CH2)2N), 3.76 – 3.67 (1 H, m, N(CH2CH2)2N), 3.57 – 3.46 (3 H, m, 
N(CH2CH2)2N), 3.39 – 3.31 (1 H, m, N(CH2CH2)2N), 3.30 – 3.23 (1 H, m, N(CH2CH2)2N), 
3.19 – 3.13 (1 H, m, N(CH2CH2)2N), 2.31 (3 H, s, CH3), 1.46 (9 H, s, NBoc); 13C NMR (126 
MHz, CDCl3) δ 168.1 (C(O)N), 154.5 (NC(O)OtBu), 137.4 (C5), 135.1 (C1), 132.6 (CH), 
131.3 (CH), 128.3 (CH), 115.6 (C2), 80.4 (OC(CH3)3), 46.6 (N(CH2CH2)2N), 41.5 
(N(CH2CH2)2N), 28.4 (OC(CH3)3), 20.9 (CH3); IR (νmax, solid, cm-1) 3003, 2965, 2979, 2922, 
2864, 1682, 1644, 1446, 1421, 1364, 1286, 1265, 1244, 1211, 1166, 1122, 1082, 1035, 1007; 
HRMS (ESI) Calcd. for C17H2379BrN2NaO3 [M+Na]+ 405.0784; Found 405.0785.  
 
tert-Butyl 4-[(1-bromonaphthalen-2-yl)carbonyl]piperazine-1-
carboxylate (49g) 
To a stirred solution of 2-bromo-2-naphthoic acid (1.00 g, 4.00 mmol, 1.00 eq.) in 
CH2Cl2 (50 mL, 0.08 M) was added oxalyl chloride (544 µL, 6.00 mmol, 1.50 eq.) and DMF 
(0.20 mL). This mixture was stirred at room temperature for an hour before being concentrated 
under reduced pressure and dissolved in diethyl ether (50 mL, 0.08 M). To this solution was 
added dropwise a mixture of 1-Boc piperazine (1.12 g, 6.00 mmol, 1.50 eq.) and 
diisopropylethylamine (1.05 mL, 6.00 mmol, 1.50 eq.) in diethyl ether (20 mL, 0.30 M). After 
stirred at room temperature for 16 hours the reaction mixture was diluted with diethyl ether 
(20 mL) and quenched with water (2 × 20 mL). The combined organics were washed with 
brine (20 mL) and dried over Na2SO4 before being concentrated under reduced pressure. The 
crude was purified by flash column chromatography (silica, 30% ethyl acetate in hexane). 
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Isolated the desired product, tert-butyl 4-[(1-bromonaphthalen-2-yl)carbonyl]piperazine-1-
carboxylate (49g) (1.34 g, 3.20 mmol, 80% yield), as a colourless solid. 
M.p. (hexane/ CH2Cl2; colourless needles): 133 – 134 °C; 1H NMR (500 MHz, CDCl3) δ 8.30 
(1 H, d, J = 8.2 Hz, H9), 7.88 (1 H, d, J = 8.3 Hz, H4), 7.86 (1H, dd, J = 7.8, 0.5 Hz, H6), 
7.66 (1 H, ddd, J = 8.2, 7.0, 1.0 Hz, H8), 7.59 (1 H, ddd, J = 7.8, 7.0, 0.9 Hz, H7), 7.31 (1 H, 
d, J = 8.3 Hz, H3), 3.92 (1 H, dt, J = 13.3, 5.3 Hz, N(CH2CH2)2N), 3.83 – 3.73 (1 H, m, 
N(CH2CH2)2N), 3.59 (2 H, t, J = 5.1 Hz, N(CH2CH2)2N), 3.52 – 3.47 (1 H, m, 
N(CH2CH2)2N), 3.40 – 3.32 (1 H, m, N(CH2CH2)2N), 3.32 – 3.24 (1 H, m, N(CH2CH2)2N), 
3.23 – 3.14 (1 H, m, N(CH2CH2)2N), 1.45 (9 H, s, NBoc); 13C NMR (126 MHz, CDCl3) δ 
168.4 (C(O)N), 154.5 (NC(O)OtBu), 135.5 (C2), 134.1 (C5), 131.9 (C10), 128.8 (C6), 128.4 
(C7), 128.3 (C4), 127.6 (C8), 127.3 (C9), 123.8 (C3), 119.5 (C1), 80.4 (OC(CH3)3), 46.6 
(N(CH2CH2)2N), 41.5 (N(CH2CH2)2N), 28.4 (OC(CH3)3); IR (νmax, solid, cm-1) 3244, 3068, 
2981, 2932, 2891, 2852, 1686, 1626, 1556, 1466, 1420, 1364, 1324, 1274, 1260, 1165, 1122, 
1069, 1030, 1020; HRMS (ESI) Calcd. for C20H2479BrN2O3 [M+H]+ 419.0965; Found 
419.0967. 
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Methyl 2'-formyl-4-methyl-[1,1'-biphenyl]-2-carboxylate (48a) 
Prepared following the general method A with Pd(PPh3)4 (120 mg, 0.100 mmol, 0.02 
eq.) using 2-formylphenyl boronic acid (1.50 g, 10.0 mmol, 2.00 eq.) and methyl-2-bromo-5-
methylbenzoate (49a) (1.14 g, 5.00 mmol, 1.00 eq.). The reaction gave the desired product as 
a 1 : 1 mixture with benzaldehyde. This mixture was purified by column chromatography 
(20% ethyl acetate in hexane). Isolated the desired product, methyl 2'-formyl-4-methyl-[1,1'-
biphenyl]-2-carboxylate (48a) (1.11 g, 4.40 mmol, 87% yield), as a colourless solid. 
M.p. (hexane/ CH2Cl2; colourless cuboids): 60 – 61 °C; 1H NMR (500 MHz, CDCl3) 9.81 
(1 H, s, CHO), 8.00 (1 H, dd, J = 7.7, 1.3 Hz, H3’), 7.86 (1 H, s, H3), 7.59 (1 H, ddd, J = 7.7, 
7.7, 1.3 Hz, H5’), 7.49 (1 H, ddd, J = 7.7, 7.7 0.9 Hz, H4’), 7.39 (1 H, dd, J = 7.7, 1.3 Hz, 
H5), 7.23 (1 H, dd, J = 7.7, 0.9 Hz, H6’), 7.18 (1 H, d, J = 7.7 Hz, H6), 3.60 (3 H, s, COOCH3), 
2.47 (3 H, s, CH3); 13C NMR (127 MHz, CDCl3 191.8 (CHO), 167.4 (COOMe), 145.3 
(C1’), 138.2 (C1), 136.4 (C4), 134.0 (C2’), 133.1 (C5’), 132.4 (C5), 131.6 (C3), 130.9 (C3’), 
130.3 (C2), 130.3 (C4’), 127.7 (C6), 127.3 (C6’), 52.0 (OCH3), 21.0 (CH3); IR (νmax, thin film 
(CH2Cl2), cm-1) 3030, 2946, 2848, 2759, 1721, 1694, 1595, 1501, 1430, 896, 836, 791, 777; 
HRMS (ESI) Calcd. for C16H14NaO3 [M+Na]+ 277.0835; Found 277.0840.  
 
Methyl 2'-formyl-4-methoxy-[1,1'-biphenyl]-2-carboxylate (48b) 
Prepared following the general method A with Pd(PPh3)4 (120 mg, 0.100 mmol, 0.02 
eq.) using 2-formylphenyl boronic acid (1.50 g, 10.0 mmol, 2.00 eq.) and methyl-2-bromo-5-
methoxybenzoate (806 L, 5.00 mmol, 1.00 eq.). The reaction gave the desired product as a 
1:1 mixture with benzaldehyde. This mixture was purified by column chromatography (20% 
ethyl acetate in hexane). Isolated the desired product, methyl 2'-formyl-4-methoxy-[1,1'-
biphenyl]-2-carboxylate (48b) (1.29 g, 4.70 mmol, 96% yield), as a colourless solid. 
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M.p. (hexane/CH2Cl2; colourless cuboids): 76 – 77 °C; 1H NMR (500MHz, CDCl3) 9.84 (1 
H, s, CHO), 8.02 (1 H, dd, J = 7.8, 0.9 Hz, H3’), 7.61 (1 H, ddd, J = 7.8, 7.4, 1.4 Hz, H4’), 
7.58 (1 H, d, J = 2.7 Hz, H3), 7.52 (1 H, ddd, J = 7.8, 7.4, 0.9 Hz, H5’), 7.26 (1 H, dd, J = 
7.8, 1.4 Hz, H6’), 7.23 (1 H, d, J = 8.2 Hz, H6), 7.15 (1 H, dd, J = 8.2, 2.7 Hz, H5), 3.94 (3 
H, s, CH3O), 3.63 (3 H, s, CH3O)13C NMR (126 MHz, CDCl3) δ 191.9 (CHO), 167.1 
(COOMe), 159.3 (C4), 145.1 (C1’), 134.2 (C2’), 133.1 (C3’), 132.9 (C5’), 131.6 (C2), 131.5 
(C1), 130.5 (C6), 127.7 (C6’), 127.3 (C5’), 117.8 (C5), 115.0 (C6), 55.6 (CH3), 52.1 (CH3); 
IR (νmax, thin film (CH2Cl2), cm-1) 3075, 2952, 2835, 2766, 1719, 1686, 1596, 1575, 1562, 
1502, 1476, 1440, 1287, 1215, 1077, 1051, 887, 832, 822, 787, 777; HRMS (ESI) Calcd. for 
C16H14NaO4 [M+Na]+ 293.0784; Found 273.0787.  
 
Methyl 4-chloro-2'-formyl-[1,1'-biphenyl]-2-carboxylate (48d) 
Prepared following the general method A with Pd(PPh3)4 (120 mg, 0.100 mmol, 0.02 
eq.) using 2-formylphenyl boronic acid (1.50 g, 10.0 mmol, 2.00 eq.) and methyl-2-bromo-5-
chlorobenzoate (1.30 g, 5.00 mmol, 1.00 eq.). The reaction gave the desired product as a 1:1 
mixture with benzaldehyde. This mixture was purified by column chromatography (20% ethyl 
acetate in hexane). Isolated the desired product, methyl 4-chloro-2'-formyl-[1,1'-biphenyl]-2-
carboxylate (48d) (1.10 g, 4.00 mmol, 80% yield), as a colourless solid. 
M.p. (hexane/CH2Cl2; colourless needles): 166 – 167 °C; 1H NMR (500MHz, CDCl3)  9.81 
(1 H, s, CHO), 8.04 (1 H, d, J = 2.3 Hz, H3), 8.00 (1 H, dd, J = 7.7, 1.5 Hz, H3’), 7.61 (1 H, 
ddd, J = 7.7, 7.7, 1.5 Hz, H5’), 7.56 (1 H, dd, J = 8.2, 2.3 Hz, H5), 7.54 (1 H, br. t, J = 7.5 
Hz, H4’), 7.24 (1 H, d, J = 8.2 Hz, H6), 7.22 (1 H, dd, J = 7.7, 1.3 Hz, H6’), 3.64 (3 H, s, 
OCH3); 13C NMR (126 MHz, CDCl3) 191.3 (CHO), 165.9 (COOMe), 143.5 (C1), 138.1 
(C1’), 134.3 (C2), 133.9 (C2’), 133.3 (C5’), 132.8 (C5), 131.8 (C4), 130.7 (C3), 130.4 (C6), 
130.1 (C3’), 128.2 (C4’), 128.2 (C6’), 52.3 (OCH3); IR (νmax, thin film (CH2Cl2), cm-1) 3054, 
2988, 2879, 2833, 2685, 2538, 1728, 1689, 1599, 1572, 1497, 1474, 1435, 1416, 1274, 1262, 
1192, 1084, 1004, 835, 750, 701; HRMS (ESI) Calcd. for C15H1135ClNaO3 [M+Na]+ 297.0289; 
Found 297.0288.  
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Methyl 5-chloro-2'-formyl-[1,1'-biphenyl]-2-carboxylate (48c) 
Prepared following the general method A with Pd(PPh3)4 (120 mg, 0.100 mmol, 0.02 
eq.) using 2-formylphenyl boronic acid (960 mg, 6.40 mmol, 2.00 eq.) and methyl-2-bromo-
4-chlorobenzoate (785 mg, 3.20 mmol, 1.00 eq.). The reaction gave the desired product as a 
1:1 mixture with benzaldehyde. This mixture was purified by column chromatography (20% 
ethyl acetate in hexane). Isolated the desired product, methyl 5-chloro-2'-formyl-[1,1'-
biphenyl]-2-carboxylate (48c) (686 mg, 2.50 mmol, 79% yield), as a colourless oil. 
1H NMR (500 MHz, CDCl3) 9.82 (1 H, s, CHO), 8.02 (1 H, d, J = 8.4 Hz, H3), 8.00 (1 H, 
dd, J = 7.2, 1.4 Hz, H3’), 7.63 (1 H, ddd, J = 7.5, 7.3, 1.4 Hz, H5’), 7.55 (1 H, ddd, J = 7.3, 
7.3, 1.1 Hz, H4’), 7.50 (1 H, dd, J = 8.4, 2.1 Hz, H4), 7.31 (1 H, d, J = 2.1 Hz, H6), 7.24 (1 
H, dd, J = 7.5, 1.1 Hz, H6’), 3.64 (3 H, s, CH3O); 13C NMR (126 MHz, CDCl3) 191.2 
(CHO), 166.2 (COOMe), 143.4 (C1), 141.6 (C5), 138.1 (C1’), 133.8 (C2’), 133.3 (C5’), 
131.8 (C3), 131.5 (C6), 129.9 (C6’), 128.7 (C4), 128.4 (C2), 128.3 (C4’), 128.2 (C3’), 52.2 
(OCH3); IR (νmax, solid, cm-1) 3053, 2986, 1725, 1697, 1590, 1560, 1435, 1266, 1106, 1019, 
736; HRMS (ESI) Calcd. for C15H1135ClNaO3 [M+Na]+ 297.0289; Found 297.0286.  
 
Ethyl 2'-formyl-4'-methoxy-[1,1'-biphenyl]-2-carboxylate (48e) 
Prepared following the general method A with “Pd-118” (27 mg, 0.05 mmol, 0.01 eq.) 
using 2-formyl-4-methoxy-phenyl boronic acid (1.20 g, 6.50 mmol, 1.20 eq.) and ethyl 2-
bromobenzoate (874 L, 5.50 mmol, 1.00 eq.). The crude reaction mixture was purified by 
column chromatography (20% ethyl acetate in hexane). Isolated the desired product, ethyl 2'-
formyl-4'-methoxy-[1,1'-biphenyl]-2-carboxylate (48e) (1.34 g, 4.70 mmol, 85% yield, 98% 
purity, 2% anisaldehyde), as a colourless oil. 
1H NMR (501 MHz, CDCl3)  9.65 (1 H, s, CHO), 8.04 (1 H, dd, J = 7.9, 1.3 Hz, H3), 7.98 
(1 H, d, J = 8.5 Hz, H6’), 7.58 (1 H, ddd, J = 7.5, 7.5, 1.3 Hz, H5), 7.52 (1 H, ddd, J = 7.9, 
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7.5, 1.1 Hz, H4), 7.31 (1 H, dd, J = 7.5, 1.1 Hz, H6), 7.01 (1 H, dd, J = 8.5, 2.6 Hz, H5’), 
6.73 (1 H, d, J = 2.6 Hz, H3’), 4.14 − 4.00 (2 H, m, OCH2CH3), 3.88 (3 H, s, CH3O), 1.01 (3 
H, t, J = 7.1 Hz, OCH2CH3); 13C NMR (126 MHz, CDCl3)  190.2 (CHO), 166.9 (COOEt), 
163.3 (C4’), 147.9 (C1), 139.0 (C2’), 131.4 (C5), 131.3 (C3), 131.0 (C1’), 130.3 (C6’), 129.7 
(C4), 128.2 (C6), 127.8 (C2), 114.9 (C5’), 113.7 (C3’), 61.0 (OCH2CH3) 55.6 (OCH3), 13.7 
(OCH2CH3); IR (νmax, thin film (CDCl3), cm-1) 3155, 3053, 2984, 2940, 2842, 1714, 1681, 
1596, 1566, 1562, 1464, 1382, 1298, 1264, 1094, 1017; HRMS (ESI) Calcd. for C17H16NaO4 
[M+Na]+ 307.0941; Found 307.0942.  
 
Ethyl 2-(2’-formylthiophen-3’-yl)benzoate (48f) 
Prepared following the general method A with “Pd-118” (32 mg, 0.06 mmol, 0.01 eq.) 
using 2-formyl-thiophene-3-boronic acid (1.20 g, 7.80 mmol, 1.20 eq.) and ethyl 2-
bromobenzoate (1.03 mL, 6.50 mmol, 1.00 eq.). The crude reaction mixture was purified by 
column chromatography (20% ethyl acetate in hexane). Isolated the desired product, ethyl 2-
(2’-formylthiophen-3’-yl)benzoate (48f) (378 mg, 1.45 mmol, 45% yield), as a yellow oil. 
1H NMR (501 MHz, CDCl3)  9.61 (1 H, s, CHO), 8.04 (1 H, dd, J = 7.3, 1.4 Hz, H3), 7.71 
(1 H, d, J = 5.0 Hz, H5’), 7.59 (1 H, ddd, J = 7.3, 7.3 1.4 Hz, H5), 7.54 (1 H, dd, J = 7.3, 7.3 
Hz, H4), 7.37 (1 H, d, J = 7.3 Hz, H6), 7.08 (1 H, d, J = 5.0 Hz, H4’), 4.13 (2 H, q, J = 6.9 
Hz, OCH2CH3), 1.10 (3 H, t, J = 7.1 Hz, OCH2CH3); 13C NMR (126 MHz, CDCl3)  183.4 
(CHO), 166.9 (COOEt), 150.7 (C1’), 138.9 (C2’), 134.5 (C1), 132.9 (C5), 131.6 (C4’), 131.5 
(C3), 131.5 (C2), 130.0 (C6), 130.6 (C5’), 128.8 (C4), 61.2 (OCH2CH3), 13.8 (OCH2CH3); 
IR (νmax, thin film (CH2Cl2), cm-1) 3057, 2984, 2820, 1715, 1660, 1599, 1420, 1382, 1365, 
1294, 1266, 1206, 1135, 1090, 1064, 906, 737; HRMS (ESI) Calcd. for C14H12NaO3S 
[M+Na]+ 283.0399; Found 283.0407.  
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tert-Butyl 4-(2'-formyl-4-methyl-[1,1'-biphenyl]-2-
carbonyl)piperazine-1-carboxylate (48h) 
Prepared following the general method A with Pd(PPh3)4 (120 mg, 0.100 mmol, 0.02 eq.) 
using 2-formylphenyl boronic acid (1.50 g, 10.0 mmol, 2.00 eq.) and tert-butyl 4-(2-bromo-
5-methylbenzoyl)piperazine-1-carboxylate (49h) (1.90 g, 5.00 mmol, 1.00 eq.). The reaction 
gave the desired product as a mixture with benzaldehyde. This mixture was purified by column 
chromatography (50% ethyl acetate in hexane). Isolated the desired product, tert-butyl 4-(2'-
formyl-4-methyl-[1,1'-biphenyl]-2-carbonyl)piperazine-1-carboxylate (48h) (1.78 g, 4.40 
mmol, 87% yield), as a colourless solid. 
M.p. (hexane/ethyl acetate; colourless needles): 89 – 90 °C; 1H NMR (340 K, 501 MHz, 
DMSO-d6)  9.76 (1 H, br. s, CHO), 7.88 (1 H, dd, J = 7.8, 1.1 Hz, H5), 7.68 (1 H, ddd, J = 
7.5, 7.5, 1.4 Hz, H4’ or H5’), 7.56 (1 H, dd, J = 7.6, 7.6 Hz, H4’ or 5’), 7.36 (1 H, ddd, J = 
7.9, 7.9, 0.9 Hz, H3’ or H6’), 7.36 (1 H, ddd, J = 7.9, 7.9, 0.9 Hz, H3’ or H6’), 7.21 − 7.28 
(2 H, m, H6 and H3), 3.49 − 3.12 (4 H, m, N(CH2CH2)2N), 3.08 – 2.90 (4 H, m, 
N(CH2CH2)2N), 2.42 (3 H, s, CH3), 1.37 (9 H, s, NBoc); 13C NMR (340 K, 126 MHz, DMSO-
d6) δ 191.1 (CHO), 168.1 (ArC(O)N), 153.7 (NC(O)OtBu), 142.6 (C1’), 138.0 (C5’), 136.1 
(C3’), 133.9 (C3), 133.3 (C5), 131.9 (C1), 131.8 (C2), 131.0 (C4), 130.8 (C2’), 129.4 (C6), 
128.2 (C6’), 79.2 (C(CH3)3), 45.9 (br, CH2), 43.0 (br, CH2), 28.0 (C(CH3)3), 20.6 (CH3) (C4’ 
missing); IR (νmax, solid, cm-1) 2975, 2923, 2860, 1690, 1632, 1596, 1457, 1415, 1364, 1284, 
1241, 1208, 1195, 1163, 1130, 1113, 1072, 1053, 1018; HRMS (ESI) Calcd. for C24H29N2O4 
[M+H]+ 409.2121; Found 409.2133.  
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tert-Butyl 4-(1-(2’-formylphenyl)-2-naphthoyl)piperazine-1-
carboxylate (48g) 
Prepared following the general method A with Pd(PPh3)4 (120 mg, 0.100 mmol, 0.02 
eq.) using 2-formylphenyl boronic acid (525 mg, 3.60 mmol, 2.00 eq.) and tert-butyl 4-[(1-
bromonaphthalen-2-yl)carbonyl]piperazine-1-carboxylate (49g) (752 mg, 1.80 mmol, 1.00 
eq.). The reaction gave the desired product as a mixture with benzaldehyde. This mixture was 
purified by column chromatography (50% ethyl acetate in hexane). Isolated the desired 
product, tert-butyl 4-(1-(2’-formylphenyl)-2-naphthoyl)piperazine-1-carboxylate (48g) (726 
mg, 1.60 mmol, 91% yield), as a colourless solid. 
M.p. (hexane/ethyl acetate; colourless needles): 101 – 103 °C; 1H NMR (340 K, 501 MHz, 
DMSO-d6)  9.48 (1 H, s, CHO), 8.11 (1 H, d, J = 8.4 Hz, H9), 8.06 (1 H, d, J = 8.2 Hz, H3’), 
7.98 (1 H, d, J = 7.6 Hz, H7), 7.78 (1 H, ddd, J = 7.5, 7.5, 1.4 Hz, H5), 7.66 (1 H, dd, J = 7.6, 
7.6 Hz, H6), 7.59 (1 H, ddd, J = 8.0, 6.9, 0.9 Hz, H4’), 7.52 (1 H, d, J = 8.4 Hz, H10), 7.49 (1 
H, ddd, J = 8.1, 7.0, 1.1 Hz, H5’), 7.44 (1 H, dd, J = 7.5, 0.6 Hz, H4), 7.25 (1 H, d, J = 8.5 
Hz, H6’), 3.30 (3 H, br. s, N(CH2CH2)2N), 3.14 (5 H, br. s, N(CH2CH2)2N), 1.38 (9 H, s, 
NBoc); 13C NMR (340 K, 126 MHz, DMSO-d6) δ 190.9 (CHO), 168.0 (ArC(O)N), 153.7 
(NC(O)OtBu), 134.9 (C2), 134.0 (C1’), 133.5 (ArCH), 132.7 (C2’), 132.3 (C1), 131.9 
(ArCH), 128.8 (ArCH), 128.3 (ArCH), 127.4 (ArCH), 126.7 (ArCH), 125.6 (ArCH), 123.0 
(ArCH), 79.2 (C(CH3)3), 46.0 (CH2), 43.4 (CH2), 43.0 (CH2), 40.8 (CH2), 28.0 (C(CH3)3), 
(21 of 25 expected carbon signals observed, missing 2 ArCH, C3 + C8); IR (νmax, thin film 
(CH2Cl2), cm-1) 3058, 3004, 2981, 2935, 2864, 2844, 2752, 1694, 1637, 1597, 1421, 1366, 
1275, 1261, 1169, 1031, 818, 764, 750. HRMS (ESI) Calcd. for C27H29N2O4 [M+H]+ 
445.2122; Found 445.2131.  
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2'-(Methoxycarbonyl)-[1,1'-biphenyl]-2-carboxylic acid (40a) 52 
Prepared following the general method B using methanol (0.48 mL, 12 mmol, 1.0 eq.) 
as the nucleophile. Crystallization from ethyl acetate and hexane gave 2'-(methoxycarbonyl)-
[1,1'-biphenyl]-2-carboxylic acid (40a) (2.02 g, 7.90 mmol, 98% yield) as a cream solid.  
M.p. (hexane/ethyl acetate; colourless plates): 111.2 – 112.0 °C (Lit.52 111 °C); 1H NMR (300 
MHz, CDCl3)  8.05 (1 H, dd, J = 7.8, 1.2 Hz, H3), 8.00 (1 H, dd, J = 7.7, 1.8 Hz, H3’), 7.55 
− 7.51 (2 H, m, H4/H4’ or H5/H5’), 7.43 − 7.41 (2 H, m, H4/H4’ or H5/H5’), 7.19 (1 H, dd, 
J = 7.7, 0.9 Hz, H6), 7.18 (1 H, dd, J = 7.7, 0.9 Hz, H6’), 3.61 (3 H, s, COOCH3); 13C NMR 
(76 MHz, CDCl3) 172.5 (C), 168.0 (C), 144.1 (C), 143.4 (C), 132.6 (ArCH), 132.0 (ArCH), 
130.9 (ArCH), 130.8 (ArCH), 130.6 (ArCH), 130.3 (ArCH), 129.5 (C), 128.9 (C), 127.7 
(ArCH), 52.3 (CH3) (14 of 15 expected carbon signals observed); IR (νmax, solid, cm-1) 2950, 
1717, 1676, 1593, 1569, 1429, 1253, 1135, 1080, 942, 754; HRMS (ESI) Calcd. for 
C15H12NaO4 [M+Na]+ 279.0628; Found 279.0630. Data agrees with literature values.52  
 
2'-(Ethoxycarbonyl)-[1,1'-biphenyl]-2-carboxylic acid (40b) 
Prepared following the general method B using ethanol (0.70 mL, 12 mmol, 1.0 eq.) 
as the nucleophile. Crystallization from ethanol gave 2'-(ethoxycarbonyl)-[1,1'-biphenyl]-2-
carboxylic acid (40b) (1.69 g, 6.24 mmol, 52% yield) as a colourless solid.  
M.p. (EtOH; colourless needles): 91 – 93 °C (Lit. 52 92 – 93 °C); 1H NMR (300 MHz, CDCl3) 
 8.01 (1 H, dd, J = 7.9, 1.1 Hz, H3), 7.99 (1 H, dd, J = 7.9, 1.4 Hz, H3’), 7.57 − 7.40 (4 H, 
m, H4, H4’, H5 and H5’), 7.21 − 7.16 (2 H, 2dd, J = 7.3, 1.1 Hz, H6 and H6’), 4.06 (2 H, qd, 
J = 7.2, 1.4 Hz, OCH2Me), 1.01 (3 H, t, J = 1.7 Hz, OCH2CH3); 13C NMR (76 MHz, CDCl3) 
171.9 (C), 167.4 (C), 144.0 (C), 142.7 (C), 132.1 (ArCH), 131.4 (ArCH), 130.5 (ArCH), 130.4 
(ArCH), 130.1 (ArCH), 130.0 (ArCH), 129.6 (C), 128.6 (C), 127.2 (ArCH), 127.2 (ArCH), 
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68.8 (OCH2Me), 13.7 (CH3); IR (νmax, thin film (CH2Cl2), cm-1) 3066, 2985, 1701, 1599, 1575, 
1476, 1444, 1406, 1368, 1294, 1137, 1098; HRMS (ESI) Calcd. for C16H14NaO4 [M+Na]+ 
293.0784; Found 293.0791. Data agrees with literature values.52 
 
2'-(Isopropoxycarbonyl)-[1,1'-biphenyl]-2-carboxylic acid (40c) 
Prepared following the general method B using 2-propanol (0.96 mL, 12 mmol) as 
the nucleophile. Purification by column chromatography (30% ethyl acetate in petrol) gave 2'-
(isopropoxycarbonyl)-[1,1'-biphenyl]-2-carboxylic acid (40c) (2.51 g, 8.82 mmol, 74% yield) 
as a colourless solid. 
M.p. (hexane/ ethyl acetate; colourless cubes): 105 – 107 °C (Lit.52(EtOH): 105°C)1H NMR 
(300 MHz, CDCl3)  8.02 (1 H, dd, J = 7.7, 1.4 Hz, H3), 7.96 (1 H, dd, J = 7.7, 1.1 Hz, H3’), 
7.54 − 7.36 (4 H, m, H4, H4’, H5 and H5’), 7.17 − 7.13 (2 H, m, H6 and H6’), 4.94 (1 H, 
sept, J = 6.2 Hz, OCH(Me)2), 1.03 (3 H, d, J = 6.2 Hz, CH3), 0.88 (3 H, J = 6.2 Hz, CH3); 
13C NMR (76 MHz, CDCl3)  171.3 (C), 167.1 (C), 143.9 (C), 142.4 (C), 132.0 (ArCH), 131.2 
(ArCH), 130.4 (C), 130.4 (ArCH), 130.2 (ArCH), 130.1 (ArCH), 129.9 (ArCH), 128.8 (C), 
127.3 (ArCH), 127.2 (ArCH), 68.3 (OCH(Me)2), 21.4 (CH3), 21.3 (CH3); IR (νmax, solid, cm-
1) 3065, 2982, 1699, 1657, 1599, 1575, 1443, 1353, 1292, 1139, 1106; HRMS (ESI) Calcd. 
for C17H16NaO4 [M+Na]+ 285.1121; Found 285.1118. Data agrees with literature values.52  
 
2'-(Butoxycarbonyl)-[1,1'-biphenyl]-2-carboxylic acid (40d) 
Prepared following the general method B using n-butanol (1.11 mL, 12.0 mmol) as 
the nucleophile. The reaction yielded 2'-(butoxycarbonyl)-[1,1'-biphenyl]-2-carboxylic acid 
(40d) (3.16 g, 10.6 mmol, 88% yield) as a slightly yellow oil and was used without further 
purification.  
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M.p. (hexane/ ethyl acetate; colourless needles): 51 – 53 °C; 1H NMR (500 MHz, CDCl3) δ 
8.06 (1 H, dd, J = 7.7, 1.4 Hz, H3), 8.03 (1 H, dd, J = 7.8, 1.1 Hz, H3’), 7.53 (1 H, ddd, J = 
7.6, 7.5, 1.4 Hz, H5), 7.49 (1 H, ddd, J = 7.5, 7.5, 1.4 Hz, H5’), 7.46 – 7.38 (2 H, m, H4’ and 
H6’), 7.21 (1 H, dd, J = 7.6, 0.9 Hz, H6), 7.18 (1 H, ddd, J = 7.7, 7.5, 0.9 Hz, H4), 4.02 (2 H, 
m, OCH2CH2CH2CH3), 1.36 (2 H, ap. quin, J = 6.9 Hz, CH2), 1.17 (2 H, ap. sextet, J = 7.3 
Hz, CH2), 0.84 (3 H, t, J = 7.33 Hz, CH3); 13C NMR (76 MHz, CDCl3)  172.0 (C), 167.5 (C), 
144.1 (C), 142.8 (C), 132.1 (ArCH), 131.4 (ArCH), 130.6 (ArCH), 130.5 (ArCH), 130.2 
(ArCH), 130.1 (ArCH), 129.7 (C), 128.6 (C), 127.2 (ArCH), 127.1 (ArCH), 64.8 (CH2), 30.3 
(CH2), 19.1 (CH2), 13.7 (CH3); IR (νmax, thin film, cm-1) 3062,  2961, 1719, 1599, 1574, 1442, 
1407, 1385, 1290, 1136, 1082; HRMS (ESI) Calcd. for C18H18NaO4 [M+Na]+ 321.1097; 
Found 321.1108. 
 
2'-((Benzyloxy)carbonyl)-[1,1'-biphenyl]-2-carboxylic acid (40f)  
Prepared following the general method B using benzyl alcohol (1.26 mL, 12.0 mmol) 
as the nucleophile. Crystallization from toluene gave 2'-((benzyloxy)carbonyl)-[1,1'-
biphenyl]-2-carboxylic acid (40f) (2.28 g, 6.87 mmol, 57% yield) as a colourless solid. 
Alternatively the crude reaction mixture could be used without further purification. 
M.p. (hexane/ ethyl acetate; colourless plates): 111-112 °C; 1H NMR (500 MHz, CDCl3) δ 
8.03 (1 H, dd, J = 7.9, 0.9 Hz, H3), 7.94 (1 H, dd, J = 7.8, 1.0 Hz, H3’), 7.51 (1 H, ddd, J = 
7.5, 7.5, 1.2 Hz, H4 or H4’), 7.47 (1 H, ddd, J = 7.5, 7.5, 1.2 Hz, H4 or H4’), 7.41 (1 H, ddd, 
J = 7.6, 7.6, 1.1 Hz, H5 or H5’), 7.35 (1 H, ddd, J = 7.7, 7.7, 1.0 Hz, H5 or H5’), 7.25 (3 H, 
ap. t, J = 3.4 Hz, OCH2C6H5), 7.22 – 7.14 (2 H, m, H6 and H6’), 7.12 – 7.10 (2 H, m, 
OCH2C6H5), 5.05 (2H, s, OCH2C6H5); 13C NMR (76 MHz, CDCl3)  171.2 (C), 167.1 (C), 
143.6 (C), 142.9 (C), 135.5 (C) 132.3 (CH), 132.1 (CH), 131.6 (CH), 130.6 (CH), 130.5 (C), 
130.3 (CH), 130.3 (CH), 130.1 (CH), 129.2 (C), 129.1 (C), 128.4 (CH), 128.3 (CH), 128.1 
(CH), 127.3 (CH), 127.2 (CH), 66.8 (OCH2Ph); IR (νmax, thin film (CH2Cl2), cm-1) 2986, 2651, 
2530, 1698, 1598, 1576, 1442, 1410, 1286, 1137, 1079; HRMS (ESI) Calcd. for C21H16NaO4 
[M+Na]+ 355.0941; Found 355.0954. 
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2'-(Diethylcarbamoyl)-[1,1'-biphenyl]-2-carboxylic acid (40g) 52 
            Prepared following the general method B using diethylamine (1.23 mL, 12.0 mmol) as 
the nucleophile. On addition of acid a white precipitate formed which was filtered to give 2'-
(diethylcarbamoyl)-[1,1'-biphenyl]-2-carboxylic acid (40g) (2.30 g, 7.74 mmol, 64% yield) as 
an insoluble colourless solid.  
M.p. (EtOH; colourless cubes): 177 – 179 °C (Lit.52 178 °C); 1H NMR (500 MHz, CDCl3)  
7.70 (1 H, d, J = 7.3 Hz, H3 or H3’), 7.50 − 7.44 (3 H, m, ArH), 7.41 (1 H, dd, J = 6.9, 6.9 
Hz, ArH), 7.37 − 7.30 (2 H, m, ArH), 7.04 (1 H, d, J = 6.9 Hz, H6 or H6’), 3.57 (1 H, quin, 
J = 6.9 Hz, N(CH2CH3)2), 3.50 (1 H, quin, J = 6.9 Hz, N(CH2CH3)2), 3.37 (1 H, dq, J = 14.2, 
7.1 Hz, N(CH2CH3)2), 3.20 (1 H, sxt, J = 6.4 Hz, N(CH2CH3)2), 1.25 (3 H, t, J = 6.6 Hz, 
N(CH2CH3)2), 0.90 (3 H, t, J = 7.1 Hz, N(CH2CH3)2); 13C NMR (76 MHz, CDCl3) 172.2 
(COOH), 170.5 (CONR2), 138.5 (C), 136.8 (C), 135.7 (C), 133.7 (C), 130.3 (ArCH), 129.8 
(ArCH), 129.6 (ArCH), 128.6 (ArCH), 128.4 (ArCH), 128.2 (ArCH), 128.1 (ArCH), 124.7 
(ArCH), 43.4 (CH2), 39.3 (CH2), 14.1 (CH3), 11.8 (CH3); IR (νmax, solid, cm-1) 2969, 2933, 
2874, 2757, 2609, 2483, 1715, 1592, 1574, 1487, 1461, 1441, 1389, 1347, 1292, 1244, 1216, 
1046; HRMS (ESI) Calcd. for C18H20NO3 [M+H]+ 298.1438; Found 298.1433. Data agrees 
with literature values.52 
 
2'-(Pyrrolidine-1-carbonyl)-[1,1'-biphenyl]-2-carboxylic acid (40h) 
Prepared following the general method B using pyrrolidine (0.99 mL, 12 mmol) as 
the nucleophile. On addition of acid a white precipitate formed which was filtered to give 2'-
(pyrrolidine-1-carbonyl)-[1,1'-biphenyl]-2-carboxylic acid (40h) (2.92 g, 9.90 mmol, 82% 
yield) as an insoluble colourless solid.  
M.p. (EtOH; colourless needles): 198 – 203 °C; 1H NMR (500 MHz, DMSO-d6)  12.81 (1 
H, br. S, COOH), 7.77 (1 H, d, J = 7.6 Hz, H3 or H3’), 7.52 (1 H, dd, J = 7.3, 7.3 Hz, ArH), 
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7.47 − 7.32 (4 H, m, ArH), 7.27 (1 H, d, J = 7.6 Hz, H6 or H6’), 7.22 (1 H, dd, J = 6.3, 1.1 
Hz, H6 or H6’), 3.16 (4 H, br. s, N(CH2)2), 1.66 (2 H, quin, J = 6.4 Hz, N(CH2CH2)2), 1.55 
(2 H, br. s, N(CH2CH2)2); 13C NMR (76 MHz, CDCl3) 170.7 (COOH), 170.6 (CONR2), 
138.6 (C), 137.2 (C), 135.5 (C), 134.2 (C), 130.5 (ArCH), 130.0 (ArCH), 129.8 (ArCH), 128.6 
(ArCH), 128.3 (ArCH), 128.2 (ArCH), 128.1 (ArCH), 125.6 (ArCH), 49.5 (NCH2), 45.9 
(NCH2), 26.0 (CH2), 24.3 (CH2); IR (νmax, thin film (CH2Cl2), cm-1) 3155, 2983, 2901, 1817, 
1793, 1721, 1642, 1603, 1583, 1566, 1469, 1382, 1297, 1216, 1165, 1096; HRMS (ESI) Calcd. 
for C18H18NO3 [M+H]+ 296.1281; Found 296.1289. 
 
2'-(Piperidine-1-carbonyl)-[1,1'-biphenyl]-2-carboxylic acid (40i) 52 
Prepared following the general method B using piperidine (1.20 mL, 12.0 mmol) as 
the nucleophile. On addition of acid a white precipitate formed which was filtered to give 2'-
(piperidine-1-carbonyl)-[1,1'-biphenyl]-2-carboxylic acid (40i) (2.80 g, 9.05 mmol, 75% 
yield) as an insoluble colourless solid.  
M.p. (EtOH; colourless needles): 156 – 158 °C (Lit.52 157 °C); 1H NMR (500 MHz, CDCl3) 
 7.72 (1 H, d, J = 6.9 Hz, H3 or H3’), 7.49 − 7.37 (4 H, m, ArH), 7.29 (2 H, br. s, ArH), 7.03 
(1 H, d, J = 6.9 Hz, H6 or H6’), 3.82 − 3.08 (10 H, m); 13C NMR (75.5 MHz, CDCl3) δ 
170.8 (COOH), 170.6 (CONR2), 139.1 (C), 137.1 (C), 135.5 (C), 133.1 (C), 131.7 (ArCH), 
129.9 (ArCH), 129.7 (ArCH), 128.6 (ArCH), 128.4 (ArCH), 128.4 (ArCH), 128.1 (ArCH), 
125.5 (ArCH), 48.7 (NCH2), 43.3 (NCH2), 26.7 (CH2), 25.5 (CH2), 24.2 (CH2); IR (νmax, solid, 
cm-1) 3051, 2962, 2935, 2851, 1696, 1579, 1567, 1447, 1433, 1252, 1229; HRMS (ESI) Calcd. 
for C19H20NO3 [M+H]+ 310.1438; Found 310.1450. Data agrees with literature values.52 
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2'-(Morpholine-4-carbonyl)-[1,1'-biphenyl]-2-carboxylic acid (40j) 
Prepared following the general method B using morpholine (1.40 mL, 12.0 mmol) as 
the nucleophile. On addition of acid a white precipitate formed which was filtered to give 2'-
(morpholine-4-carbonyl)-[1,1'-biphenyl]-2-carboxylic acid (40j) (3.25 g, 10.5 mmol, 87% 
yield) as an insoluble colourless solid.  
M.p. (EtOH; colourless needles): 212 – 214 °C; 1H NMR (300 MHz, DMSO-d6)  12.82 (1 
H, br. s, COOH), 7.83 (1 H, d, J = 7.4 Hz, H3 or H3’), 7.55 (1 H, ddd, J = 7.5, 7.5, 1.0 Hz, 
ArH), 7.48 (1 H, ddd, J = 7.5, 7.5, 1.0 Hz, ArH), 7.44 − 7.29 (4 H, m, ArH), 7.27 − 7.17 (1 
H, m, ArH), 3.42 (2 H, br. s, N(CH2CH2)2O ), 3.18 (2 H, br. s, N(CH2CH2)2O ), 2.99 (3 H, br. 
s, N(CH2CH2)2O ), 2.78 (1 H, br. s, N(CH2CH2)2O); 13C NMR (75 MHz, DMSO-d6)  168.7 
(COOH), 168.1 (CONR2), 139.2 (C), 137.6 (C), 134.9 (C), 132.0 (C), 130.9 (ArCH), 130.6 
(ArCH), 129.8 (ArCH), 129.6 (ArCH), 128.4 (ArCH), 127.7 (ArCH), 127.3 (ArCH), 127.0 
(ArCH), 65.9 (OCH2), 65.6 (OCH2), 46.3 (CH2N), 41.4 (CH2N); IR (νmax, solid, cm-1) 2983, 
2912, 2853, 2587, 2458, 1701, 1582, 1567, 1436, 1264, 1247, 1236; HRMS (ESI) Calcd. for 
C18H17NNaO4 [M+Na]+ 334.1050; Found 334.1054. 
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2'-(4-(tert-Butoxycarbonyl)piperazine-1-carbonyl)-[1,1'-biphenyl]-2-
carboxylic acid (40l) 
Prepared following the general method B on a 24 mmol scale using N-Boc piperazine 
(4.46g, 24.0 mmol, 1.00 eq.) as the nucleophile. On addition of acid a white precipitate formed 
which was filtered to give 2'-(4-(tert-butoxycarbonyl)piperazine-1-carbonyl)-[1,1'-biphenyl]-
2-carboxylic acid (40l) (6.46 g, 15.6 mmol, 66% yield) as an insoluble colourless amorphous 
solid.  
M.p. (hexane/ ethyl acetate; colourless needles): 151 – 152 °C; 1H NMR (340 K, 501 MHz, 
DMSO-d6)  12.64 − 12.37 (1 H, br., COOH), 7.81 (1 H, dd, J = 7.7, 1.1 Hz, H3 or H3’), 7.52 
(1 H, ddd, J = 7.6, 7.6, 1.4 Hz, ArH), 7.45 (1 H, ddd, J = 7.7, 7.7, 1.3 Hz, ArH), 7.43 − 7.38 
(2 H, m, ArH), 7.36 − 7.32 (1 H, m, ArH), 7.31 (1 H, d, J = 7.5 Hz, H6 or H6’), 7.26 − 7.20 
(1 H, m, ArH), 3.35 (2 H, br. s, N(CH2CH2)2N), 3.14 (6 H, br. s, N(CH2CH2)2N), 1.36 (9 H, 
s, BocH); 13C NMR (340 K, 126 MHz, DMSO-d6) 168.5 (COOH), 168.4 (C), 153.7 (C), 
139.3 (C), 138.0 (C), 135.1 (C), 132.1 (C), 131.0 (ArCH), 130.5 (ArCH), 130.0 (ArCH), 129.5 
(ArCH), 128.3 (ArCH), 127.7 (ArCH), 127.3 (ArCH), 126.7 (ArCH), 79.2 (C(CH3)3), 47.5 
(br, CH2), 42.2 (br, CH2), 28.0 (C(CH3)3); IR (νmax, thin film (CH2Cl2), cm-1) 2986, 2924, 2868, 
2767, 2604, 1714, 1691, 1583, 1568, 1448, 1418, 1365, 1289, 1250, 1230, 1166, 1126, 1110, 
1015; HRMS (ESI) Calcd. for C23H27N2O5 [M+H]+ 411.1914; Found 411.1919. 
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2'-(Methoxycarbonyl)-4'-methyl-[1,1'-biphenyl]-2-carboxylic acid 
(40n) 
Prepared following the general procedure C using 1-methylcyclohexene and methyl 
2'-formyl-4-methyl-[1,1'-biphenyl]-2-carboxylate (48a) (1.02 g, 4.00 mmol, 1.00 eq.). This 
mixture was purified by column chromatography (gradient of 0 − 100% ethyl acetate in 
hexane). Isolated the desired product, 2'-(methoxycarbonyl)-4'-methyl-[1,1'-biphenyl]-2-
carboxylic acid (40n) (1.11 g, 4.00 mmol, 99% yield, purity >95%), as a yellow solid. 
M.p. (hexane/ethyl acetate; colourless amorphous solid): 157 – 159 °C; 1H NMR (500 MHz, 
CDCl3)  8.73 − 8.36 (1 H, br, COOH), 8.00 (1 H, ddd, J = 7.7, 1.4 Hz, H3), 7.78 (1 H, d, J 
= 1.3 Hz, H3’), 7.53 (1 H, ddd, J = 7.5, 7.5 1.4 Hz, H5), 7.44 (1 H, ddd, J = 7.7, 7.5 1.3 Hz, 
H4), 7.35 (1 H, dd, J = 7.7, 1.3 Hz, H5’), 7.16 (1 H, dd, J = 7.5, 1.3 Hz, H6), 7.11 (1 H, d, J 
= 7.7 Hz, H6’), 3.66 (3 H, s, COOCH3), 2.45 (3 H, s, ArCH3); 13C NMR (126 MHz, CDCl3 
171.0 (COOH), 168.0 (COOMe), 143.4 (C), 140.0 (C), 137.0 (C), 132.3 (ArCH), 131.8 
(ArCH), 130.5 (ArCH), 130.4 (ArCH), 130.3 (ArCH), 130.3 (ArCH), 129.1 (C), 127.1 (CH), 
51.9 (OCH3), 21.0 (CH3) (15 of 16 expected carbon signals observed); IR (νmax, thin film 
(CH2Cl2), cm-1) 2924, 2650, 2577, 1721, 1694, 1672, 1597, 1572, 1449, 1435, 1406, 1294, 
1248, 1201, 1099, 1083, 948; HRMS (ESI) Calcd. for C16H14NaO4 [M+Na]+ 293.0784; Found 
293.0787.  
 
4'-Methoxy-2'-(methoxycarbonyl)-[1,1'-biphenyl]-2-carboxylic acid 
(40o) 
Prepared following the general procedure C with hydrogen peroxide using methyl 2'-
formyl-4-methoxy-[1,1'-biphenyl]-2-carboxylate (48b) (804 mg, 3.00 mmol, 1.00 eq.). The 
reaction produced the desired product as a colourless solid. This mixture was purified by 
column chromatography (gradient of 0 − 100% ethyl acetate in hexane). Isolated the desired 
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product, 4'-methoxy-2'-(methoxycarbonyl)-[1,1'-biphenyl]-2-carboxylic acid (40o) (610 mg, 
2.10 mmol, 71% yield), as a colourless solid. 
M.p. (hexane/ethyl acetate; colourless needles): 167 – 168 °C; 1H NMR (500 MHz, CDCl3)  
8.01 (1 H, dd, J = 7.8, 1.2 Hz, H3), 7.53 (1 H, ddd, J = 7.6, 7.6, 1.2 Hz, H5), 7.50 (1 H, d, J 
= 2.7 Hz, H3’), 7.42 (1 H, ddd, J = 7.6, 7.6, 1.3 Hz, H4), 7.17 (1 H, dd, J = 7.6, 1.3 Hz, H6), 
7.12 (1 H, d, J = 8.4 Hz, H6’), 7.07 (1 H, dd, J = 8.4, 2.7 Hz, H5’), 3.90 (3 H, s, OCH3), 3.63 
(3 H, s, COOCH3); 13C NMR (126 MHz, CDCl3) δ 170.5 (COOH), 167.8 (C), 158.6 (C), 143.0 
(C), 135.0 (C), 131.9 (ArCH), 131.5 (ArCH), 130.7 (ArCH), 130.3 (C), 130.3 (ArCH), 129.2 
(C), 127.2 (ArCH), 117.7 (ArCH), 114.6 (ArCH), 55.5 (CH3), 52.1 (CH3); IR (νmax, thin film 
(CDCl3), cm-1) 3434 (br), 3055, 2987, 2953, 2839, 1726, 1698, 1608, 1574, 1509, 1436, 1320, 
1289, 1265, 1227, 1080, 1050; HRMS (ESI) Calcd. for C16H14NaO5 [M+Na]+ 309.0737; 
Found 309.0733.  
 
4'-Chloro-2'-(methoxycarbonyl)-[1,1'-biphenyl]-2-carboxylic acid 
(40q) 
Prepared following the general procedure C with 1-methylcyclohexene using methyl 
4-chloro-2'-formyl-[1,1'-biphenyl]-2-carboxylate (48d) (1.00 g, 3.60 mmol, 1.00 eq.). This 
mixture was purified by column chromatography (gradient of 0 − 100% ethyl acetate in 
hexane). Isolated the desired product, 4'-chloro-2'-(methoxycarbonyl)-[1,1'-biphenyl]-2-
carboxylic acid (40q) (1.06 g, 3.60 mmol, 99% yield, purity >95%), as a colourless solid. 
M.p. (hexane/ethyl acetate; colourless needles): 174 – 175 °C; 1H NMR (500 MHz, CDCl3)  
8.07 (1 H, dd, J = 7.6, 1.4 Hz, H3), 7.99 (1 H, d, J = 2.3 Hz, H3’), 7.57 (1 H, ddd, J = 7.6, 
7.6, 1.4 Hz, H5), 7.51 (1 H, dd, J = 8.2, 2.3 Hz, H5’), 7.47 (1 H, ddd, J = 7.6, 7.6, 1.1 Hz, 
H4), 7.16 (1 H, dd, J = 7.6, 1.1 Hz, H6), 7.17 (1 H, d, J = 8.2 Hz, H6’), 3.65 (3 H, s, 
COOCH3); 13C NMR (126 MHz, CDCl3) 171.2 (COOH), 166.2 (C), 142.6 (C), 141.5 (C), 
133.2 (C), 132.3 (ArCH), 131.6 (ArCH), 131.5 (ArCH), 130.7 (ArCH), 130.7 (C), 130.3 
(ArCH), 129.9 (ArCH), 128.3 (C), 127.6 (ArCH), 52.0 (CH3); IR (νmax, thin film (CH2Cl2), 
cm-1) 3075 (br), 2957, 2872, 2673, 2545, 1728, 1689, 1599, 1573, 1474, 1436, 1415, 1274, 
1191, 1147, 1083, 1047, 1004; HRMS (ESI) Calcd. for C15H1135ClNaO4 [M+Na]+ 313.0238; 
Found 313.0240.  
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5'-Chloro-2'-(methoxycarbonyl)-[1,1'-biphenyl]-2-carboxylic acid 
(40p) 
Prepared following the general procedure C with 1-methylcyclohexene using methyl 
5-chloro-2'-formyl-[1,1'-biphenyl]-2-carboxylate (48c) (659 mg, 2.40 mmol, 1.00 eq.). This 
mixture was purified by column chromatography (gradient of 0 − 100% ethyl acetate in 
hexane). Isolated the desired product, 5'-chloro-2'-(methoxycarbonyl)-[1,1'-biphenyl]-2-
carboxylic acid (40p) (697 mg, 2.40 mmol, 99% yield, purity >95%), as a colourless solid. 
M.p. (hexane/ethyl acetate; colourless needles): 143 – 144 °C; 1H NMR (500 MHz, CDCl3)  
8.08 (1 H, dd, J = 7.9, 1.3 Hz, H3), 7.95 (1 H, d, J = 8.5 Hz, H3’), 7.58 (1 H, ddd, J = 7.6, 
7.6, 1.3 Hz, H5), 7.47 (1 H, ddd, J = 7.9, 7.6, 1.2 Hz, H4), 7.41 (1 H, dd, J = 8.5, 2.2 Hz, 
H4’), 7.21 (1 H, d, J = 2.2 Hz, H6’), 7.18 (1 H, dd, J = 7.6, 1.2 Hz, H6), 3.62 (3 H, s, 
COOCH3); 13C NMR (126 MHz, CDCl3) 170.2 (COOH), 166.6 (C), 144.8 (C), 142.4 (C), 
137.7 (C), 132.3 (ArCH), 131.3 (ArCH), 130.6 (ArCH), 130.2 (ArCH), 130.1 (ArCH), 128.2 
(C), 127.7 (ArCH), 127.7 (C), 127.5 (ArCH), 52.0 (CH3); IR (νmax, thin film (CH2Cl2), cm-1) 
3063 (br), 2966, 2872, 2662, 2542, 1730, 1693, 1592, 1568, 1473, 1439, 1415, 1250, 1192, 
1143, 1086, 1020; HRMS (ESI) Calcd. for C15H1135ClNaO4 [M+Na]+ 313.0238; Found 
313.0237.  
 
2'-(Ethoxycarbonyl)-4-methoxy-[1,1'-biphenyl]-2-carboxylic acid 
(40r) 
Prepared following the general procedure C with hydrogen peroxide using ethyl 2'-
formyl-4'-methoxy-[1,1'-biphenyl]-2-carboxylate (48e) (1.00 g, 3.50 mmol, 1.00 eq.). The 
reaction mixture was purified by column chromatography (gradient of 0 − 100% ethyl acetate 
in hexane). Isolated the desired product, 2'-(ethoxycarbonyl)-4-methoxy-[1,1'-biphenyl]-2-
carboxylic acid (40r) (923 mg, 3.10 mmol, 88% yield), as a cream solid. 
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M.p. (hexane/ethyl acetate; colourless needles): 104 – 105 °C; 1H NMR (500 MHz, CDCl3)  
8.04 (1 H, d, J = 8.8 Hz, H6), 8.00 (1 H, dd, J = 7.6, 1.2 Hz, H3’), 7.52 (1 H, ddd, J = 7.6, 
7.5, 1.2 Hz, H5’), 7.44 (1 H, ddd, J = 7.6, 7.6, 1.3 Hz, H4’), 7.20 (1 H, dd, J = 7.6, 1.1 Hz, 
H6’), 6.93 (1 H, dd, J = 8.8, 2.6 Hz, H5), 6.67 (1 H, d, J = 2.6 Hz, H3), 4.09 (2 H, qq, J = 
7.2, 3.2 Hz, COOCH2CH3), 3.85 (3 H, s, CH3), 1.05 (3 H, t, J = 7.1 Hz, COOCH2CH3); 13C 
NMR (126 MHz, CDCl3)  171.1 (COOH), 167.1 (C), 162.4 (C), 146.7 (C), 142.9 (C), 133.0 
(ArCH), 131.3 (ArCH), 129.9 (ArCH), 129.9 (ArCH), 129.6 (C), 127.2 (ArCH), 120.7 (C), 
115.9 (ArCH), 112.4 (ArCH), 60.6 (CH2CH3) 55.5 (CH3), 13.7 (CH3); IR (νmax, thin film 
(CDCl3), cm-1) 2981, 2650, 2557, 1727, 1682, 1599, 1568, 1474, 1440, 413, 1397 1367, 1334, 
1259, 1186, 1140, 1110, 1080, 1016; HRMS (ESI) Calcd. for C17H16NaO5 [M+Na]+ 323.0890; 
Found 323.0893.  
 
3-(2-(Ethoxycarbonyl)-4-methylphenyl)thiophene-2-carboxylic acid 
(40s) 
Prepared following the general procedure C with hydrogen peroxide using ethyl 2-
(2’-formylthiophen-3’-yl)benzoate (48f) (800 mg, 3.00 mmol, 1.00 eq.). The reaction mixture 
was purified by column chromatography (gradient of 0 − 100% ethyl acetate in hexane). 
Isolated the desired product, 3-(2-(ethoxycarbonyl)-4-methylphenyl)thiophene-2-carboxylic 
acid (40s) (833 mg, 3.00 mmol, 99% yield), as a yellow solid. 
M.p. (hexane/CH2Cl2; colourless needles): 158 °C; 1H NMR (500 MHz, CDCl3)  8.02 (1 H, 
dd, J = 7.8, 1.3 Hz, H3’), 7.56 (1 H, d, J = 5.0 Hz, H5), 7.52 (1 H, ddd, J = 7.5, 7.5, 1.3 Hz, 
H5’), 7.45 (1 H, ddd, J = 7.6, 7.6, 1.2 Hz, H4’), 7.26 (1 H, dd, J = 7.8, 1.2 Hz, H6’), 6.98 (1 
H, d, J = 5.0 Hz, H4), 4.11 (2 H, q, J = 7.0 Hz, COOCH2CH3), 1.09 (3 H, t, J = 7.3 Hz, 
COOCH2CH3); 13C NMR (126 MHz, CDCl3)  167.1 (COOH), 166.9 (C), 149.1 (C), 136.9 
(C), 131.5 (ArCH), 131.3 (ArCH), 131.1 (ArCH), 130.4 (ArCH), 130.4 (ArCH), 130.2 
(ArCH), 127.9 (ArCH), 127.1 (C), 60.8 (OCH2CH3), 13.8 (OCH2CH3); IR (νmax, solid, cm-1) 
3062, 2985, 2855, 2639, 2569, 1707, 1650, 1599, 1571, 1539, 1440, 1421, 1364, 1281, 1252, 
1133, 1102, 1065, 1041; HRMS (ESI) Calcd. for C14H12NaO4S [M+Na]+ 299.0348; Found 
299.0354.  
135 
 
2'-(4-(tert-Butoxycarbonyl)piperazine-1-carbonyl)-4'-methyl-[1,1'-
biphenyl]-2-carboxylic acid (40t) 
Prepared following the general procedure C with hydrogen peroxide using tert-butyl 
4-(2'-formyl-4-methyl-[1,1'-biphenyl]-2-carbonyl)piperazine-1-carboxylate (48h) (816 mg, 
2.00 mmol, 1.00 eq.). The reaction mixture was purified by column chromatography (gradient 
of 0 − 100% ethyl acetate in hexane). Isolated the desired product, 2'-(4-(tert-
butoxycarbonyl)piperazine-1-carbonyl)-4'-methyl-[1,1'-biphenyl]-2-carboxylic acid (40t) 
(848 mg, 2.00 mmol, 99% yield), as a yellow solid.  
M.p. (hexane/ethyl acetate; yellow needles): 118 – 120 °C; 1H NMR (340 K, 501 MHz, 
DMSO-d6)  7.79 (1 H, dd, J = 7.7, 1.4 Hz, H3), 7.51 (1 H, ddd, J = 7.6, 7.6, 1.4 Hz, H5), 
7.44 (1 H, ddd, J = 7.5, 7.5, 1.2 Hz, H4), 7.29 (1 H, dd, J = 7.7, 1.2 Hz, H6), 7.23 (1 H, dd, J 
= 7.8, 1.3 Hz, H5’), 7.16 (1 H, d, 1.3 Hz, H3’), 7.11 (1 H, d, J = 7.8 Hz, H6’), 3.86 (1 H, br. 
s, N(CH2CH2)2N), 3.80 − 3.60 (3 H, br. m, N(CH2CH2)2N), 3.51 (1 H, br. s, N(CH2CH2)2N), 
3.46 − 3.05 (3 H, br. m, N(CH2CH2)2N), 2.37 (3 H, s, CH3), 1.37 (9 H, s, COOC(CH3)3); 13C 
NMR (340 K, 126 MHz, DMSO-d6) δ 168.6 (C), 168.5 (C), 153.7 (C), 139.2 (C), 136.7 (C), 
135.0 (C), 134.9 (C), 132.2 (C), 130.9 (C6), 130.4 (C5), 129.8 (C6’), 129.4 (C3), 129.0 (C5’), 
127.5 (C4), 127.3 (C3’), 79.2 (C(CH3)3), 45.7 (br, CH2), 43.3 (br, CH2), 42.9 (br, CH2), 40.9 
(br, CH2), 28.0 (C(CH3)3), 20.5 (CH3); IR (νmax, solid, cm-1) 3004, 2978, 2921, 2874, 2594, 
1709, 1678, 1592, 1508, 1473, 1417, 1364, 1284, 1248, 1162, 1128, 1077, 1042, 1020; HRMS 
(ESI) Calcd. for C24H29N2O5 [M+H]+ 425.2071; Found 425.2086.  
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2-(2’-(4-(tert-Butoxycarbonyl)piperazine-1-carbonyl)naphthalen-1’-
yl)benzoic acid (40m) 
Prepared following the general procedure C with hydrogen peroxide using tert-butyl 
4-(1-(2’-formylphenyl)-2-naphthoyl)piperazine-1-carboxylate (48g) (400 mg, 0.900 mmol, 
1.00 eq.). The reaction mixture was purified by column chromatography (gradient of 0 − 100% 
ethyl acetate in hexane). Isolated the desired product, 2-(2’-(4-(tert-
butoxycarbonyl)piperazine-1’-carbonyl)naphthalen-1-yl)benzoic acid (40m) (413 mg, 0.900 
mmol, 99% yield), as a yellow solid. 
M.p. (hexane/ethyl acetate; colourless needles): 123 – 124 °C; 1H NMR (500 MHz, CDCl3)  
7.97 (1 H, d, J = 8.4 Hz, ArH), 7.90 (1 H, d, J = 8.2 Hz, ArH), 7.82 (1 H, d, J = 7.3 Hz, ArH), 
7.61 − 7.50 (3 H, m, ArH), 7.43 (1 H, t, J = 7.5 Hz, ArH), 7.35 (1 H, d, J = 8.4 Hz, ArH), 
7.22 (1 H, d, J = 8.5 Hz, ArH), 7.07 (1 H, d, J = 7.2 Hz, ArH), 3.84 − 3.76 (1 H, m, 
N(CH2CH2)2N), 3.71 − 3.57 (2 H, m, N(CH2CH2)2N), 3.55 (2 H, s, N(CH2CH2)2N), 3.48 − 
3.42 (1 H, m, N(CH2CH2)2N), 3.29 − 3.21 (1 H, m, N(CH2CH2)2N), 3.17 − 3.09 (1 H, m, 
N(CH2CH2)2N), 1.47 (9 H, s, NBoc); 1H NMR (340 K, 501 MHz, DMSO-d6)  8.00 (1 H, br. 
s, ArH), 7.96 (2 H, d, J = 8.5 Hz, ArH), 7.63 (1 H, td, J = 7.5, 1.3 Hz, ArH), 7.56 (1 H, td, J 
= 7.7, 1.3 Hz, ArH), 7.52 (1 H, td, J = 7.5, 1.1 Hz, ArH), 7.45 − 7.39 (2 H, m, ArH), 7.33 (1 
H, d, J = 7.1 Hz, ArH), 7.27 (1 H, d, J = 8.5 Hz, ArH), 3.30 (3 H, br. s, N(CH2CH2)2N), 3.14 
(5 H, br. s, N(CH2CH2)2N), 1.40 (9 H, s, COOC(CH3)3); 13C NMR (340 K, 126 MHz, DMSO-
d6)  168.6 (C), 168.0 (C), 167.4 (C), 153.7 (C), 137.2 (C), 132.7 (C), 132.0 (C), 131.2 
(ArCH), 129.8 (ArCH), 128.1 (ArCH), 127.9 (ArCH), 127.5 (ArCH), 126.6 (ArCH), 126.2 
(ArCH), 125.6 (C), 123.4 (C), 79.2 (C(CH3)3), 45.8 (br), 43.3 (br), 40.9 (br), 28.0 (C(CH3)3) 
(21 of 23 expected carbon signals observed); IR (νmax, solid, cm-1) 3058, 2975, 2927, 2862, 
2606, 1718, 1692, 1633, 1584, 1476, 1418, 1393, 1364, 1286, 1246, 1233, 1162, 1126, 1074, 
1053, 1032, 1017; HRMS (ESI) Calcd. for C27H29N2O5 [M+H]+ 461.2071; Found 461.2083.  
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Methyl 2'-(hydroxycarbamoyl)-[1,1'-biphenyl]-2-carboxylate (39a) 
Prepared following the general procedure D using 2'-(methoxycarbonyl)-[1,1'-
biphenyl]-2-carboxylic acid (40a) (1.56 g, 6.00 mmol, 1.00 eq.). Isolated the desired product, 
methyl 2'-(hydroxycarbamoyl)-[1,1'-biphenyl]-2-carboxylate (39a) (1.32 g, 4.80 mmol, 81% 
yield), as a colourless solid. 
M.p. (hexane/ethyl acetate; colourless needles): 129 – 131 °C; 1H NMR (300 MHz, CDCl3) δ 
9.25 (1H, br, NHOH or NHOH), 7.87 (1 H, dd, J = 7.7, 1.4 Hz, H3), 7.70 − 7.67 (1 H, m, 
H3’), 7.51 (1 H, ddd, 7.5, 7.5, 1.4 Hz, H5) 7.48 − 7.41 (3H, m, H4, H4’ and H5’), 7.21 (1 H, 
dd, J = 7.2, 1.5 Hz, H6), 7.08 − 7.05 (1 H, m, H6’) 3.76 (3H, s, OCH3); 13C NMR (75.5 MHz, 
CDCl3) δ 169.4 (C), 166.5 (C), 140.9 (C), 139.4 (C), 131.9 (C5), 131.5 (C), 130.7 (C6), 130.3 
(CH), 130.2 (C), 129.6 (C3), 129.3 (C6’), 128.5 (C3’), 128.1 (CH), 127.9 (CH), 52.7 (CH3); 
IR (νmax, solid, cm-1) 3302, 3061, 2953, 2870, 1702, 1673, 1643, 1594, 1575, 1436, 1313, 
1277, 1138, 771, 754; HRMS (ESI) Calcd. for C15H13NNaO4 [M+Na]+ 294.0737; Found 
294.0741. 
 
Ethyl 2'-(hydroxycarbamoyl)-[1,1'-biphenyl]-2-carboxylate (39b)  
Prepared following the general procedure D using 2'-(ethoxycarbonyl)-[1,1'-
biphenyl]-2-carboxylic acid (40b) (2.16 g, 8.00 mmol, 1.00 eq.). Isolated the desired product, 
ethyl 2'-(hydroxycarbamoyl)-[1,1'-biphenyl]-2-carboxylate (39b) (1.57 g, 6.24 mmol, 78% 
yield), as a colourless solid.  
M.p. (hexane/ethyl acetate; colourless needles): 112 – 114 °C; 1H NMR (500 MHz, CDCl3) δ 
9.26 (1 H, br, NHOH or NHOH), 7.89 (1 H, dd, J = 7.7, 1.5 Hz, H3), 7.75 (1 H, dd, J = 6.8, 
2.0 Hz, H3’), 7.51 (1 H, ddd, J = 7.5, 7.5, 1.5 Hz, H5), 7.48 − 7.41 (3 H, m, H4, H4’ and 
H5’), 7.21 (1 H, dd, J = 7.4, 0.8 Hz, H6), 7.08 (1 H, dd, J = 6.8, 2.0 Hz, H6’), 4.26 − 4.17 (2 
H, m, OCH2Me), 1.14 (3 H, t, J = 7.1 Hz, CH3); 13C NMR (75.5 MHz, CDCl3) δ 168.8 (C), 
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166.7 (C), 140.6 (C), 139.6 (C), 131.7 (C5), 130.7 (C), 130.5 (C6), 130.3 (CH), 130.2 (C), 
129.5 (C3), 129.4 (C6’), 128.5 (C3’), 128.0 (ArCH), 127.8 (ArCH), 61.6 (CH2), 13.8 (CH3); 
IR (νmax, thin film (CH2Cl2), cm-1) 3194 (br), 3062, 2983, 2902, 1702, 1654, 1596, 1574, 1471, 
1368, 1292, 1137, 1091, 1017, 756; HRMS (ESI) Calcd. for C16H15NNaO4 [M+Na]+ 
308.0893; Found 308.0886. 
 
Isopropyl 2'-(hydroxycarbamoyl)-[1,1'-biphenyl]-2-carboxylate (39c)  
Prepared following the general procedure D using 2'-(isopropoxycarbonyl)-[1,1'-
biphenyl]-2-carboxylic acid (40c) (2.27 g, 8.00 mmol, 1.00 eq.). Isolated the desired product, 
isopropyl 2'-(hydroxycarbamoyl)-[1,1'-biphenyl]-2-carboxylate (39c) (1.86 g, 6.22 mmol, 
78% yield), as a colourless solid.  
M.p. (Et2O; colourless needles): 127 – 129 °C; 1H NMR (300 MHz, CDCl3) δ 9.19 (1 H, br, 
NHOH or NHOH), 7.75 (1 H, d, J = 7.5 Hz, H3), 7.67 (1 H, d, J = 7.0 Hz H3’), 7.45 − 7.35 
(4 H, m, ArH), 7.14 (1 H, d, J = 7.5 Hz, H6), 7.00 (1 H, d, J = 7.5 Hz, H6’), 6.94 (1 H, br, 
NH), 4.96 (1 H, sept, J = 6.5 Hz, OCH(Me)2), 1.10 (3 H, d, J = 6.5 Hz, CH3), 1.00 (3 H, d, J 
= 6.5 Hz, CH3); 13C NMR (75.5 MHz, CDCl3) δ 169.1 (C), 166.2 (C), 140.3 (C), 139.5 (C), 
131.5 (C5), 131.4 (C), 131.3 (C6) 130.4 (C), 130.3 (ArCH), 129.4 (C3), 129.4 (C6’), 128.6 
(C3’), 128.1 (ArCH), 127.9 (ArCH), 69.6 (ArCH), 21.7 (CH3), 21.3 (CH3); IR (νmax, thin film 
(CH2Cl2), cm-1) 3302, 3067, 2983, 2930, 1703, 1657, 1597, 1575, 1468, 1376, 1293, 1105, 
1091; HRMS (ESI) Calcd. for C17H17NNaO4 [M+Na]+ 322.1050; Found 322.1050. 
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Butyl 2'-(hydroxycarbamoyl)-[1,1'-biphenyl]-2-carboxylate (39d)  
Prepared following the general procedure D using 2'-(butoxycarbonyl)-[1,1'-
biphenyl]-2-carboxylic acid (40d) (1.45 g, 4.86 mmol, 1.00 eq.). Isolated the desired product, 
butyl 2'-(hydroxycarbamoyl)-[1,1'-biphenyl]-2-carboxylate (39d) (1.00 g, 3.19 mmol, 66% 
yield) as colourless oil. The product was slowly crystallised from toluene to form an off-white 
solid.  
M.p. (toluene; colourless needles): 123 – 125 °C; 1H NMR (500 MHz, CDCl3) δ 9.24 (1H, br, 
NHOH or NHOH), 7.86 (1H, d, J = 7.3 Hz, H3), 7.72 (1H, dd, J = 6.9, 1.4 Hz, H3’), 7.54 − 
7.42 (4H, m, ArH), 7.21 (1H, d, J = 7.1 Hz, H6), 7.08 (1H, dd, J = 6.9, 1.4 Hz, H6’), 4.22 − 
4.10 (2H, m, OCH2CH2-), 1.53 (2H, ap. quin, J = 6.9 Hz -CH2CH2CH2-) 1.30 (2H, ap. sextet, 
J = 7.3 Hz, CH2), 0.90 (3H, t, J = 7.3 Hz, CH3); 13C NMR (75.5 MHz, CDCl3) δ 169.1 (C), 
166.4 (C), 140.6 (C), 139.5 (C), 131.7 (C5), 130.7 (C), 130.6 (C6), 130.3 (C), 129.5 (C3), 
129.1 (C6’), 128.6 (C3’), 128.2 (ArCH), 128.1 (ArCH), 127.9 (ArCH), 65.7 (CH2), 30.4 
(CH2), 19.1 (CH2) 13.7 (CH3); IR (νmax, thin film (CH2Cl2), cm-1) 3379, 2960, 1704, 1658, 
1597, 1574, 1470, 1388, 1291, 1137, 1090, 755; HRMS (ESI) Calcd. for C18H19NNaO4 
[M+Na]+ 336.1206; Found 336.1209. 
 
Benzyl 2'-(hydroxycarbamoyl)-[1,1'-biphenyl]-2-carboxylate (39f)  
Prepared following the general procedure D using 2'-((benzyloxy)carbonyl)-[1,1'-
biphenyl]-2-carboxylic acid (40f) (2.66 g, 8.00 mmol, 1.00 eq.). Isolated the desired product, 
benzyl 2'-(hydroxycarbamoyl)-[1,1'-biphenyl]-2-carboxylate (39f) (1.06 g, 3.05 mmol, 38% 
yield), as colourless oil. The product was slowly crystallised from room temperature toluene 
to form an off-white solid.  
M.p. (toluene; colourless plates): 144 – 145 °C; 1H NMR (300 MHz, CDCl3) δ 8.87 (1H, br, 
NHOH or NHOH), 7.87 (1H, dd, J = 7.5, 1.5 Hz, H3), 7.65 − 7.62 (1H, m, H3’), 7.52 − 7.41 
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(4H, m, ArH), 7.35 − 7.33 (3H, m ArH), 7.24 − 7.17 (3H, m, ArH), 7.08 − 7.06 (1H, m, H6’), 
5.14, (2H, s, OCH2Ph); 13C NMR (75.5 MHz, CDCl3) δ 168.7 (C), 166.4 (C), 140.7 (C), 139.5 
(C), 134.9 (C) 131.8 (C5), 131.4 (C), 130.7 (C6), 130.3 (ArCH), 130.3 (C), 129.7 (C3), 129.4 
(C6’), 128.7 (ArCH), 128.6 (C3’), 128.5 (ArCH), 128.5 (ArCH), 128.1 (ArCH), 127.9 
(ArCH), 67.6 (OCH2Ph); IR (νmax, thin film (CH2Cl2), cm-1) 3599, 3426 (br), 1710, 1666, 
1609, 1496, 1454, 1421, 1387, 1014; HRMS (ESI) Calcd. for C21H18NO4 [M+H]+ 348.1230; 
Found 321.1233. 
 
N2,N2-Diethyl-N2'-hydroxy-[1,1'-biphenyl]-2,2'-dicarboxamide (39g) 
Prepared following the general procedure E using 2'-(diethylcarbamoyl)-[1,1'-
biphenyl]-2-carboxylic acid (40g) (891 mg, 3.00 mmol, 1.00 eq.). On addition of acid a white 
precipitate formed which was filtered to give N2,N2-diethyl-N2'-hydroxy-[1,1'-biphenyl]-2,2'-
dicarboxamide (39g) (869 mg, 2.78 mmol, 93% yield, purity 90%) as a colourless solid.  
Also prepared following the general procedure D using 2'-(diethylcarbamoyl)-[1,1'-
biphenyl]-2-carboxylic acid (40g) (891 mg, 3.00 mmol, 1.00 eq.). On addition of acid a white 
precipitate formed which was filtered to give N2,N2-diethyl-N2'-hydroxy-[1,1'-biphenyl]-2,2'-
dicarboxamide (39g) (711 mg, 2.30 mmol, 76% yield) as a colourless solid.  
M.p. (EtOH; colourless cubes): 156 – 157 °C; 1H NMR (500 MHz, CDCl3) δ 12.02 (1 H, br, 
NHOH or NHOH), 7.72 (1 H, d, J = 7.3 Hz, H3’), 7.46 − 7.36 (4 H, m, ArH), 7.31 − 7.29 (1 
H, m, H3), 7.23 − 7.22 (1 H, m, H6), 7.02 (1 H, d, J = 7.3 Hz, H6’), 6.92 (1 H, br, NHOH or 
NHOH), 3.67 − 3.56 (1 H, m, NCH2Me), 3.56 − 3.46 (1 H, m, NCH2Me), 3.34 − 3.24 (1 H, 
m, NCH2Me), 3.17 − 3.06 (1 H, m, NCH2Me), 1.23 (3 H, t, J = 7.1 Hz, CH3), 0.87 (3 H, t, J 
= 7.1 Hz, CH3); 13C NMR (75.5 MHz, CDCl3) δ 170.7 (C), 165.4 (C), 138.3 (C), 137.6 (C), 
133.4 (C), 130.4 (C), 129.7 (ArCH), 129.4 (ArCH), 129.2 (ArCH), 129.1 (ArCH), 128.3 
(ArCH), 128.2 (ArCH), 127.9 (ArCH), 124.7 (ArCH), 43.1 (N(CH2CH3)2), 38.7 
(N(CH2CH3)2), 14.0 (N(CH2CH3)2), 11.8 (N(CH2CH3)2); IR (νmax, thin film (CH2Cl2), cm-1) 
3433, 3054, 2987, 1723, 1634, 1606, 1592, 1506, 1438, 1422, 1157, 1007; HRMS (ESI) Calcd. 
for C18H20N2NaO3 [M+Na]+ 335.1366; Found 335.1360. 
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N-Hydroxy-2'-(pyrrolidine-1-carbonyl)-[1,1'-biphenyl]-2-
carboxamide (39h)  
Prepared following the general procedure E using 2'-(pyrrolidine-1-carbonyl)-[1,1'-
biphenyl]-2-carboxylic acid (40h) (2.36 g, 8.00 mmol, 1.00 eq.). Isolated the desired product, 
N-hydroxy-2'-(pyrrolidine-1-carbonyl)-[1,1'-biphenyl]-2-carboxamide (39h) (1.49 g, 4.80 
mmol, 60% yield), as a colourless solid. 
M.p. (hexane/ethyl acetate; colourless needles): 204 – 205 °C; 1H NMR (500 MHz, CDCl3) δ 
12.00 (1 H, br, NHOH or NHOH), 7.71 (1 H, dd, J = 7.8, 0.9 Hz, H3), 7.46 − 7.35 (5 H, m, 
ArH), 7.20 (1 H, dd, J = 6.9, 1.8 Hz, H6’), 7.03 (1 H, br, NHOH or NHOH), 6.97 (1 H, dd, J 
= 7.3, 0.9 Hz, H6), 3.61 − 3.28 (4 H, m, NCH2), 2.04 − 1.81 (4 H, m, NCH2CH2); 13C NMR 
(75.5 MHz, CDCl3) δ 170.7 (C), 170.5 (C), 138.6 (C), 137.3 (C), 135.5 (C), 134.3 (C), 130.5 
(ArCH CH), 130.0 (ArCH), 129.8 (ArCH), 128.6 (ArCH), 128.3 (ArCH), 128.2 (ArCH), 
128.1 (ArCH), 125.6 (ArCH), 49.4 (CH2), 45.9 (CH2), 26.0 (CH2), 24.3 (CH2); IR (νmax, thin 
film (CH2Cl2), cm-1) 3432, 3055, 2986, 1725, 1643, 1604, 1582, 1567, 1455, 1438, 1382, 
1265; HRMS (ESI) Calcd. for C18H19N2O3 [M+H]+ 310.1351; Found 310.1298. 
 
N-Hydroxy-2'-(piperidine-1-carbonyl)-[1,1'-biphenyl]-2-carboxamide 
(39i)  
Prepared following the general procedure E using 2'-(piperidine-1-carbonyl)-[1,1'-biphenyl]-
2-carboxylic acid (40i) (2.47 g, 8.00 mmol, 1.00 eq.). Isolated the desired product, N-hydroxy-
2'-(piperidine-1-carbonyl)-[1,1'-biphenyl]-2-carboxamide (39i) (2.05 g, 6.33 mmol, 79% 
yield, purity 85%, 15% 40i), as a colourless solid. 
M.p. (hexane/ethyl acetate; colourless needles): 170 – 171 °C; 1H NMR (500 MHz, CDCl3) δ 
12.10 (1 H, br. s, NHOH or NHOH), 7.74 (1 H, dd, J = 7.7, 1.1 Hz, H3), 7.46 (1 H, ddd, J = 
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7.6, 7.6, 1.3 Hz, ArH), 7.42 − 7.39 (3 H, m, ArH), 7.29 − 7.27 (1 H, dd, J = 6.2, 2.1 Hz, H3’), 
7.21 (1 H, dd, J = 6.9, 2.0 Hz, H6’), 7.02 (1 H, d, J = 7.4 Hz, H6), 6.93 (1 H, br, NHOH or 
NHOH), 3.56 − 3.47 (4 H, m, N(CH2CH2)2CH2), 1.68 − 1.46 (6 H, m, N(CH2CH2)2CH2); 13C 
NMR (75.5 MHz, CDCl3) δ 170.5 (C), 165.1 (C), 139.1 (C), 138.6 (C), 134.3 (C), 133.2 (C) 
130.0 (ArCH), 129.5 (ArCH), 129.2 (ArCH), 129.1 (ArCH), 128.6 (ArCH), 128.3 (ArCH), 
127.8 (ArCH), 125.5 (ArCH), 48.5 (CH2), 42.7 (CH2), 26.5 (CH2), 25.5 (CH2), 24.3 (CH2); 
IR (νmax, thin film (CH2Cl2), cm-1) 3428, 3055, 2946, 1653, 1606, 1446, 1286, 1005; HRMS 
(ESI) Calcd. for C19H20N2NaO3 [M+Na]+ 347.1366; Found 347.1363. 
 
N-Hydroxy-2'-(morpholine-4-carbonyl)-[1,1'-biphenyl]-2-
carboxamide (39j)  
Prepared following the general procedure E using 2'-(morpholine-4-carbonyl)-[1,1'-biphenyl]-
2-carboxylic acid (40j) (2.47 g, 8.00 mmol, 1.00 eq.). Isolated the desired product, N-hydroxy-
2'-(morpholine-4-carbonyl)-[1,1'-biphenyl]-2-carboxamide (39j) (1.49 g, 4.17 mmol, 52% 
yield), as a colourless solid. 
M.p. (hexane/ethyl acetate; colourless needles): 186 – 188 °C; 1H NMR (500 MHz, CDCl3) δ 
11.72 (1 H, br, NHOH or NHOH), 7.74 (1 H, d, J = 7.8 Hz, H3), 7.45 (1 H, dd, J = 7.3, 7.3 
Hz, ArH), 7.44 − 7.42 (3 H, m, ArH), 7.30 − 7.27 (1 H, m, H3’), 7.24 − 7.21 (1 H, m, H6’), 
6.99 (1 H, d, J = 6.9 Hz, H6), 3.77 − 3.46 (8 H, m, N(CH2CH2)2O); 13C NMR (75.5 MHz, 
CDCl3) δ 170.5 (C), 164.7 (C), 138.9 (C), 136.6 (C), 133.3 (C), 133.2 (C) 130.2 (ArCH), 129.7 
(ArCH), 129.2 (ArCH), 129.1 (ArCH), 128.5 (ArCH), 128.4 (ArCH), 128.0 (ArCH), 125.6 
(ArCH), 66.9 (CH2), 66.7 (CH2), 47.8 (CH2), 42.2 (CH2); IR (νmax, thin film (CH2Cl2), cm-1) 
3431, 3055, 2986, 1653, 1611, 1438, 1421, 1301, 1005; HRMS (ESI) Calcd. for 
C18H18N2NaO4 [M+Na]+ 349.1159; Found 349.1163. 
 
143 
 
tert-Butyl-4-(2'-(hydroxycarbamoyl)-[1,1'-biphenyl]-2-
carbonyl)piperazine-1-carboxylate (39l) 
Prepared following the general procedure D using 2'-(4-(tert-butoxycarbonyl)piperazine-1-
carbonyl)-[1,1'-biphenyl]-2-carboxylic acid (40l) (656 mg, 1.60 mmol, 1.00 eq.). Column 
chromatography eluting with ethyl acetate (0 – 100% gradient of ethyl acetate in hexane), 
yielded tert-butyl 4-(2'-(hydroxycarbamoyl)-[1,1'-biphenyl]-2-carbonyl)piperazine-1-
carboxylate (39l) (225 mg, 0.529 mmol, 33% yield, purity 85%, 15% 40l) as a colourless solid. 
M.p. (hexane/ethyl acetate; colourless needles): 112 – 114 °C; 1H NMR (340 K, 501 MHz, 
DMSO-d6)  7.83 (1 H, d, J = 7.8 Hz, H3), 7.58 (1 H, ddd, J = 7.6, 7.6, 1.4 Hz, ArH), 7.49 
(1 H, ddd, J = 7.6, 7.6, 1.1 Hz, ArH), 7.47 − 7.40 (2 H, m, ArH), 7.40 − 7.33 (2 H, m, ArH), 
7.20 (1 H, dd, J = 5.6, 3.2 Hz, ArH), 3.33 (2 H, br. s, N(CH2CH2)2N), 3.22 – 2.58 (6 H, br. 
m, N(CH2CH2)2N), 1.36 (9 H, s, BocH) (missing NHOH); 13C NMR (340 K, 126 MHz, 
DMSO-d6) 168.7 (C(O)NHOH), 167.8 (C), 153.2 (C), 131.4 (C), 130.5 (ArCH), 130.1 (C), 
129.3 (ArCH), 129.2 (ArCH), 129.1 (C), 128.0 (ArCH), 127.4 (ArCH), 127.0 (ArCH), 126.5 
(ArCH), 79.2 (C(CH3)3), 36.8 (br, CH2), 36.3 (br, CH2), 35.8 (br, CH2), 35.1 (br, CH2), 27.6 
(OC(CH3)3) (missing 2 C=O); IR (νmax, thin film (CH2Cl2), cm-1) 3060, 3006, 2979, 2929, 
2857, 1717, 1680, 1620, 1460, 1404, 1362, 1290, 1260, 1248, 1230, 1158, 1122, 1109, 1010, 
1002; HRMS (ESI) Calcd. for C23H28N3O5 [M+H]+ 426.2023; Found 426.2036. 
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Methyl-2'-(hydroxycarbamoyl)-4-methyl-[1,1'-biphenyl]-2-
carboxylate (39n) 
Prepared following the general procedure D using 2'-(methoxycarbonyl)-4'-methyl-
[1,1'-biphenyl]-2-carboxylic acid (40n) (969 mg, 3.50 mmol, 1.00 eq.). Isolated the desired 
product, methyl 2'-(hydroxycarbamoyl)-4-methyl-[1,1'-biphenyl]-2-carboxylate (39n) (496 
mg, 1.74 mmol, 50% yield), as a colourless oil. 
1H NMR (501 MHz, CDCl3)  9.21 (1 H, br. s, NHOH or NHOH), 7.71 (1 H, dd, J = 6.3, 2.7 
Hz, H3’), 7.68 (1 H, d, J = 1.2 Hz, H3), 7.48 − 7.41 (2 H, m, H4’ and H5’), 7.33 (1 H, dd, J 
= 7.7, 1.2 Hz, H5), 7.12 (1 H, d, J = 7.7 Hz, H6), 7.06 (1 H, dd, J = 6.0, 2.7 Hz, H6’), 3.75 
(3 H, s, COOCH3), 2.44 (3 H, s, ArCH3); 13C NMR (127 MHz, CDCl3 169.5 (C(O)NHOH), 
166.6 (COOMe), 139.5 (C), 138.1 (C), 136.0 (C), 132.6 (ArCH), 131.6 (C), 130.6 (ArCH), 
130.3 (ArCH), 130.1 (ArCH), 130.0 (C), 129.5 (ArCH), 128.5 (ArCH), 127.8 (ArCH), 52.6 
(COOCH3), 21.0 (ArCH3); IR (νmax, thin film (CH2Cl2), cm-1) 3434, 3269, 3055, 2987, 2954, 
2759, 1708, 1660, 1473, 1437, 1422, 1306, 1265, 1210, 1109, 1092, 896; HRMS (ESI) Calcd. 
for C16H15NNaO4 [M+Na]+ 308.0893; Found 308.0896.  
 
Methyl-2'-(hydroxycarbamoyl)-4-methoxy-[1,1'-biphenyl]-2-
carboxylate (39o) 
Prepared following the general procedure D using 4'-methoxy-2'-(methoxycarbonyl)-
[1,1'-biphenyl]-2-carboxylic acid (40o) (715 mg, 2.50 mmol, 1.00 eq.). Isolated the desired 
product, methyl 2'-(hydroxycarbamoyl)-4-methoxy-[1,1'-biphenyl]-2-carboxylate (39o) (518 
mg, 1.72 mmol, 69% yield), as a colourless oil. 
1H NMR (501 MHz, CDCl3)  9.43 − 8.52 (1 H, br. s, NHOH or NHOH), 7.65 (1 H, dd, J = 
5.7, 3.2 Hz, H3’), 7.44 − 7.40 (2 H, m, H4’ and H5’), 7.37 (1 H, d, J = 2.7 Hz, H3), 7.13 (1 
H, d, J = 8.4 Hz, H6), 7.05 (1 H, dd, J = 5.4, 3.5 Hz, H6’), 7.03 (1 H, dd, J = 8.4, 2.7 Hz, 
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H5), 3.86 (3 H, s, ArOCH3), 3.73 (3 H, s, COOCH3) (missing NHOH or NHOH);13C NMR 
(126 MHz, CDCl3) δ 169.0 (C(O)NHOH), 167.0 (COOMe), 159.0 (C), 139.3 (C), 133.0 (C), 
132.0 (C), 131.9 (C6), 131.2 (C), 131.1 (C4’ or C5’), 129.8 (C6’), 128.5 (C3’), 127.7 (C4’ or 
C5’), 117.7 (C5), 114.7 (C3), 55.5 (ArOCH3), 52.6 (COOCH3); IR (νmax, thin film (CDCl3), 
cm-1) 3400, 3153, 2945, 1793, 1711, 1655, 1607, 1466, 1436, 1383, 1321, 1293, 1262, 1228, 
1086, 1041; HRMS (ESI) Calcd. for C16H16NNaO5 [M+Na]+ 324.0842; Found 324.0843.  
 
Methyl 4-chloro-2'-(hydroxycarbamoyl)-[1,1'-biphenyl]-2-carboxylate 
(39q) 
Prepared following the general procedure D using 4'-chloro-2'-(methoxycarbonyl)-
[1,1'-biphenyl]-2-carboxylic acid (40q) (1.02 g, 3.50 mmol, 1.00 eq.). Isolated the desired 
product, methyl 4-chloro-2'-(hydroxycarbamoyl)-[1,1'-biphenyl]-2-carboxylate (39q) 
(692 mg, 2.26 mmol, 65% yield) as a colourless oil. 
1H NMR (501 MHz, CDCl3) δ 7.85 (1 H, d, J = 2.2 Hz, H3), 7.67 (1 H, dd, J = 6.2, 2.8 Hz, 
H3’), 7.50 – 7.45 (3 H, m, H5 and H4’ and H5’), 7.18 (1 H, d, J = 8.2 Hz, H6), 7.08 – 7.04 
(1 H, m, H6’), 3.76 (3 H, s, COOCH3) (missing NHOH and NHOH); 13C NMR (126 MHz, 
CDCl3) δ 169.4 (C(O)NHOH), 166.4 (COOMe), 139.4 (C), 138.5 (C), 138.1 (C), 134.1 (C), 
132.1 (ArCH), 131.8 (ArCH), 131.6 (C), 131.5 (C), 130.5 (ArCH), 129.6 (ArCH), 129.4 
(ArCH), 128.4 (ArCH), 128.2 (ArCH), 52.87 (COOCH3); IR (νmax, thin film (CDCl3), cm-1) 
3233, 3057, 2953, 1715, 1659, 1592, 1470, 1436, 1396, 1290, 1264, 1147, 1108, 1086, 1005; 
HRMS (ESI) Calcd. for C15H1235ClNNaO3 [M+Na]+ 328.0347; Found 328.0353. 
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Methyl 5-chloro-2'-(hydroxycarbamoyl)-[1,1'-biphenyl]-2-carboxylate 
(39p) 
Prepared following the general procedure D using 5'-chloro-2'-(methoxycarbonyl)-
[1,1'-biphenyl]-2-carboxylic acid (40p) (720 mg, 2.20 mmol, 1.00 eq.). Isolated the desired 
product, methyl 5-chloro-2'-(hydroxycarbamoyl)-[1,1'-biphenyl]-2-carboxylate (39p) 
(401 mg, 1.31 mmol, 59% yield), as a colourless oil. 
1H NMR (501 MHz, CDCl3) δ 9.20 (1 H, s, NHOH or NHOH), 7.82 (1 H, d, J = 8.4 Hz, H3), 
7.65 (1 H, dd, J = 5.8, 3.2 Hz, H3’), 7.50 – 7.44 (2 H, m, H4’ and H5’), 7.42 (1 H, dd, J = 
8.4, 2.1 Hz, H4) 7.24 (1 H, d, J = 1.9 Hz, H6), 7.09 – 7.03 (1 H, m, H6’), 3.74 (3 H, s, 
COOCH3); 13C NMR (126 MHz, CDCl3) δ 168.3 (C(O)NHOH), 166.5 (COOMe), 142.9 (C), 
138.4 (C), 138.1 (C), 131.5 (C), 131.1 (ArCH), 130.9 (ArCH), 130.5 (ArCH), 129.2 (ArCH), 
128.5 (C), 128.4 (ArCH), 128.3 (2 × ArCH), 52.7 (COOCH3); IR (νmax, thin film (CDCl3), 
cm-1) 3400, 2917, 1709, 1655, 1590, 1560, 1468, 1436, 1388, 1298, 1105, 1020; HRMS (ESI) 
Calcd. for C15H1235ClNNaO3 [M+Na]+ 328.0347; Found 328.0351.  
 
Ethyl-2'-(hydroxycarbamoyl)-4'-methoxy-[1,1'-biphenyl]-2-
carboxylate (39r) 
Prepared following the general procedure D using 2'-(ethoxycarbonyl)-4-methoxy-
[1,1'-biphenyl]-2-carboxylic acid (40r) (511 mg, 1.80 mmol, 1.00 eq.). Isolated the desired 
product, ethyl 2'-(hydroxycarbamoyl)-4'-methoxy-[1,1'-biphenyl]-2-carboxylate (39r) 
(164 mg, 0.55 mmol, 30% yield), as a colourless solid. 
M.p. (hexane/CH2Cl2; colourless needles): 63 – 65 °C; 1H NMR (501 MHz, CDCl3) δ 8.46 (2 
H, br. s, NHOH), 7.82 (1 H, dd, J = 7.4, 1.5 Hz, H3), 7.55 (1 H, d, J = 8.6 Hz, H6’), 7.42 (1 
H, ddd, J = 7.5, 7.5, 1.3 Hz, H4 or H5), 7.37 (1 H, ddd, J = 7.5, 7.5, 1.3 Hz, H4 or H5), 7.16 
(1 H, dd, J = 7.4, 1.0 Hz, H6), 6.89 (1 H, dd, J = 8.6, 2.6 Hz, H5’), 6.56 (1 H, d, J = 2.6 Hz, 
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H3’), 4.13 (2 H, m, OCH2CH3), 3.75 (3 H, s, CH3O), 1.09 (3 H, t, J = 7.1 Hz, OCH2CH3); 13C 
NMR (126 MHz, CDCl3) δ 168.5 (C(O)NHOH), 166.9 (COOEt), 160.6 (C), 141.7 (C), 140.8 
(C), 131.6 (C), 130.6 (C4 or C5), 130.4 (C6), 130.3 (C6’), 129.6 (C3), 127.9 (C4 or C5), 
124.5 (C), 115.0 (C3’), 113.0 (C5’), 61.5 (COOCH2CH3), 55.4 (OCH3), 13.8 (COOCH2CH3); 
IR (νmax, thin film (CDCl3), cm-1) 3176, 2980, 2938, 2905, 2839, 1702, 1651, 1600, 1568, 
1474, 1441, 1389, 1367, 1324, 1292, 1260, 1212, 1094, 1017; HRMS (ESI) Calcd. for 
C17H18NO5 [M+H]+ 316.1179; Found 316.1186.  
 
Ethyl 2-(2’-(hydroxycarbamoyl)thiophen-3’-yl)-5-benzoate (39s) 
Prepared following the general procedure D using 3-(2-(ethoxycarbonyl)-4-
methylphenyl)thiophene-2-carboxylic acid (40s) (227 mg, 0.82 mmol, 1.00 eq.). Isolated the 
desired product, ethyl 2-(2-(hydroxycarbamoyl)thiophen-3-yl)-5-benzoate (39s) (155 mg, 
0.533 mmol, 66% yield) as a colourless oil. 
1H NMR (500 MHz, CDCl3) δ 7.97 (1 H, dd, J = 7.7, 1.4 Hz, H3), 7.57 (1 H, ddd, J = 7.5, 
7.5, 1.4 Hz, H5), 7.51 (1 H, ddd, J = 7.6, 7.6, 1.3 Hz, H4), 7.47 (1 H, d, J = 5.0 Hz, H5’), 
7.29 (1 H, dd, J = 7.5, 1.3 Hz, H6), 6.85 (1 H, d, J = 5.0 Hz, H4’), 4.14 (2 H, q, J = 7.1 Hz, 
OCH2CH3), 1.10 (3 H, t, J = 7.1 Hz, OCH2CH3) (missing NHOH); 13C NMR (126 MHz, 
CDCl3) δ 167.3 (C), 161.7 (C), 141.9 (C), 135.7 (C), 132.2 (C5), 131.1 (C), 130.8 (C6), 130.6 
(C4’), 130.5 (C3), 130.5 (C), 128.9 (C5’), 128.7 (C4), 61.5 (OCH2CH3), 13.8 (OCH2CH3); 
IR (νmax, thin film (CH2Cl2), cm-1) 3170, 3106, 2980, 2902, 1704, 1638, 1599, 1573, 1540, 
1475, 1444, 1410, 1367, 1287, 1256, 1206, 1135, 1090; HRMS (ESI) Calcd. for C14H14NO4S 
[M+H]+ 292.0637; Found 292.0637.  
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tert-Butyl 4-(2'-(hydroxycarbamoyl)-4-methyl-[1,1'-biphenyl]-2-
carbonyl)piperazine-1-carboxylate (39t) 
Prepared following the general procedure D using 2'-(4-(tert-
butoxycarbonyl)piperazine-1-carbonyl)-4'-methyl-[1,1'-biphenyl]-2-carboxylic acid (40t) 
(848 mg, 2.00 mmol, 1.00 eq.) and with the addition of DIPEA (520 L, 3.00 mmol, 1.50 eq.) 
to prevent deprotection of the Boc group. Isolated the desired product, tert-butyl 4-(2'-
(hydroxycarbamoyl)-4-methyl-[1,1'-biphenyl]-2-carbonyl)piperazine-1-carboxylate (39t) 
(419 mg, 0.954 mmol, 48% yield) as a colourless foam. 
1H NMR (340 K, 501 MHz, DMSO-d6) δ 10.80 (1 H, br. s, OH), 8.74 (1 H, br. s, NHOH), 
7.48 – 7.37 (3 H, m, ArH), 7.27 – 7.11 (4 H, m, ArH), 3.11 (8 H, s, N(CH2CH2)2N), 2.37 (3 
H, s, ArCH3), 1.38 (9 H, s, NBoc); 1H NMR (501 MHz, CDCl3) δ 11.65 (1 H, s, OH), 7.70 (1 
H, d, J = 6.8 Hz, H3’), 7.43 (1 H, dd, J = 7.4, 7.4 Hz, H4’), 7.39 (1 H, dd, J = 7.5, 7.5 Hz, 
H5’), 7.21 (1 H, d, J = 7.5 Hz, H6), 7.10 (1 H, d, J = 7.8 Hz, H5), 7.06 (1 H, s, H3), 6.96 (1 
H, br. s, H6’), 3.65 (1 H, br. s, N(CH2CH2)2N), 3.61 – 3.42 (5 H, m, N(CH2CH2)2N), 3.35 (1 
H, br. s, N(CH2CH2)2N), 3.23 (1 H, br. s, N(CH2CH2)2N), 2.41 (3 H, s, ArCH3), 1.46 (9 H, s, 
NBoc); 13C NMR (340 K, 126 MHz, DMSO-d6) δ 169.0 (C), 165.7 (C), 153.7 (C), 150.4 (C), 
137.8 (C), 137.0 (C), 135.2 (C), 134.5 (C), 130.2 (C6), 129.4 (C5), 129.3 (C3’), 129.1 (C4’ 
and C5’), 128.2 (C6’), 127.2 (C3), 79.1 (C(CH3)3), 45.9 (CH2), 43.6 (CH2), 42.8 (CH2), 41.0 
(CH2), 28.0 (C(CH3)3), 20.5 (CH3); IR (νmax, solid, cm-1) 3183, 2975, 2926, 2858, 1688, 1654, 
1606, 1476, 1415, 1364, 1364, 1330, 1286, 1245, 1160, 1127, 1093, 1077, 1049, 1016; HRMS 
(ESI) Calcd. for C24H29N3NaO5 [M+Na]+ 462.1999; Found 462.2010.  
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tert-Butyl 4-(1-(2’-(hydroxycarbamoyl)phenyl)-2-
naphthoyl)piperazine-1-carboxylate (39m) 
Prepared following the general procedure D using 2-(2’-(4-(tert-
butoxycarbonyl)piperazine-1’-carbonyl)naphthalen-1-yl)benzoic acid (40m) (276 mg, 0.599 
mmol, 1.00 eq.) with the addition of DIPEA (156 L, 0.900 mmol, 1.50 eq.) to prevent 
deprotection of the Boc group. Isolated the desired product, tert-butyl 4-(1-(2-
(hydroxycarbamoyl)phenyl)-2-naphthoyl)piperazine-1-carboxylate (39m) (229 mg, 0.482 
mmol, 80% yield), as a colourless foam. 
1H NMR (501 MHz, CDCl3) δ 11.84 (1 H, s, OH), 7.91 (1 H, d, J = 8.0 Hz, H3), 7.86 (1 H, 
d, J = 8.1 Hz, H9), 7.78 (1 H, d, J = 7.6 Hz, H3’), 7.55 (1 H, t, J = 7.6 Hz, H4’) 7.53 – 7.44 
(2 H, m, H5’ and H8), 7.38 (1 H, t, J = 8.0 Hz, H7), 7.32 (1 H, dd, J = 8.4, 1.4 Hz, H4), 7.22 
(1 H, d, J = 8.2 Hz, H6), 7.02 (1 H, d, J = 7.4 Hz, H6’), 3.80 – 3.60 (1 H, m, N(CH2CH2)2N), 
3.60 – 3.42 (5 H, m, N(CH2CH2)2N), 3.37 (1 H, br. s, N(CH2CH2)2N), 3.26 (1 H, br. s, 
N(CH2CH2)2N), 1.58 (9 H, s, NBoc); 13C NMR (126 MHz, CDCl3) δ 171.2 (C), 164.7 (C), 
154.4 (C), 136.6 (C), 135.0 (C), 134.7 (C), 133.4 (C), 132.3 (C), 131.0 (C), 130.2 (C4’ and 
C5’), 129.4 (C3’), 129.2 (C6’), 128.9 (C3), 128.0 (C9), 127.7 (C7), 127.4 (C8), 126.5 (C6), 
122.0 (C4), 80.7 (C(CH3)3), 47.1 (CH2), 43.7 (C), 41.7 (CH2), 28.4 (C(CH3)3); IR (νmax, thin 
film (CH2Cl2), cm-1) 3184, 3004, 2973, 2935, 2861, 1690, 1652, 1595, 1458, 1416, 1364, 1283, 
1244, 1211, 1162, 1132, 1115, 1051, 1016. HRMS (ESI) Calcd. for C27H30N3O5 [M+H]+ 
476.2180; Found 476.2197.  
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6-Methoxyphenanthridine (41a) 
Prepared following general procedure F using methyl 2'-(hydroxycarbamoyl)-[1,1'-
biphenyl]-2-carboxylate (39a) (271 mg, 1.00 mmol, 1.00 eq.). Column chromatography (20% 
ethyl acetate in hexane) provided 6-methoxyphenanthridine (41a) (144 mg, 0.689 mmol, 69% 
yield) as a colourless solid. 
M.p. (hexane/ethyl acetate; colourless needles): 55 – 56 °C (Lit.52 54.5 °C); 1H NMR (300 
MHz, CDCl3) δ 8.50 (1 H, d, J = 8.4 Hz, H10), 8.42 (1 H, dd, J = 8.1, 0.8 Hz, H1), 8.37 (1 
H, dd, J = 8.1, 0.6 Hz, H7), 7.92 (1 H, dd, J = 8.2, 0.6 Hz, H4), 7.81 (1 H, ddd, J = 8.1, 7.2, 
1.3 Hz, H9), 7.67 − 7.61 (2 H, m, H3 and H8), 7.50 (1 H, ddd, J = 8.2, 7.1, 1.3 Hz, H2). 4.25 
(3 H, s, OCH3); 13C NMR (75.5 MHz, CDCl3) δ 158.2 (C), 142.3 (C), 133.7 (C), 130.8 
(ArCH), 128.8 (ArCH), 127.8 (ArCH), 127.2 (ArCH), 125.0 (ArCH), 124.4 (ArCH), 122.1 
(ArCH), 121.9 (ArCH), 121.5 (C), 119.1 (C), 53.6 (CH3); IR (νmax, thin film (CH2Cl2), cm-1) 
3080, 2947, 2927, 2854, 1622, 1591, 1532, 1488, 1473, 1436, 1359, 1323, 1227, 1097; HRMS 
(ESI) Calcd. for C14H12NO [M+H]+ 210.0913; Found 210.0912. Data agrees with literature 
values.52  
 
6-Ethoxyphenanthridine (41b) 
Prepared following general procedure F using ethyl 2'-(hydroxycarbamoyl)-[1,1'-
biphenyl]-2-carboxylate (39b) (285 mg, 1.00 mmol, 1.00 eq.). Column chromatography (20% 
ethyl acetate in hexane) provided 6-ethoxyphenanthridine (41b) as a colourless solid (185 mg, 
0.831 mmol, 83% yield). 
M.p. (hexane/ethyl acetate; colourless needles): 56 – 58 °C (Lit.52 55 °C); 1H NMR (500 MHz, 
CDCl3) δ 8.51 (1 H, d, J = 8.2 Hz, H10), 8.43 (1 H, d, J = 8.2 Hz, H1), 8.41 (1 H, d, J = 8.2 
Hz, H7) 7.89 (1 H, d, J = 8.2 Hz, H4), 7.81 (1 H, ddd, J = 8.2, 7.4, 1.2 Hz, H9), 7.65 (1 H, 
ddd, J = 7.4, 7.4 0.7 Hz, H8), 7.63 (1 H, ddd, J = 7.3, 7.3, 1.2 Hz, H2), 7.49 (1 H, ddd, J = 
8.1, 7.3, 1.1 Hz, H3), 4.73 (2 H, quin, J = 7.0 Hz, OCH2CH3), 1.57 (3 H, t, J = 7.0 Hz, 
151 
 
OCH2CH3); 13C NMR (75.5 MHz, CDCl3) δ 158.9 (C), 143.4 (C), 134.8 (C), 130.8 (C9), 128.7 
(C3), 127.8 (C4), 127.2 (C8), 125.1 (C7), 124.3 (C2), 122.4 (C), 122.1 (C1), 121.8 (C10), 
120.2 (C), 62.0 (OCH2), 14.7 (CH3); IR (νmax, thin film (CH2Cl2), cm-1) 3054, 2986, 2918, 
1619, 1591, 1488, 1375, 1318, 1265, 1089, 896; HRMS (ESI) Calcd. for C15H14NO [M+H]+ 
221.1070; Found 224.1078. Data agrees with literature values.52 
 
6-Isopropoxyphenanthridine (41c) 
Prepared following general procedure F using isopropyl 2'-(hydroxycarbamoyl)-[1,1'-
biphenyl]-2-carboxylate (39c) (299 mg, 1.00 mmol, 1.00 eq.). Column chromatography (20% 
ethyl acetate in hexane) provided 6-isopropoxyphenanthridine (41c) (206 mg, 0.869 mmol, 
87% yield) as a colourless solid. 
M.p. (hexane/ethyl acetate; colourless needles): 73 – 74 °C (Lit.52 73 °C); 1H NMR (300 MHz, 
CDCl3) δ 8.52 (1 H, d, J = 8.1 Hz, H10), 8.42 (1 H, d, J = 8.2, H1), 8.40 (1 H, dd, J = 8.1, 
0.7 Hz, H7), 7.87 (1 H, dd, J = 8.1, 1.2 Hz, H4), 7.82 (1 H, ddd, J = 8.3, 7.0, 1.4 Hz, H9), 
7.67 − 7.60 (2 H, m, H3 and H8), 7.49 (1H, ddd, J = 8.1, 7.0, 1.4 Hz, H2), 5.79 (1 H, sept, J 
= 6.2 Hz, OCH(Me)2), 1.52 (6 H, d, J = 6.2 Hz, 2 × CH3); 13C NMR (75.5 MHz, CDCl3)  
158.7 (C), 144.0 (C), 135.2 (C), 130.1 (C9), 128.2 (C3), 127.5 (C4), 126.5 (C8), 124.5 (C7), 
123.5 (C2), 122.7 (C), 121.6 (C1), 121.4 (C10), 121.0 (C), 68.7 (CHMe2), 22.6 (Me); IR (νmax, 
thin film (CH2Cl2), cm-1) 3078, 2981, 2930, 2871, 1618, 1589, 1377, 1314, 1109; HRMS (ESI) 
Calcd. for C16H16NO [M+H]+ 238.1226; Found 238.1218. Data agrees with literature values.52 
 
6-Butoxyphenanthridine (41d) 
Prepared following general procedure F using butyl 2'-(hydroxycarbamoyl)-[1,1'-
biphenyl]-2-carboxylate (39d) (313 mg, 1.00 mmol, 1.00 eq.). Column chromatography (20% 
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ethyl acetate in petrol) provided 6-butoxyphenanthridine (41d) (171 mg, 0.681 mmol, 68% 
yield) as a colourless solid. 
M.p. (hexane/ CH2Cl2; colourless needles): 49 – 50 °C; 1H NMR (500 MHz, CDCl3) δ 8.49 (1 
H, d, J = 8.2 Hz, H10), 8.42 (1 H, dd, J = 8.2, 1.4 Hz, H1), 8.42 (1 H, dd, J = 8.2, 1.4 Hz, 
H7), 7.94 (1 H, dd, J = 8.2, 0.9 Hz, H4), 7.80 (1 H, ddd, J = 8.2, 7.6, 1.4 Hz, H9), 7.68 − 7.64 
(2 H, m, H3 and H8), 7.50 (1 H, ddd, J = 8.2, 7.6, 1.4 Hz, H2), 4.70 (2 H, t, J = 6.6 Hz, 
OCH2CH2-), 1.97 (2 H, ap. quin., J = 6.6 Hz, CH2), 1.66 (2 H, tq, J = 7.6, 7.5 Hz, CH2), 1.10 
(3 H, t, J = 7.6 Hz, CH3); 13C NMR (75.5 MHz, CDCl3) δ 159.0 (C), 143.5 (C), 134.8 (C), 
130.8 (C9), 128.7 (C3), 128.3 (C4), 127.8 (C8), 127.2 (C7), 125.3 (C2), 125.1 (C1), 124.2 
(C10), 122.4 (C), 120.3 (C), 65.9 (OCH2), 31.2 (CH2), 19.6 (CH2), 14.0 (CH3); IR (νmax, thin 
film (CH2Cl2), cm-1) 3052, 2960, 2932, 1620, 1590, 1488, 1465, 1398, 1342, 1320, 1265, 1088, 
739; HRMS (ESI) Calcd. for C17H18NO [M+H]+ 252.1383; Found 252.1380.  
 
6-(Benzyloxy)phenanthridine (41f) 
Prepared following general procedure F on a smaller scale using benzyl 2'-
(hydroxycarbamoyl)-[1,1'-biphenyl]-2-carboxylate (39f) (165 mg, 0.516 mmol, 1.00 eq.). 
Column chromatography (20% ethyl acetate in petrol) provided 6-(benzyloxy)phenanthridine 
(41f) (17 mg, 0.06 mmol, 12% yield) as a colourless oil. 
1H NMR (300 MHz, CDCl3) δ 8.53 (1 H, d, J = 8.2 Hz, H10), 8.43 − 8.49 (2 H, m, H1 and 
H7), 7.95 (1 H, d, J = 8.0 Hz, H4), 7.83 (1 H, ddd, J = 7.7, 7.7, 1.4 Hz, H9), 7.70 − 7.61 (4 
H, m, H3 and H8 and ArH), 7.55 − 7.35 (4 H, m, H2 and ArH), 5.75 (2 H, s, OCH2Ph); 13C 
NMR (75.5 MHz, CDCl3) δ 157.5 (C), 142.2 (C), 136.4 (C), 133.8 (C), 129.9 (CH), 127.7 
(CH), 127.4 (2CH), 127.1 (2CH), 126.8 (2CH), 126.2 (CH), 124.1 (CH), 123.4 (CH), 121.5 
(C), 121.1 (CH), 120.8 (CH), 119.0 (C), 66.7 (OCH2); IR (νmax, thin film (CH2Cl2), cm-1) 3067, 
3034, 2925, 2851, 1620, 1590, 1579, 1488, 1470, 1462, 1391, 1342, 1315, 1224, 1123, 1086, 
728; HRMS (ESI) Calcd. for C20H16NO [M+H]+ 286.1226; Found 286.1234.  
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N,N-Diethylphenanthridin-6-amine (41g) 
Prepared following general procedure F using N2,N2-diethyl-N2'-hydroxy-[1,1'-
biphenyl]-2,2'-dicarboxamide (39g) (312 mg, 1.00 mmol, 1.00 eq.). Column chromatography 
(20% ethyl acetate in petrol) provided the N,N-diethylphenanthridin-6-amine (41g) (65 mg, 
0.26 mmol, 26% yield) as a colourless oil. 
1H NMR (500 MHz, CDCl3) δ 8.56 (1 H, d, J = 8.2 Hz, H10), 8.45 (1 H, d, J = 8.2 Hz, H1), 
8.27 (1 H, d, J = 8.2 Hz, H7), 7.98 (1 H, d, J = 7.8 Hz, H4), 7.77 (1 H, dd, J = 7.8, 7.8 Hz, 
H9), 7.66 (1 H, ddd, J = 8.2, 8.2, 1.4 Hz, H3), 7.63 (1 H, ddd, J = 8.2, 8.2, 1.4 Hz, H8), 7.49 
(1 H, ddd, J = 7.8, 7.8, 0.9 Hz, H2), 3.60 (4 H, q, J = 7.3 Hz, N(CH2CH3)2), 1.32 (6 H, t, J = 
7.3 Hz, N(CH2CH3)2); 13C NMR (75.5 MHz, CDCl3) δ 160.1 (C), 144.4 (C), 135.4 (C), 130.2 
(CH), 129.0 (CH), 128.8 (CH), 127.1 (CH), 126.9 (CH), 124.6 (CH), 123.2 (C), 123.0 (CH), 
122.7 (C), 122.2 (CH), 46.2 (2 × CH2), 13.7 (2 × CH3); IR (νmax, thin film (CH2Cl2), cm-1) 
3071, 2969, 2931, 1611, 1581, 1566, 1461, 1349, 1288, 1230, 1071, 729; HRMS (ESI) Calcd. 
for C17H19N2 [M+H]+ 251.1543; Found 251.1554. Data agrees with literature values.52 
 
6-(Pyrrolidin-1-yl)phenanthridine (41h) 
Prepared following general procedure F using N-hydroxy-2'-(pyrrolidine-1-
carbonyl)-[1,1'-biphenyl]-2-carboxamide (39h) (310 mg, 1.00 mmol, 1.00 eq.). Column 
chromatography (20% ethyl acetate in petrol) provided 6-(pyrrolidin-1-yl)phenanthridine 
(41h) (114 mg, 0.460 mmol, 46% yield) as a colourless solid. 
M.p. (hexane/ CH2Cl2; colourless needles): 92 – 94 °C; 1H NMR (500 MHz, CDCl3) δ 8.53 (1 
H, d, J = 8.2 Hz, H10), 8.36 (1 H, d, J = 7.8 Hz, H1), 8.29 (1 H, d, J = 8.2 Hz, H7), 7.79 (1 
H, d, J = 7.8 Hz, H4), 7.74 (1 H, dd, J = 7.3, 7.3 Hz H9), 7.56 (1 H, dd, J = 7.6, 7.6 Hz, H3), 
7.56 (1 H, dd, J = 7.6, 7.6 Hz, H8), 7.34 (1 H, dd, J = 7.3, 7.3 Hz, H2), 3.50 – 3.40 (4 H, m, 
N(CH2CH2)2), 1.96 – 1.80 (4 H, m, N(CH2CH2)2); 13C NMR (75 MHz, CDCl3) δ 161.3 (C), 
144.1 (C), 135.0 (C), 130.1 (CH), 128.7 (ArCH), 128.5 (ArCH), 126.9 (ArCH), 126.7 
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(ArCH), 124.5 (ArCH), 122.7 (ArCH), 122.6 (C), 122.0 (C), 121.9 (ArCH), 52.6 
(N(CH2CH2)2), 26.3 (N(CH2CH2)2); IR (νmax, thin film (CH2Cl2), cm-1) 3078, 2981, 2930, 
2871, 1618, 1589, 1377, 1314, 1109; HRMS (ESI) Calcd. for C17H17N2 [M+H]+ 249.1386; 
Found 249.1385.  
 
6-(Piperidin-1-yl)phenanthridine (41i) 
Prepared following general procedure F using N-hydroxy-2'-(piperidine-1-carbonyl)-
[1,1'-biphenyl]-2-carboxamide (39i) (324 mg, 1.00 mmol, 1.00 eq.). Column chromatography 
(20% ethyl acetate in petrol) provided 6-(piperidin-1-yl)phenanthridine (41i) (170 mg, 0.649 
mmol, 65% yield) as a colourless solid. 
M.p. (hexane/ethyl acetate; colourless needles): 86 – 87 °C (Lit.52 86 °C); 1H NMR (500 MHz, 
CDCl3) δ 8.54 (1 H, d, J = 8.2 Hz, H10), 8.42 (1 H, d, J = 7.8 Hz, H1), 8.23 (1 H, d, J = 8.2 
Hz, H7), 7.97 (1 H, d, J = 8.2 Hz, H4), 7.75 (1 H, dd, J = 7.8, 7.8 Hz H9), 7.64 (1 H, dd, J = 
6.9, 6.9 Hz, H3), 7.62 (1 H, dd, J = 7.8, 7.8 Hz, H8), 7.48 (1 H, dd, J = 7.6, 7.6 Hz, H2), 3.48 
(4 H, t, J = 6.0 Hz, N(CH2CH2)2CH2), 1.90 (4 H, t, J = 6.0 Hz, N(CH2CH2)2CH2), 1.75 (2 H, 
quin, J = 6.0 Hz, N(CH2CH2)2CH2); 13C NMR (75.5 MHz, CDCl3) δ 161.2 (C), 144.0 (C), 
134.9 (C), 129.9 (ArCH), 128.6 (ArCH), 128.4 (ArCH), 126.8 (ArCH), 126.6 (ArCH), 124.4 
(ArCH), 122.5 (ArCH), 122.4 (C), 121.9 (C), 121.8 (ArCH), 52.5 (2 × CH2), 26.2 (2 × CH2), 
24.9 (CH2); IR (νmax, thin film (CH2Cl2), cm-1) 3054, 2986 2938, 2849, 1611, 1582, 1567 1464, 
1419, 1384, 1370, 1224, 1119, 1011; HRMS (ESI) Calcd. for C18H19N2 [M+H]+ 263.1543; 
Found 263.1549. Data agrees with literature values.52 
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4-(Phenanthridin-6-yl)morpholine (41j) 
Prepared following general procedure F using N-hydroxy-2'-(morpholine-1-
carbonyl)-[1,1'-biphenyl]-2-carboxamide (39j) (326 mg, 1.00 mmol, 1.00 eq.). Column 
chromatography (20% ethyl acetate in petrol) provided 4-(phenanthridin-6-yl)morpholine 
(41j) (156 mg, 0.591 mmol, 59% yield) as a colourless solid. 
M.p. (hexane/ CH2Cl2; colourless needles): 98 – 101 °C; 1H NMR (500 MHz, CDCl3) δ 8.56 
(1 H, d, J = 8.2 Hz, H10), 8.44 (1 H, d, J = 8.2 Hz, H1), 8.22 (1 H, d, J = 8.2 Hz, H7), 7.97 
(1 H, d, J = 8.2 Hz, H4), 7.78 (1 H, dd, J = 7.8, 7.8 Hz, H9), 7.65 (1 H, dd, J = 7.5, 7.5 Hz, 
H3), 7.63 (1 H, dd, J = 7.5, 7.5 Hz, H8), 7.51 (1 H, dd, J = 7.5, 7.5 Hz, H2), 4.02 (4 H, t, J = 
4.6 Hz, N(CH2CH2)2O), 3.53 (4 H, t, J = 4.6 Hz, N(CH2CH2)2O); 13C NMR (75.5 MHz, 
CDCl3) δ 159.9 (C), 143.7 (C), 135.0 (C), 130.2 (ArCH), 128.8 (ArCH), 128.6 (ArCH), 126.7 
(ArCH), 126.4 (ArCH), 124.9 (ArCH), 122.8 (ArCH), 122.7 (C), 121.9 (ArCH), 121.3 (C), 
67.1 (2 × CH2), 51.7 (2 × CH2); IR (νmax, thin film (CH2Cl2), cm-1) 3069, 2962, 2915, 2850, 
1611, 1581, 1455, 1382, 1363, 1222, 1116, 1020, 862; HRMS (ESI) Calcd. for C17H17N2O 
[M+H]+ 265.1335; Found 265.1345.  
 
tert-Butyl 4-(phenanthridin-6-yl)piperazine-1-carboxylate (41l) 
Prepared following general procedure F using tert-butyl 4-(2'-(hydroxycarbamoyl)-
[1,1'-biphenyl]-2-carbonyl)piperazine-1-carboxylate (39l) (106 mg, 0.249 mmol, 1.00 eq.). 
Column chromatography (20% ethyl acetate in petrol) provided tert-butyl 4-(2'-
(hydroxycarbamoyl)-[1,1'-biphenyl]-2-carbonyl)piperazine-1-carboxylate (41l) (46 mg, 0.13 
mmol, 52% yield) as a colourless solid. 
M.p. (hexane/ CH2Cl2; colourless needles): 155 – 158 °C; 1H NMR (500 MHz, CDCl3) δ 8.57 
(1 H, d, J = 8.2 Hz, H10), 8.43 (1 H, d, J = 8.1 Hz, H1), 8.20 (1 H, d, J = 8.2 Hz, H7), 7.94 
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(1 H, br. s, H4), 7.79 (1 H, dd, J = 7.6, 7.6 Hz, H9), 7.66 – 7.60 (2 H, m, H3 and H8), 7.51 (1 
H, ddd, J = 8.1, 4.6, 0.5 Hz, H2), 3.77 – 3.70 (4 H, br. s, N(CH2CH2)2N), 3.47 (4 H, s, 
N(CH2CH2)2N), 1.51 (9H, s, NBoc); 13C NMR (126 MHz, CDCl3) δ 159.9 (C), 155.0 (C), 
143.7 (C), 135.0 (C), 130.3 (C8), 128.8 (C2 or C9), 128.5 (C1), 126.8 (C2 or C9), 126.3 
(C10), 125.0 (C3), 122.8 (C7), 122.6 (C), 121.8 (C), 121.3 (C4), 79.9 (C), 51.1 
(N(CH2CH2)2N), 43.4 (N(CH2CH2)2N), 28.5 (C(CH3)3); IR (νmax, thin film (CDCl3), cm-1) 
3069, 2978, 2917, 2849, 1686, 1610, 1582, 1525, 1459, 1418, 1366, 1279, 1249, 1222, 1166, 
1125, 1017; HRMS (ESI) Calcd. for C22H25N3O2 [M+H]+ 364.2019; Found 364.2029.  
6-Methoxy-3-methylphenanthridine (41n) 
Prepared following general procedure F using methyl 2'-(hydroxycarbamoyl)-4-
methyl-[1,1'-biphenyl]-2-carboxylate (39n) (428 mg, 1.50 mmol, 1.00 eq.). Column 
chromatography (20% ethyl acetate in petrol) provided 6-methoxy-3-methylphenanthridine 
(41n) (207 mg, 0.928 mmol, 62% yield) as a colourless solid. 
M.p. (hexane/ethyl acetate; colourless needles): 82 − 83 °C; 1H NMR (501 MHz, CDCl3) δ 
8.40 (1 H, d, J = 8.4 Hz, H1), 8.39 (1 H, dd, J = 8.1, 1.3 Hz, H10), 8.16 (1 H, d, J = 1.9 Hz, 
H4), 7.91 (1 H, d, J = 8.0 Hz, H7), 7.64 (1 H, dd, J = 8.4, 1.9 Hz, H2), 7.60 (1 H, ddd, J = 
8.3, 7.1, 1.4 Hz, H8), 7.48 (1 H, ddd, J = 8.3, 7.1, 1.4 Hz, H9) 4.25 (3 H, s, COOCH3), 2.57 
(3 H, s, ArCH3); 13C NMR (126 MHz, CDCl3) δ 159.1 (C), 157.8 (C), 137.3 (C), 132.6 (C), 
132.6 (ArCH), 130.0 (C), 128.3 (ArCH), 127.6 (ArCH), 126.2 (C), 124.6 (ArCH), 124.4 
(ArCH), 121.9 (ArCH), 121.8 (ArCH), 53.7 (OCH3), 21.6 (ArCH3); IR (νmax, thin film 
(CH2Cl2), cm-1) 3061, 2956, 2919, 2857, 1587, 1539, 1471, 1445, 1360, 1322, 1230, 1094, 
1035, 1003; HRMS (ESI) Calcd. for C15H14NO [M+H]+ 224.1069; Found 224.1070.  
 
157 
 
3,6-Dimethoxyphenanthridine (41o) 
Prepared following general procedure F using methyl 2'-(hydroxycarbamoyl)-4-
methoxy-[1,1'-biphenyl]-2-carboxylate (39o) (64 mg, 0.21 mmol, 1.00 eq.). Column 
chromatography (20% ethyl acetate in petrol) provided 3,6-dimethoxyphenanthridine (41o) 
(31 mg, 0.13 mmol, 62% yield) as a colourless solid. 
M.p. (Petrol/ CH2Cl2; colourless needles): 83 – 85 °C; 1H NMR (501 MHz, CDCl3) δ 8.38 (1 
H, d, J = 9.0 Hz, H1), 8.33 (1 H, dd, J = 8.1, 1.2 Hz, H10), 7.89 (1 H, dd, J = 8.1, 1.2 Hz, 
H7), 7.69 (1 H, d, J = 2.7 Hz, H4), 7.58 (1 H, ddd, J = 8.2, 7.1, 1.4 Hz, H8), 7.46 (1 H, ddd, 
J = 8.2, 7.1, 1.3 Hz, H9), 7.40 (1 H, dd, J = 9.0, 2.8 Hz, H2), 4.24 (3 H, s, OCH3), 3.97 (3 H, 
s, CH3); 13C NMR (126 MHz, CDCl3) δ 158.9 (C), 158.6 (C), 142.3 (C), 128.9 (C), 127.8 
(ArCH), 127.7 (ArCH), 124.4 (ArCH), 123.6 (ArCH), 122.6 (C), 121.6 (ArCH), 121.4 
(ArCH), 121.3 (C), 104.9 (ArCH), 55.6 (OCH3), 53.6 (OCH3); IR (νmax, thin film (CH2Cl2), 
cm-1) 3060, 2944, 2838, 1624, 1581, 1537, 1488, 1470, 1453, 1433, 1370, 1354, 1318, 1283, 
1233, 1215, 1097; HRMS (ESI) Calcd. for C15H14NO2 [M+H]+ 240.1015; Found 240.1019.  
 
3-Chloro-6-methoxyphenanthridine (41q) 
Prepared following general procedure F using methyl 4-chloro-2'-
(hydroxycarbamoyl)-[1,1'-biphenyl]-2-carboxylate (39q) (612 mg, 2.00 mmol, 1.00 eq.). 
Column chromatography (20% ethyl acetate in petrol) provided 3-chloro-6-
methoxyphenanthridine (41q) (234 mg, 0.963 mmol, 48% yield) as a colourless solid. 
M.p. (hexane/ethyl acetate; colourless needles): 100 – 101 °C; 1H NMR (501 MHz, CDCl3) δ 
8.34 (1 H, d, J = 8.8 Hz, H1), 8.30 (1 H, dd, J = 8.1, 1.1 Hz, H10), 8.28 (1 H, d, J = 2.2 Hz, 
H4), 7.88 (1 H, dd, J = 8.2, 1.2 Hz, H7), 7.69 (1 H, dd, J = 8.8, 2.3 Hz, H2), 7.63 (1 H, ddd, 
J = 8.3, 7.1, 1.4 Hz, H8), 7.47 (1 H, ddd, J = 8.2, 7.1, 1.3 Hz, H9), 4.21 (3 H, s, OCH3); 13C 
NMR (126 MHz, CDCl3) δ 158.1 (C), 143.2 (C), 133.2 (C), 133.1 (C), 131.3 (C2), 129.0 (C8), 
127.9 (C7), 124.7 (C9), 124.5 (C4), 123.6 (C1), 122.0 (C10), 121.8 (C), 121.0 (C), 53.7 
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(OCH3); IR (νmax, thin film (CH2Cl2), cm-1) 3073, 2951, 2851, 1617, 1587, 1530, 1471, 1435, 
1360, 1318, 1226, 1124, 1080; HRMS (ESI) Calcd. for C14H1135ClNO [M+H]+ 244.0524; 
Found 244.0520.  
 
2-Chloro-6-methoxyphenanthridine (41p) 
Prepared following general procedure F using methyl 5-chloro-2'-
(hydroxycarbamoyl)-[1,1'-biphenyl]-2-carboxylate (39p) (367 mg, 1.20 mmol, 1.00 eq.). 
Column chromatography (20% ethyl acetate in petrol) provided 2-chloro-6-
methoxyphenanthridine (41p) (138 mg, 0.568 mmol, 51% yield) as a colourless solid. 
M.p. (hexane/ethyl acetate; colourless needles): 104 – 105 °C; 1H NMR (501 MHz, CDCl3) δ 
8.39 (1 H, d, J = 1.9 Hz, H1), 8.26 (1 H, dd, J = 8.1, 0.8 Hz, H10), 8.23 (1 H, d, J = 8.6 Hz, 
H4), 7.87 (1 H, dd, J = 8.1, 0.8 Hz, H7), 7.63 (1 H, ddd, J = 8.2, 7.2, 1.3 Hz, H8), 7.54 (1 H, 
dd, J = 8.6, 2.0 Hz, H3), 7.46 (1 H, ddd, J = 8.2, 7.2, 1.3 Hz, H9 ), 4.21 (3 H, s, OCH3); 13C 
NMR (126 MHz, CDCl3) δ 158.7 (C), 143.8 (C), 137.3 (C), 136.1 (C), 129.4 (C8), 127.9 (C7), 
127.7 (C3), 126.7 (C4), 124.6 (C9), 122.1 (C10), 121.6 (C1), 121.4 (C), 118.3 (C), 53.7 
(OCH3); IR (νmax, thin film (CH2Cl2), cm-1) 3069, 3002, 2950, 2848, 1614, 1588, 1487, 1472, 
1429, 1356, 1337, 1314, 1231, 1182, 1102, 1022; HRMS (ESI) Calcd. for C14H1135ClNO 
[M+H]+ 244.0524; Found 244.0520. 
 
6-Ethoxy-9-methoxyphenanthridine (41r) 
Prepared following general procedure F using ethyl 2'-(hydroxycarbamoyl)-4'-methoxy-[1,1'-
biphenyl]-2-carboxylate (39r) (95 mg, 0.30 mmol, 1.00 eq.). Column chromatography (20% 
ethyl acetate in petrol) provided 6-ethoxy-9-methoxyphenanthridine (41r) (37 mg, 0.15 mmol, 
49% yield) as a colourless amorphous solid. 
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1H NMR (501 MHz, CDCl3) δ 8.44 (1 H, d, J = 8.3 Hz, H11), 8.38 (1 H, dd, J = 8.1, 1.3 Hz, 
H1 or H4), 7.82 (1 H, d, J = 2.8 Hz, H8), 7.80 – 7.77 (2 H, m, H2 or H3 and H1 or H4 ), 7.63 
(1 H, ddd, J = 8.1, 7.1, 1.1 Hz, H2 or H3), 7.26 (1 H, dd, J = 8.3, 2.8 Hz, H10), 4.67 (2 H, q, 
J = 7.1 Hz, OCH2CH3), 3.98 (3 H, s, OCH3), 1.54 (3 H, t, J = 7.1 Hz, OCH2CH3); 13C NMR 
(126 MHz, CDCl3) δ 168.5 (C), 156.6 (C), 134.4 (C), 130.5 (ArCH), 129.0 (ArCH), 127.2 
(C2 or C3), 125.1 (C1 or C4), 123.7 (C), 123.1 (C), 121.8 (C11), 120.3 (C), 117.8 (C9), 104.1 
(C7), 61.7 (OCH2CH3), 55.7 (OCH3), 14.7 (OCH2CH3); IR (νmax, thin film (CH2Cl2), cm-1) 
3020, 2972, 2925, 2896, 2853, 1621, 1590, 1531, 1499, 1438, 1398, 1371, 1317, 1244, 1217, 
1154, 1118, 1098, 1031; HRMS (ESI) Calcd. for C16H16NO2 [M+H]+ 254.1175; Found 
254.1175.  
 
6-Ethoxythieno[2,3-c]isoquinoline (41s) 
Prepared following general procedure F using ethyl 2-(2-
(hydroxycarbamoyl)thiophen-3-yl)-5-benzoate (39s) (145 mg, 0.498 mmol, 1.00 eq.). Column 
chromatography (30% ethyl acetate in petrol) provided 6-ethoxythieno[2,3-c]isoquinoline 
(41s) (49 mg, 0.21 mmol, 43% yield) as a colourless solid. 
M.p. (hexane/ethyl acetate; colourless needles): 68 – 69 °C; 1H NMR (500 MHz, CDCl3) δ 
8.37 (1 H, d, J = 8.3 Hz, H1 or H4), 8.13 (1 H, d, J = 8.2 Hz, H1 or H4), 7.76 (1 H, ddd, J = 
8.2, 7.1, 1.2 Hz, H2 or H3), 7.69 (1 H, d, J = 5.8 Hz, H9), 7.55 (1 H, ddd, J = 8.2, 7.1, 1.1 
Hz, H2 or H3), 7.31 (1 H, d, J = 5.9 Hz, H8), 4.65 (2 H, q, J = 7.1 Hz, OCH2CH3), 1.54 (3 
H, t, J = 7.1 Hz, OCH2CH3); 13C NMR (126 MHz, CDCl3) δ 158.8 (C), 153.4 (C), 133.7 (C), 
130.8 (C2 or C3), 125.6 (C2 or C3), 125.3 (C1 or C4), 123.1 (C), 122.6 (C1 or C4), 121.0 
(C8), 119.7 (C9), 117.8 (C), 62.5 (OCH2CH3), 14.6 (OCH2CH3); IR (νmax, thin film (CH2Cl2), 
cm-1) 3066, 2978, 2931, 2897, 1620, 1574, 1554, 1473, 1463, 1440, 1374, 1344, 1298, 1265, 
1245, 1160, 1105, 1076, 1030; HRMS (ESI) Calcd. for C13H12NOS [M+H]+ 230.0634; Found 
230.0632.  
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tert-Butyl 4-(3-methylphenanthridin-6-yl)piperazine-1-carboxylate 
(41t) 
Prepared following general procedure F using 2’ tert-butyl 4-(2'-(hydroxycarbamoyl)-
4-methyl-[1,1'-biphenyl]-2-carbonyl)piperazine-1-carboxylate (39t) (416 mg, 0.952 mmol, 
1.00 eq.). Column chromatography (20% ethyl acetate in petrol) provided tert-butyl 4-(3-
methylphenanthridin-6-yl)piperazine-1-carboxylate (41t) (242 mg, 0.642 mmol, 68% yield) 
as an colourless amorphous solid. 
1H NMR (501 MHz, CDCl3) δ 8.46 (1 H, d, J = 8.4 Hz, H1), 8.40 (1 H, dd, J = 8.1, 0.8 Hz, 
H10), 7.97 (1 H, s, H4), 7.91 (1 H, d, J = 8.0 Hz, H7), 7.63 – 7.58 (2 H, m, H2 and H8), 7.48 
(1 H, ddd, J = 8.1, 7.3, 1.1 Hz, H9), 3.77 – 3.71 (4 H, m, N(CH2CH2)2N), 3.48 – 3.42 (4 H, 
m, N(CH2CH2)2N), 2.58 (3 H, s, ArCH3), 1.51 (9 H, s, N-Boc); 13C NMR (126 MHz, CDCl3) 
δ 159.7 (C), 155.0 (C), 143.3 (C), 136.7 (C), 132.8 (C), 131.9 (ArCH), 128.5 (ArCH), 128.3 
(ArCH), 125.7 (ArCH), 124.9 (ArCH), 122.8 (C), 122.7 (ArCH), 121.7 (ArCH), 121.5 (C), 
79.8 (C), 77.2 (ArCH3), 51.3 (N(CH2CH2)2N), 43.7 (N(CH2CH2)2N), 28.4 (C(CH3)3); IR (νmax, 
thin film (CH2Cl2), cm-1) 3059, 2974, 2924, 2852, 1687, 1572, 1521, 1476, 1456, 1420, 1391, 
1263, 1202, 1165, 1054, 1034, 998, 969, 829, 759, 735; HRMS (ESI) Calcd. for C23H28N3O2 
[M+H]+ 378.2176; Found 378.2176.  
 
tert-Butyl 4-(benzo[k]phenanthridin-8-yl)piperazine-1-carboxylate 
(41m) 
Prepared following general procedure F using tert-butyl 4-(1-(2-
(hydroxycarbamoyl)phenyl)-2-naphthoyl)piperazine-1-carboxylate (39m) (90 mg, 0.20 
mmol, 1.00 eq.). Column chromatography (20% ethyl acetate in petrol) provided tert-butyl 4-
161 
 
(benzo[k]phenanthridin-8-yl)piperazine-1-carboxylate (41m) (22 mg, 0.05 mmol, 27% yield) 
as a colourless solid. 
M.p. (hexane/ CH2Cl2 yellow needles): 181 – 184 °C; 1H NMR (501 MHz, CDCl3) δ 9.11 – 
9.05 (1 H, m, ArH), 8.89 (1 H, d, J = 8.3 Hz, ArH), 8.13 (1 H, d, J = 8.8 Hz, ArH), 8.08 – 
8.00 (2 H, m, ArH), 7.90 (1 H, d, J = 8.8 Hz, ArH), 7.74 – 7.70 (2 H, m, ArH), 7.68 (1 H, dd, 
J = 7.6, 7.6 Hz, ArH), 7.53 (1 H, dd, J = 7.5, 7.5 Hz, ArH), 3.78 – 3.69 (4 H, m, 
N(CH2CH2)2N), 3.52 – 3.42 (4 H, m, N(CH2CH2)2N), 1.52 (9 H, s, N-Boc); 13C NMR (126 
MHz, CDCl3) δ 159.7 (C), 155.0 (C), 145.6 (C), 134.7 (C), 134.3 (C), 129.6 (C), 128.8 
(ArCH), 128.4 (ArCH), 128.4 (ArCH), 128.3 (ArCH), 127.6 (ArCH), 127.4 (ArCH), 126.9 
(ArCH), 126.5 (ArCH), 124.7 (ArCH), 123.0 (C), 122.7 (ArCH), 120.1 (C), 79.9 (C), 51.3 
(N(CH2CH2)2N), 43.7 (N(CH2CH2)2N), 28.5 (C(CH3)3); IR (νmax, thin film (CH2Cl2), cm-1) 
3055, 2972, 2924, 2854, 1696, 1569, 1478, 1459, 1422, 1365, 1247, 1170, 1123, 1080, 1025, 
825, 760, 742; HRMS (ESI) Calcd. for C26H28N3O2 [M+H]+ 414.2176; Found 414.2182.  
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 Experimental Procedures from Chapter 4 
2-{[(2S)-2’-(Methoxycarbonyl)pyrrolidin-1-yl]carbonyl}benzoic acid 
(65)  
Prepared following the literature procedure reported by Jarho et al.89 To a stirred 
solution of ʟ-proline methyl ester hydrochloride salt (4.00 g, 24.0 mmol, 1.10 eq.) in CH2Cl2 
(75 mL, 0.32 M) at room temperature was added triethylamine (6.67 mL, 48.0 mmol, 2.20 
eq.). After 10 minutes phthalic anhydride (3.23 g, 22.0 mmol, 1.00 eq.) was added portionwise 
and the reaction mixture left to stir at room temperature for 4 hours. The reaction mixture is 
then washed with 2 M HCl (2 × 50 mL) and the organics dried with brine and Na2SO4 before 
being concentrated under reduced pressure. Recrystallization from ethyl acetate and hexane 
provided 2-{[(2S)-2’-(methoxycarbonyl)pyrrolidin-1-yl]carbonyl}benzoic acid (65) (2.73 g, 
9.85 mmol, 45% yield) as a colourless solid. 
M.p. (hexane/ethyl acetate; colourless needles): 138 – 140 °C; [α]22D – 77.5 (c = 1.39, MeOH); 
1H NMR (501 MHz, CDCl3) δ 10.65 (1 H, br. s, COOH) 8.05 (1 H, dd, J = 7.8, 1.2 Hz, H3 or 
H6), 7.61 (1 H, ddd, J = 7.5, 7.5, 1.2 Hz, H5 or H4), 7.47 (1 H, ddd, J = 7.8, 7.8 1.0 Hz, H4 
or H5), 7.43 (1 H, dd, J = 7.5, 1.0 Hz, H6 or H3), 4.76 (1 H, dd, J = 8.7, 4.9 Hz, H2’), 3.80 
(3 H, s, COOCH3), 3.32 (1 H, ddd, J = 10.2, 7.1, 6.2 Hz, H5’a), 3.23 (1 H, dt, J = 10.2, 6.9 
Hz, H5’b), 2.33 (1 H, ddd, J = 15.9, 12.8, 8.7 Hz, H3’a), 2.09 – 1.85 (3 H, m, H4’ and H3’b); 
13C NMR (126 MHz, CDCl3) δ 172.7 (COOMe), 170.1 (C(O)N), 169.3 (COOH), 138.8 (C2), 
133.2 (C5 or C4), 131.0 (C3 or C6), 129.1 (C4 or C5), 127.2 (C6 or C3), 127.0 (C1), 58.6 
(C2’), 52.4 (COOCH3), 48.9 (C5’), 29.6 (C3’), 24.7 (C4’); IR (νmax, solid, cm-1) 2978, 2883, 
2778, 2606, 2486, 1735, 1712, 1603, 1589, 1493, 1449, 1432, 1344, 1238, 1204, 1174, 1139, 
1077, 1037, 993, 973, 927, 903, 852, 792, 773; HRMS (ESI) Calcd. for C28H30N2NaO10 
[2M+Na]+ 577.1793; Found 577.1797.  
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Methyl (2S)-1-[2-(azidocarbonyl)benzoyl]pyrrolidine-2’-carboxylate 
(70) 
To a stirred solution of 2-{[(2S)-2’-(Methoxycarbonyl)pyrrolidin-1-
yl]carbonyl}benzoic acid (65) (2.50 g, 9.00 mmol, 1.10 eq.) in acetone (23 mL, 0.36 M) and 
triethylamine (1.40 mL, 10.0 mmol, 1.20 eq.) at room temperature was added DPPA (1.77 
mL, 8.20 mmol, 1.00 eq.) After 24 hours the reaction mixture was checked by IR for 
consumption of DPPA (2170 cm-1) and formation of acyl azide (2136 cm-1). When DPPA had 
been consumed the reaction mixture was concentrated under reduced pressure and the residue 
redissolved in ethyl acetate (20 mL), washed with saturated NaHCO3 (aq) (2 × 30 mL) and 
dried with brine and Na2SO4. The combined organics were concentrated under reduced 
pressure before being purified by column chromatography (gradient 0 − 100% ethyl acetate) 
yielding methyl (2S)-1-[2-(azidocarbonyl)benzoyl]pyrrolidine-2-carboxylate (70) (882 mg, 
2.90 mmol, 32% yield) as a colourless oil. 
CAUTION: All azides should be treated as potentially explosive and were routinely prepared 
and handled behind a blast shield using glassware free from transition metal contamination. 
Residual sodium azide and DPPA present in the aqueous phase after workup were quenched 
by stirring with 20% aq. NaNO2 (40% excess) followed by dropwise addition of 20% aq. 
H2SO4. 
1H NMR (501 MHz, CDCl3) δ 7.97 (1 H, dd, J = 7.9, 1.1 Hz, H3 or H6), 7.64 (1 H, ddd, J = 
7.5, 7.5, 1.2 Hz, H5 or H4), 7.47 (1 H, ddd, J = 7.9, 7.9, 4.0 Hz, H4 or H5), 7.44 (1 H, dd, J 
= 7.5, 1.1 Hz, H6 or H3), 4.76 (1 H, dd, J = 8.7, 4.9 Hz, H2’), 3.80 (3 H, s, COOCH3), 3.32 
(1 H, ddd, J = 10.0, 7.3, 6.0 Hz, H5’a), 3.19 (1 H, dt, J = 10.0, 6.8 Hz, H5’b), 2.34 (1 H, ddd, 
J = 15.7, 12.7, 7.5 Hz, H3’a), 2.12 – 1.85 (3 H, m, H4’ and H3’b); 13C NMR (126 MHz, 
CDCl3) δ 172.6 (COOMe), 171.8 (C(O)N), 168.8 (CON3), 139.0 (C2), 134.1 (C5 or C4), 
130.3 (C3 or C6), 129.1 (C4 or C5), 127.7 (C6 or C3), 127.4 (C1), 58.4 (C2’), 52.3 
(COOCH3), 48.7 (C5’), 29.6 (C3’), 24.8 (C4’); IR (νmax, neat, cm-1) 2954, 2880, 2135 (CON3), 
1741, 1693, 1637, 1491, 1446, 1415, 1363, 1238, 1173, 1092, 1036, 987, 924, 863, 779; 
HRMS (ESI) Calcd. for C28H28N8NaO8 [2M+Na]+ 627.1922; Found 627.1919.  
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(11aS)-11-Methoxy-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-
c][1,4]benzodiazepin-5-one (58a) 
Prepared by a modification of procedure of A. McGonagle for the catalytic aza-Wittig 
reaction of phenanthridines.52 A solution of methyl (2S)-1-[2-
(azidocarbonyl)benzoyl]pyrrolidine-2-carboxylate (70) (604 mg, 2.00 mmol, 1.00 eq.) in 
anhydrous toluene (10 mL, 0.20 M) was heated to reflux. The reaction was monitored by IR 
following the disappearance of the azide (2133 cm-1) and the formation of isocyanate (2269 
cm-1). Upon complete consumption of the acyl azide a solution of phospholene oxide (25) (19 
mg, 0.10 mmol, 5 mol%) in anhydrous toluene (14 mL, 0.007 M) was added to the solution 
of isocyanate. The reaction mixture was stirred at reflux under nitrogen and monitored by LC-
MS to follow the disappearance of the isocyanate and associated products. After 48 hours the 
crude reaction mixture was concentrated under reduced pressure. Purification by flash 
chromatography (gradient of 0 − 50% ethyl acetate in hexane) provided (11aS)-11-methoxy-
1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one (58a) (457 mg, 1.99 mmol, 
99% yield) as a colourless solid. 
(11aS)-11-methoxy-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-
one (58a) could also be prepared with 10 mol% of phospholene oxide (25) (38 mg, 0.20 mmol, 
10 mol%) with 24 hours of stirring, yielding the desired product (58a) (397 mg, 173 mmol, 
87% yield) as a colourless solid. 
M.p. (hexane/dichloromethane; colourless cubes): 201 – 203 °C; [α]22D + 663.0 (c = 0.47 g/ml, 
MeOH) (Lit: [α]25D = +537.8, c = 1.41, EtOH); 1H NMR (501 MHz, CDCl3) δ 7.98 (1 H, dd, 
J = 7.9, 1.6 Hz, H3 or H6), 7.45 (1 H, ddd, J = 8.1, 7.7, 1.6 Hz, H5 or H4), 7.20 (1 H, ddd, J 
= 7.9, 7.7, 1.2 Hz, H4 or H5), 7.16 (1 H, dd, J = 8.1, 1.2 Hz, H6), 3.99 (1 H, dd, J = 5.8, 2.3 
Hz, H2’), 3.90 (3 H, s, OCH3), 3.90 – 3.84 (1 H, m, H5’a), 3.57 – 3.48 (1 H, m, H5’b), 2.68 
– 2.57 (1 H, m, H3’a), 2.09 – 1.97 (3 H, m, H4’ and H3’b); 13C NMR (126 MHz, CDCl3) δ 
166.0 (C1’), 162.5 (C7’), 144.3 (C1), 131.7 (C5 or C4), 130.4 (C3 or C6), 127.6 (C7’), 126.6 
(C6 or C3), 124.3 (C4 or C5), 54.7 (OCH3 or C2’), 54.6 (OCH3 or C2’), 47.0 (C5’), 26.7 
(C3’), 24.1 (C4’); IR (νmax, solid, cm-1) 2994, 2951, 2877, 1645, 1631, 1616, 1599, 1458, 1411, 
1320, 762; HRMS (ESI) Calcd. for C13H14N2O2 [M+H]+ 231.1128; Found 231.1129. Data 
agrees with literature values.19 
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Methyl (2S)-1-{2-[(diisopropylcarbamoyl)amino]benzoyl}pyrrolidine-
2-carboxylate (62) 
Conditions A: To a stirred solution of 2-{[(2S)-2’-(methoxycarbonyl)pyrrolidin-1-
yl]carbonyl} benzoic acid (65) (2.77 g, 10.0 mmol, 1.10 eq.) in anhydrous acetone (23 mL, 
0.39 M) and triethylamine (1.50 mL, 11.0 mmol, 1.20 eq.) at room temperature was added 
DPPA (1.94 mL, 9.00 mmol, 1.00 eq.) After 24 hours the reaction mixture was checked by IR 
for consumption of DPPA (2170 cm-1) and formation of acyl azide (2136 cm-1). When DPPA 
had been consumed the reaction mixture was concentrated under reduced pressure and 
redissolved in ethyl acetate (30 mL), washed with saturated NaHCO3(aq) (2 × 30 mL) and 
dried with brine and Na2SO4. The combined organics were concentrated under reduced 
pressure at room temperature. The residue was redissolved in anhydrous toluene (150 mL, 
0.06 M) and heated to reflux (110 °C) for half an hour before being cooled to 60 °C. To the 
stirred solution of isocyanate, diisopropylamine (2.56 mL, 18.0 mmol, 2.00 eq.) was added. 
After a further two hours at 60 °C the isocyanate had been consumed and the reaction mixture 
was partitioned between ethyl acetate (100 mL) and 2 M HCl (2 × 100 mL). The combined 
organics were dried with brine and Na2SO4 and were concentrated under reduced pressure. 
Purification by flash chromatography, (gradient of 0 − 50% ethyl acetate in hexane) provided 
methyl (2S)-1-{2-[(diisopropylcarbamoyl)amino]benzoyl}pyrrolidine-2-carboxylate (62) 
(2.13 g, 5.70 mmol, 63% yield) as a colourless crystalline solid. 
Alternatively, methyl (2S)-1-{2-[(diisopropylcarbamoyl)amino]benzoyl}pyrrolidine-
2-carboxylate (62) could be produced on large scale using continuous flow methodology 
developed by Ley et al.90 Prepared using a Vaportech R4 system as the flow and heating 
system. A solution of 2-{[(2S)-2-(methoxycarbonyl)piperidin-1-yl]carbonyl}benzoic acid 
(65) (12.2 g, 44.0 mmol, 1.1 eq.), triethylamine (11.2 mL, 80.0 mmol, 2.0 eq.) and 
diisopropylamine (17.1 mL, 120 mmol, 3.0 eq.) in anhydrous acetonitrile (200 mL, 0.2 M) 
was prepared and placed in a jar with screw lid, adapted for use with the flow system (channel 
1). This solution was mixed with a solution of DPPA (8.6 mL, 40 mmol, 1.0 eq.) in acetonitrile 
(200 mL, 0.2 M) placed in a jar with screw lid, adapted for use with the flow system (channel 
2) using a T-mixing piece (individual flow rate 0.25 mL min-1 each). The combined streams 
were directed to a 10 mL CFC coil heated to 120 C (retention time of 16 min). Upon 
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completion the crude reaction mixture was collected and tested for consumption of DPPA 
(2170 cm-1) and acyl azide (2136 cm-1) before being concentrated under reduced pressure. The 
reaction mixture was redissolved in ethyl acetate (600 mL) and washed with 2M HCl (2 × 200 
mL) and saturated NaHCO3(aq) (200 mL), dried with brine and Na2SO4 and concentrated 
under reduced pressures. Trituration with diethyl ether gave methyl (2S)-1-{2-
[(diisopropylcarbamoyl)amino]benzoyl}pyrrolidine-2-carboxylate (62) (9.41 g, 25.1 mmol, 
63% yield) as colourless needles. 
M.p. (hexane/ethyl acetate; colourless cubes): 101 – 103 °C; [α]22D – 50.5 (c = 1.33, MeOH); 
1H NMR (501 MHz, CDCl3) δ 8.67 (1 H, s, ArNHC(O)NiPr2), 8.10 (1 H, d, J = 8.3 Hz, H3 or 
H6), 7.35 – 7.26 (2 H, m, H3 or H6 and H4 or H5), 6.89 (1 H, dd, J = 7.4,7.4 Hz, H4 or H5), 
4.56 (1 H, dd, J = 8.5, 4.0 Hz, H2’), 3.84 (2 H, dt, J = 13.4, 6.7 Hz, N(CHC2H6)2), 3.69 (3 H, 
s, COOCH3), 3.68 – 3.54 (2 H, m, H5’), 2.32 – 2.18 (1 H, m, H3’a), 2.02 – 1.90 (2 H, m, 
H3’b and H4’a), 1.87 – 1.76 (1 H, m, H4’b), 1.28 (12 H, d, J = 6.9 Hz, N(CHC2H6)2); 13C 
NMR (126 MHz, CDCl3) δ 172.4 (COOMe), 169.6 (ArC(O)N), 154.3 (NC(O)NiPr2), 139.4 
(C1), 131.1 (C5), 127.4 (C3), 122.4 (C2), 121.8 (C6), 120.4 (C4), 59.1 (C2’), 52.1 (OCH3), 
50.5 (C5’), 46.0 (NCH(CH3)2), 29.3 (C3’), 25.2 (C4’), 21.1 (NCH(CH3)2); IR (νmax, solid, cm-
1) 3308, 2967, 2935, 2878, 1743, 1659, 1580, 1508, 1413, 1301, 1149, 762; HRMS (ESI) 
Calcd. for C20H30N3O4 [M+H]+ 376.2231; Found 376.2240. 
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 Experimental Procedures from Chapter 5 
 
Methyl 2-((triphenylphosphoranylidene)amino) benzoate (84).105 
Methyl 2-((triphenylphosphoranylidene)amino) benzoate (84) was prepared 
following the procedure of Wamhoff et al.105 A mixture of hexachloroethane (2.37 g, 10.0 
mmol, 1.00 eq.) and triphenylphosphine (3.15 g, 12.0 mmol, 1.20 eq.) in CH2Cl2 (30 mL, 0.33 
M) was stirred at room temperature for 5 minutes before triethylamine (2.78 mL, 20.0 mmol, 
2.00 eq.) and methyl anthranilate (1.29 mL, 10.0 mmol, 1.00 eq.) were added. After 20 hours 
the reaction was poured onto distilled water (50 mL) and extracted with CH2Cl2 (3 × 30 mL). 
The combined organic phases were dried (Na2SO4) and concentrated under reduced pressure. 
Trituration with EtOH gave the desired product (84) (3.60 g, 8.76 mmol, 88% yield) as a 
colourless solid. 
M.p. (CH2Cl2/hexane, colourless needles): 163 − 166 °C (lit.104: 164 − 166 °C); 1H NMR (300 
MHz, CDCl3) δ 7.83 (6 H, m, PPh3H), 7.67 (1 H, ddd, J = 7.4, 2.2, 2.2 Hz, ArH), 7.58 − 7.43 
(9H, m, PPh3H), 6.97 (1 H, ddd, J = 7.4, 7.4, 1.6 Hz, ArH), 6.65 (1 H, dd, J = 7.4, 7.4 Hz, 
ArH), 6.54 (1 H, d, J = 7.4 Hz, ArH), 3.91 (3 H, s, CO2CH3); 13C NMR (75.5 MHz, CDCl3) 
δ 169.7 (d, J = 1.3 Hz, C), 151.4 (C), 132.8 (d, J = 9.9 Hz, ArCH), 132.2 (d, J = 9.9 Hz, C), 
131.8 (d, J = 2.8 Hz, ArCH), 131.5 (ArCH), 131.1 (d, J = 1.6 Hz, ArCH) 128.7 (d, J = 12.1 
Hz, ArCH), 125.9 (C), 123.4 (d, J = 10.7 Hz, ArCH), 116.6 (ArCH), 51.1 (OCH3); 31P NMR 
(300 MHz, CDCl3) δ 0.98; IR (νmax, thin film (CH2Cl2), cm-1) 3061, 1692, 1591, 1475, 1356, 
1295, 1249, 1120; Data agrees with literature values.104  
 
Standard protocol for the catalytic aza-enyne metathesis cascade 
reaction. 
 
To a stirred mixture of DMAD (3.00 mmol, 3.00 eq.) and 3-methyl-1-phenyl-2-phospholene 
oxide (25) (20 mg, 0.10 mmol, 10 mol%) in refluxing toluene (0.5 mL, 2 M) was added a 
solution of isocyanato ester (63) (1.00 mmol, 1.0 eq.) in toluene (2 or 4 mL, 0.50 or 0.25 M) 
over a set number of hours (6, 7 or 16 hours). After the slow addition the reaction was left 
until 18 hours had passed. A 1H NMR spectrum of the crude reaction mixture was taken to 
work out the ratio of products. In some cases the reaction was purified using an SCX column 
which was first equilibrated with methanol and then flushed through with diethyl ether to 
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remove the formed urea, methanol to remove DMAD based impurities then finally flushed 
through with 1N ammonia in methanol solution to remove the quinoline product. If further 
purification was required column chromatography and recrystallization from ethyl acetate and 
hexanes was used. 
 
Standard protocol for the stoichiometric aza-enyne metathesis 
cascade reaction. 
 
To a stirred mixture of DMAD (3.00 mmol, 3.00 eq.) in toluene (2.5 mL, 0.40 M) was added 
iminophosphorane (84) (1.00 mmol, 1.00 eq.). The reaction was then heated to reflux. A 1H 
NMR of the crude reaction mixture was taken to work out the ratio of products. The reaction 
was purified using an SCX column which was first equilibrated with methanol and then 
flushed through with diethyl ether to remove the formed urea, methanol to remove DMAD 
based impurities then finally flushed through with 1N ammonia in methanol solution to 
remove the quinoline and the imine product. If further purification was required column 
chromatography (50% ethyl acetate in hexanes) was used. 
 
2,3-Quinolinedicarboxylic acid, 4-methoxy-, 2,3-dimethyl ester 
(79).113  
Prepared following the general procedure for catalytic aza-enyne metathesis using 
slow addition of 2-isocyanato-benzoic acid, methyl ester (63) (177 mg 1.00 mmol, 1.00 eq.) 
in toluene (0.5 mL, 2 M) added over 16 hours to a solution of dimethyl acetylenedicarboxylate 
(368 μL, 3.00 mmol, 3.00 eq.) and phospholene oxide (25) (20 mg, 0.10 mmol, 10 mol%) in 
refluxing toluene (4.0 mL, 0.25 M). Purification using an SCX column (eluting with 1M NH3 
in MeOH) and subsequent column chromatography (50% ethyl acetate in hexane) gave the 
highest isolated yield of the quinoline product, 2,3-quinolinedicarboxylic acid, 4-methoxy-, 
2,3-dimethyl ester, (79) (69 mg, 0.25 mmol, 25% yield). 
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M.p. (hexane/ethyl acetate; colourless needles): 60 − 61 °C (lit.113: 64 °C); 1H NMR (300 
MHz, CDCl3) δ 8.26 − 8.19 (2 H, m, ArH), 7.86 − 7.80 (1 H, m, ArH), 7.71 − 7.66 (1 H, m, 
ArH), 4.17 (3 H, s, OCH3), 4.05 (3 H, s, CO2CH3), 4.02 (3 H, s, CO2CH3); 13C NMR (75.5 
MHz, CDCl3) δ 166.8 (C), 165.4 (C), 162.1 (C), 148.5 (C), 147.0 (C), 131.5 (CH), 130.4 (CH), 
128.7 (CH), 124.0 (C), 122.5 (CH), 117.5 (C), 62.5 (CH3), 53.5 (OCH3), 53.2 (OCH3); IR(νmax, 
solid ,cm-1) 3022, 2988, 2947, 2861, 1723, 1716, 1616, 1580, 1564, 1498, 1360, 1257, 1236, 
1214, 1045, 967, 770; HRMS (ESI) Calcd. for C14H13NNaO5 [M+Na]+ 298.0686; Found 
298.0682. Data agrees with literature values.113  
 
2,3-Quinolinedicarboxylic acid, 4-methoxy-, 2,3-dimethyl ester (79) 
and 2-(2-methoxycarbonylphenylimino)-3-(triphenyl-λ5-
phosphanylidene)-succinic acid dimethyl ester (85) 
 
Prepared following the general procedure for stoichiometric aza-enyne metathesis 
using dimethyl acetylenedicarboxylate (368 μL, 3.00 mmol, 3.00 eq.) and methyl 2-
((triphenylphosphoranylidene)amino)benzoate (84) (411 mg, 1.00 mmol, 1.00 eq.). 
Purification using an SCX column (eluting with 1 M NH3 in MeOH) and subsequent column 
chromatography (50% ethyl acetate in hexane) gave the isolated desired quinoline product 
(79) (65 mg, 0.24 mmol, 24% yield) as a brown solid and the imine 2-(2-
methoxycarbonylphenylimino)-3-(triphenyl-λ5-phosphanylidene)-succinic acid dimethyl 
ester (85) (203 mg, 0.367 mmol, 37% yield) as a brown solid. 
2,3-Quinolinedicarboxylic acid, 4-methoxy-, 2,3-dimethyl ester (79): M.p. (hexane/ethyl 
acetate; colourless needles): 60 − 61 °C (lit.113: 64 °C); 1H NMR (300 MHz, CDCl3) δ 8.26 − 
8.19 (2 H, m, ArH), 7.86 − 7.80 (1 H, m, ArH), 7.71 − 7.66 (1 H, m, ArH), 4.17 (3 H, s, 
OCH3), 4.05 (3 H, s, CO2CH3), 4.02 (3 H, s, CO2CH3); 13C NMR (75.5 MHz, CDCl3) δ 166.8 
(C), 165.4 (C), 162.1 (C), 148.5 (C), 147.0 (C), 131.5 (CH), 130.4 (CH), 128.7 (CH), 124.0 
(C), 122.5 (CH), 117.5 (C), 62.5 (CH3), 53.5 (OCH3), 53.2 (OCH3); IR(νmax, solid ,cm-1) 3022, 
2988, 2947, 2861, 1723, 1716, 1616, 1580, 1564, 1498, 1360, 1257, 1236, 1214, 1045, 967, 
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770; HRMS (ESI) Calcd. for C14H13NNaO5 [M+Na]+ 298.0686; Found 298.0682. Data agrees 
with literature values.113 
2-(2-methoxycarbonylphenylimino)-3-(triphenyl-λ5-phosphanylidene)-succinic acid 
dimethyl ester (85): 1H NMR (300 MHz, CDCl3) δ 7.92 − 7.87 (6 H, m, PPh3H), 7.67 (1 H, 
dd, J = 7.7, 0.8 Hz, ArH), 7.59 − 7.47 (9 H, m, PPh3H), 7.00 (1 H, dd, J = 7.3, 7.3 Hz, ArH), 
6.82 (1 H, dd, J = 7.3, 7.3 Hz, ArH), 5.60 (1 H, d, J = 7.7 Hz, ArH), 3.83 (3 H, s, CO2CH3), 
3.49 (3 H, s, CO2CH3), 3.28 (3 H, s, CO2CH3); 13C NMR (75.5 MHz, CDCl3) δ 168.5 (d, J = 
14.8 Hz, C), 167.0 (C), 166.0 (d, J = 13.2 Hz, C), 159.2 (d, J = 7.1 Hz, C), 151.2 (C), 134.2 
(d, J = 10.0 Hz, ArCH), 132.0 (d, J = 2.9 Hz, ArCH), 131.7 (ArCH), 130.3 (ArCH), 128.5 (d, 
J = 12.6 Hz, ArCH), 126.3 (C), 125.1 (C), 122.3 (C), 121.8 (ArCH), 120.7 (ArCH) 51.7 
(OCH3), 51.2 (OCH3), 49.8 (OCH3); 31P NMR (300 MHz, CDCl3) δ 17.7 (s); IR(νmax, thin film 
(CH2Cl2),cm-1) 3063, 2993, 2949, 1728 , 1651 , 1645 , 1581, 1563, 1484, 1435, 1359, 1298, 
1271,1219,1197, 1172, 1106, 1082; HRMS (ESI) Calcd. for C32H29NO6P [M+H]+ 554.1727; 
Found 554.1717. 
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